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Background:  Low-fat diet (D) and exercise (E) are recommended for reducing 
cardiovascular disease risk.  However, the independent and combined effects of D 
and E on C-reactive protein (CRP) and metabolic syndrome (MS) are unknown.   
Purpose:  The purpose of this dissertation was to examine the changes in CRP and 
MS between control (C), D, E and diet plus exercise (D+E). 
Methods:  Men (n=197) and postmenopausal women (n=180) with elevated low-
density lipoprotein cholesterol and reduced high-density lipoprotein cholesterol, were 
randomized into a one-year trial with four groups: C, D, E or D+E (Stefanick et al., 
1998).  Weight loss was not an intervention focus.  This secondary data analysis 
evaluated stored plasma samples for high-sensitivity CRP.  MS prevalence was 
retrospectively found using the NCEP-ATP III definition.  CRP change (∆CRP) was 
examined between intervention groups using ANCOVA.  Differences between groups 
  
for MS at follow-up were retrospectively investigated using logistic regression.  All 
analyses were stratified by gender and controlled for baseline values, body fat change 
and other appropriate covariates.   
Results:  In women, ∆CRP was different between D+E vs. C (-0.7 ± 0.33 mg/L, p = 
0.04) and D+E vs. E (-0.9 ± 0.32 mg/L, p = 0.004).  Women also had a decrease in 
CRP within D+E (∆ log CRP 0.2 ± 0.035 mg/L; p = 0.0002).  After the intervention, 
∆CRP did not differ for men between or within treatment groups.  MS at follow-up 
was not different between C, D, E or D+E in either men or women.  In women with 
MS, ∆CRP was different between D+E vs. C (-1.3 ± 0.43 mg/L; p = 0.006), D+E vs. 
E (-1.1 ± 0.44 mg/L; p = 0.02), and D vs. C (-1.2 ± 0.43 mg/L; p = 0.009).  In women 
with MS, CRP decreased from baseline within D+E (∆ log CRP 0.2 ± 0.039 mg/L; 
p=0.0008).  At follow-up, there were no differences between or within groups for 
∆CRP in men with MS, or men without MS and women without MS. 
Conclusion:  D and D+E may be effective treatments for reducing CRP in women 
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  Chapter 1 
         Introduction 
Lifestyle interventions such as low-fat diet and exercise can have positive effects 
on cardiometabolic risk factors.  However, it is unclear how the individual and combined 
components of lifestyle interventions influence emerging cardiovascular risk factors such 
as chronic inflammation (C-reactive protein) and clustering of risk factors (metabolic 
syndrome).  Associations exist between cardiovascular disease and elevated levels of C-
reactive protein (CRP) (Ridker, 2003b; Ridker, 2003a; Ridker, Bassuk & Toth, 2003a) 
and metabolic syndrome status (Ford, 2004; Lakka et al., 2002).  Thus, establishing the 
effects of lifestyle interventions on CRP and metabolic syndrome are important to 
manage the development and progression of cardiovascular disease.   
 
   Dissertation Purpose  
The purpose of this dissertation was to systematically analyze an existing data set 
for the independent and combined effects of a low-fat diet and exercise on CRP and 
metabolic syndrome.  The Diet for Elevated Risk Trial (DEER) was conducted in 1992 at 
Stanford University (Stefanick et al., 1998).  This dissertation adds two measures: a new 
laboratory analysis for CRP and a retrospective analysis of metabolic syndrome. 
First, a brief synopsis of background information is provided for CRP and 





    C-Reactive Protein 
 Chronic inflammation, a novel cardiovascular risk factor, is an increase in 
circulating pro-inflammatory cytokines such as C-reactive protein (CRP).  CRP is an 
acute phase reactant which is released from the liver and is considered a downstream 
marker of chronic inflammation.  CRP increases with aging (Rumley et al., 2006), body 
mass index (Ford, 1999) and is higher in women than in men (Ford, Giles, Myers, & 
Mannino, 2003; Ford, Giles, Mokdad, & Myers, 2004b).  It is estimated that 
approximately 25% of adults have elevated levels of CRP (Pearson et al., 2003) which is 
linked to mortality (Harris et al., 1999) and cardiovascular disease (Ridker, 2003b; 
Ridker, 2003a; Ridker, Bassuk, & Toth, 2003a).  
 Comparisons between low-fat diet and diet plus exercise show that the 
combination results in larger changes in CRP than diet alone, although none of these 
studies included a control group for comparison (You et al., 2004; Esposito et al., 2003; 
Esposito et al., 2004).  These randomized trials also induced concurrent weight loss (You 
et al., 2004; Esposito et al., 2003; Esposito et al., 2004).  The release of CRP may be 
controlled by cytokines which can be stored and released from adipose tissue (Petersen et 
al., 2005).  Therefore, the amount of body fat (Visser, Bouter, McQuillan, Wener, & 
Harris, 1999) and the change in body fat (Selvin, Paynter, & Erlinger, 2007) are directly 
related to the circulating levels of CRP.  Thus, comparisons between the independent and 
combined effects of low-fat diet and exercise on CRP are difficult to distinguish from the 
influence of fat loss. 
 Another challenge with the present low-fat diet plus exercise interventions is that 
many only include a single gender, limiting the generalizability results (Dvorakova-
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Lorenzova et al., 2006; Esposito et al., 2003; Roberts et al., 2006; Wegge, Roberts, Ngo, 
& Barnard, 2004; You, Berman, Ryan, & Nicklas, 2004).  Since CRP baseline levels are 
higher in women, it is important to account for these differences (Ford et al., 2003; Ford 
et al., 2004b).  Diet plus exercise interventions which include both genders, have not 
adjusted for the differences in CRP levels within their analyses (Bo et al., 2007; Esposito 
et al., 2004).  Furthermore, it is possible that a higher CRP baseline value may alter the 
magnitude of change from lifestyle intervention. 
 Few randomized controlled trials have examined the independent responses of 
CRP to low-fat diet, exercise and diet plus exercise.  Low-fat dietary interventions have 
shown reductions of CRP levels (Clifton, Keogh, Foster, & Noakes, 2005; Heilbronn, 
Noakes, & Clifton, 2001; O'Brien et al., 2005; Seshadri et al., 2004; Tchernof, Nolan, 
Sites, Ades, & Poehlman, 2002), though other studies do not show significant changes in 
CRP when compared to a control group (Erlinger, Miller, III, Charleston, & Appel, 
2003).  Exercise trials have also shown varying results for CRP, where some studies 
show significant reductions when compared to a control group (Mattusch, Dufaux, Heine, 
Mertens, & Rost, 2000; Milani, Lavie, & Mehra, 2004), while other studies have had no 
effect on CRP levels (Hammett et al., 2004; Huffman et al., 2006).  Combined low-fat 
diet and exercise interventions have significantly reduced CRP levels (Bo et al., 2007; 
Roberts et al., 2006; Wegge et al., 2004), though control groups were not always included 
for comparison (Roberts et al., 2006;Wegge et al., 2004). 
Specific Aim #1:  To determine the effects of a low-fat diet and/or exercise intervention 
on change in CRP in men and women high cardiovascular risk. 
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 Hypothesis 1:  The low-fat diet plus exercise will significantly change CRP levels 
in both men and women when compared to the control group.  Changes in CRP levels in 
the low-fat diet only or exercise only groups will not differ from the control group.  
 
    Metabolic Syndrome 
 Metabolic syndrome is a clustering of abnormal metabolic, lipid and non-lipid 
variables.  The National Cholesterol Education Program (NCEP) has operationally 
defined metabolic syndrome as meeting at least three of the following criteria:  1) 
abdominal obesity, 2) elevated triglycerides, 3) low high density lipoprotein cholesterol 
(HDL), 4) hypertension and 5) high fasting glucose (2001).     
The prevalence of metabolic syndrome has increased over the past ten years:   
23% in 1994 (Ford, Giles, & Dietz, 2002), 27% by 1999 (Ford, Giles, & Mokdad, 
2004a), and 35% in 2002 (Ford, 2005).  Individuals with the presence of metabolic 
syndrome are two to three times more likely to die from cardiovascular disease (Ford, 
2004; Lakka et al., 2002).  Therefore, it is paramount to find effective treatments to 
reverse metabolic syndrome in order to curb the progression of cardiovascular disease. 
 The NCEP recommends reducing intake of saturated fat and cholesterol, 
increasing physical activity and achieving weight loss to reverse metabolic syndrome 
(2001).  While these lifestyle modifications have shown benefits for individual 
cardiovascular risk factors (Grundy et al., 2004b), evidence for improving metabolic 
syndrome prevalence with low-fat diet and/or exercise has not been consistent.  
Few randomized controlled trials have systematically examined the individual and 
combined effects of low-fat diet and exercise on metabolic syndrome.  Diet plus exercise 
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demonstrates more success for reversing metabolic syndrome than diet or exercise alone, 
however these interventions also included concomitant weight loss (Anderssen, et al., 
2007; Okura et al., 2007).  Weight loss can improve many of the individual metabolic and 
lipid components of metabolic syndrome (Yu-Poth et al., 1999), making it difficult to 
identify the successful component(s) of the intervention.  Another challenge within the 
current diet plus exercise research for metabolic syndrome is the absence of a control 
group for comparison, which may limit the interpretation of results (Roberts et al., 2006; 
Muzio et al., 2005; Esposito et al., 2004; Okura et al., 2007). 
Studies which examine the independent effects for low-fat diet or exercise on 
metabolic syndrome prevalence have been limited.  Interventions which included a low-
fat diet have reduced the prevalence of metabolic syndrome, however, dietary protocols 
included multiple dietary alterations besides fat reduction with purposeful weight loss 
(Azadbakht et al., 2005; Marfella et al., 2004).  These additional alterations may also 
influence and alter metabolic syndrome.  Exercise interventions have shown success for 
reversal of metabolic syndrome (Johnson et al., 2007; Katzmarzyk et al., 2003; Milani & 
Lavie, 2003; Shubair et al., 2004), however, other studies did not show significant 
differences in metabolic syndrome prevalence when compared to a control group 
(Anderssen et al., 2007;Stewart et al., 2005).  Combined low-fat diet plus exercise 
interventions which either controlled for weight loss (Esposito et al., 2004) or allowed 
ad-libitum intake (Roberts et al., 2006), found significant reductions in the prevalence of 
metabolic syndrome.  However, none of these combined diet plus exercise studies 
incorporated a randomized controlled design.   
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Specific Aim #2:  To determine the effects of a low-fat diet and/or exercise intervention 
on metabolic syndrome prevalence in men and women at high cardiovascular risk.  
 Hypothesis 2:  The low-fat diet and diet plus exercise groups will lower metabolic 
syndrome prevalence compared to the control group.  The exercise group will not result 
in a difference in metabolic syndrome prevalence compared to the control group.   
 
C-Reactive Protein and Metabolic Syndrome 
The process of atherosclerosis leading to cardiovascular disease has been 
hypothesized to be controlled through inflammation (Bhagat & Vallance, 1997; Libby, 
2002; Ross, 1999).   Individuals with metabolic syndrome also possess elevated levels of 
CRP (Ford, 2003; Pitsavos, Panagiotakos, Chrysohoou, Kavouras, & Stefanadis, 2005; 
Saltevo, Vanhala, Kautiainen, Kumpusalo, & Laakso, 2007).  CRP and metabolic 
syndrome are each independent predictors of cardiovascular events (Rutter, Meigs, 
Sullivan, D'Agostino, Sr., & Wilson, 2004; Sattar et al., 2003) and the combination of 
both adds predictive and prognostic value to cardiovascular disease and type II diabetes 
risk (Ridker, Buring, Cook, & Rifai, 2003b; Sattar et al., 2003).   
Few studies have compared the independent and combined effects of low-fat diet 
and exercise in individuals with metabolic syndrome.   Many lifestyle interventions 
examine the effect of diet and exercise on individuals with hypertension, obesity or 
dyslipidemia, however these results may not be generalizable to individuals with 
metabolic syndrome who have multiple lipid and metabolic disorders.  Thus, determining 
the most effective lifestyle treatment to lower CRP levels in individuals with metabolic 
syndrome without weight loss remains understudied.  Combined diet plus exercise studies 
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show significant reductions in CRP in individuals with metabolic syndrome (Bo et al., 
2007; Esposito et al., 2004; Roberts et al., 2006), even without purposeful weight loss 
(Bo et al., 2007; Roberts et al., 2006).  However, these studies are either in a single 
gender (Roberts et al., 2006) or combine gender in the statistical analyses (Bo et al., 
2007; Esposito et al., 2004).  As previously mentioned,  women have higher levels of 
CRP than their age-matched male counterparts (Ford et al., 2003; Ford et al., 2004b), and 
higher CRP values at baseline can result in larger decreases in CRP with both low-fat diet 
(Seshadri et al., 2004) and exercise (Goldhammer et al., 2005; Lakka et al., 2005). 
Specific Aim #3:  To explore the changes in CRP from low-fat diet and/or exercise in men 
and women with and without metabolic syndrome. 
 Hypothesis 3:  Individuals with metabolic syndrome will show significant 
changes in CRP from baseline from low-fat diet, exercise and diet plus exercise. 
 
Dissertation Organization 
 This dissertation is organized in seven chapters.  In the next chapter, a literature 
review is presented for CRP and metabolic syndrome which focus on low-fat diet and 
exercise interventions.  In Chapter 3, methodology of the original DEER study is 
presented.  Chapter 4 presents the analysis for CRP in response to the independent and 
combined effects of low-fat diet and exercise.  Chapter 5 describes metabolic syndrome 
changes with low-fat diet, exercise and diet plus exercise interventions.  Chapter 6 
explores the changes from low-fat diet and/or exercise for CRP in individuals with and 
without metabolic syndrome.  Chapter 7 summarizes the three studies and gives 




  Literature Review 
 
 
Part I:  C-Reactive Protein 
 
Acute Inflammation and C-Reactive Protein 
 
The immune system’s response to an infection or injury involves a cascade of 
events to provide a natural defense.  During this infection or tissue injury, various 
substances are released from the injured tissues locally and systemically around the body, 
which regulate the amplitude and duration of the immune response (van der Meide & 
Schellekens, 1996).  The systemic reaction is termed the “acute phase response” which 
results in physiological, nutritional, biochemical and behavioral adaptations (Gabay & 
Kushner, 1999).  During the acute phase response, specific circulating inflammatory 
markers, cytokines, increase at a rapid rate to more than 1000 fold (Ballou & Kushner, 
1992; Gabay et al., 1999). 
The first cytokine to be released during the acute phase response from infection is 
tumor necrosis factor (TNF-α), a pro-inflammatory cytokine.  Elevated levels of 
circulating TNF-α signals an increase in the release of interleukin–6 (IL-6), which can act 
as either a pro- or anti-inflammatory cytokine (Petersen & Pedersen, 2005).  IL-6 and 
TNF-α are tightly regulated together in a negative feedback loop.  While TNF-α induces 
the release of IL-6, IL-6 can then inhibit the production of TNF-α.  IL-6 is also the major 
regulator of C-reactive protein (CRP) release into the bloodstream.    
CRP is an acute phase protein which has been defined as a chemical whose 
concentration increases or decreases by at least 25% during an inflammatory disorder 
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(Morley & Kushner, 1982).  Thus, plasma CRP reflects the ongoing TNF-α production 
and acts as a “downstream” marker of inflammation.  In humans, CRP can rapidly 
increase within 3-4 hours of exposure to bacteria or injury, peak within 24-72 hours and 
then rapidly fall to basal levels (Gewurz, Mold, Siegel, & Fiedel, 1982; Kushner & 
Feldmann, 1978).  CRP values from 10-40 mg/L indicate mild inflammation while values 
40-200 mg/L indicate acute inflammation and/or bacterial infection (Myers et al., 2004). 
 
   Chronic Inflammation and CRP 
Regardless of the presence of an acute infection, humans have CRP present in the 
bloodstream.  Chronic low-grade systemic inflammation refers to a condition in which 
there is a two to three fold increase in systemic concentrations of cytokines (Petersen et 
al., 2005).   
 Research has linked elevated low-grade basal inflammation (CRP) to 
development of metabolic syndrome (Das, 2002; Ridker et al., 2003b), progression of 
type II diabetes (Pradhan, Cook, Buring, Manson, & Ridker, 2003), increased 
atherosclerosis (Libby, 2002; Ross, 1999), increased coronary risk (Ridker & Morrow, 
2003), increased cardiovascular disease events (Ridker, 2003b; Ridker, 2003a; Ridker et 
al., 2003a) and mortality (Harris et al., 1999).  CRP may be a better predictor of first time 
cardiovascular events than traditional risk factors, such as LDL cholesterol (Ridker, Rifai, 
Rose, Buring, & Cook, 2002).  Most Americans have CRP plasma levels under 3 mg/L 
which was historically regarded as clinically insignificant (Black, Kushner, & Samols, 
2004).  However, recently, the Centers for Disease Control (CDC) and American Heart 
Association (AHA) jointly re-categorized CRP as < 1.0 mg/L as low risk, average risk 
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1.0-3.0 mg/L; and high risk > 3.0 mg/L (Myers et al., 2004).  It is estimated that 
approximately 25% of American adults have CRP levels classified as “high risk” 
(Pearson et al., 2003).   
Quantification and Measurement for C-Reactive Protein 
CRP is quantified with a standard fasting blood sample.  The 
immunoturbidimetric method creates an antigen-antibody reaction which occurs between 
CRP in the sample and an anti-CRP antibody that has been sensitized to latex particles, 
and agglutination results.  This antigen-antibody complex causes an increase in light 
scattering, which is detected spectrophotometrically, with the magnitude of the change 
being proportional to the concentration of CRP in the sample.  Five-point calibration 
curves are standardized against the reference material CRM470.  Immunoturbidimetric 
methods read the light scattered by antibody complexes.  Since the photomultiplier tube 
is directly across from the light source, there is a decrease in the transmitted light due to 
scattering, reflectance and absorption.  Values of density and absorption are read at 570 
nm with a background subtract of 800 nm.   This assay has a sensitivity of 0.03 mg/L.  
The day-to-day variability of the assay at concentrations of 0.91, 3.07 and 13.38 mg/L are 
2.81, 1.61 and 1.1%, respectively. 
This dissertation project utilizes a secondary data analysis which has blood 
plasma samples that have been frozen for approximately 15 years at -80°C without any 
freeze-thaw cycles.  CRP is a stable protein with low temporal and diurnal variation and a 
long half life (Meier-Ewert et al., 2001; Ockene et al., 2001).  CRP measurement and 
quantification is stable for seven freeze-thaw cycles (Aziz et al., 2003), even after 20 
years of  storage at -70 °C (Lewis, Callas, Jenny, & Tracy, 2001).  Inflammatory cytokine 
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quantification may be limited for this secondary data analysis utilizing long-term stored 
blood samples due to short half-lives (May et al., 1992).  Due to its stability over time, 
CRP may be a better clinical marker of inflammation when compared to other 
inflammatory cytokines such as TNF- α and IL-6 (Myers et al., 2004; Roberts, 2004).  
Thus, for the purposes of this dissertation project, CRP will be the major focus as a 
marker of inflammation. 
Individual Characteristics and Lifestyle Influences on Levels of C-Reactive Protein 
 Quantification of CRP has allowed research to link elevated low-grade systemic 
chronic inflammation with various lifestyle factors.  CRP has a positive linear 
relationship with aging (Rumley et al., 2006).  Women tend to have approximately 35% 
higher levels of CRP (mean 2.5 mg/L) than men (mean 1.6 mg/L), even after controlling 
for oral contraception use (Ford et al., 2003; Ford et al., 2004b).  Hormone replacement 
therapy (HRT) has shown 45-60% increases in CRP levels in some studies (Albert, 
Glynn, Buring, & Ridker, 2004; Cushman et al., 1999), while other studies show no 
significant differences in CRP levels with those on HRT (Smith, Dykes, Douglas, 
Krishnaswamy, & Berk, 1999; Hodis et al., 2008).   
CRP has positive linear relationships with weight status (Ford, 1999) and body fat 
percentage (Lemieux et al., 2001).  One of the hypothesized theories for the increased 
cytokine production of TNF-α and IL-6, which is present in low grade inflammation is 
from adipose tissue (Pedersen, 2005).  The release of CRP is controlled by these 
inflammatory cytokines, which can be located and released from the adipose tissue 
(Petersen et al., 2005).  Therefore, more body fat a person has, the higher the release of 
inflammatory cytokines and ultimately, the higher the release of CRP (Visser et al., 
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1999).  Approximately 30% of IL-6 is released into circulation at rest, directly from 
adipose tissue (Mohamed-Ali et al., 1997).  Thus, an individual’s body composition 
directly relates to the circulating magnitude of CRP. 
CRP levels can be modified through lifestyle changes.  Behaviors such as 
smoking increase levels of CRP (Frohlich et al., 2003), while moderate alcohol 
consumption has been known to lower levels of CRP (Albert, Glynn, & Ridker, 2003). 
Other lifestyle behaviors such as weight loss, physical activity, and dietary intake can 
also influence CRP levels.  CRP levels are directly related to weight loss and the change 
in weight (Due, Toubro, Stender, Skov, & Astrup, 2005; Clifton et al., 2005).  For each 
kilogram of weight loss, the mean change in CRP level is estimated to be -0.13 mg/L 
(Selvin et al., 2007).   
Complex relationships exist between CRP and physical activity, fitness and 
dietary changes.  First, theorized physiological mechanisms are discussed in an attempt to 
explain how CRP levels are modified through low-fat diet and increased physical 
activity.  Next, evidence is presented from intervention research which evaluates the 
changes in CRP in response to low-fat diet and/or increased physical activity.  
Dietary Mechanism for Reducing CRP Levels 
 
The exact physiological mechanism relating dietary fat intake to CRP levels is 
poorly understood.  Increased intake of dietary fat can induce a pro-inflammatory profile 
increasing circulating levels of cytokines such as IL-6 and TNF-α (Nappo et al., 2002).  
Consumption of n-3 polyunsaturated fatty acids, a type of fat common in low-fat foods, 
can inhibit cytokine release directly from the endothelium in a vascular model of 
atherosclerosis (De, Liao, & Libby, 2000).  The lower levels of cytokines may result in 
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lower circulating CRP levels.  Low-fat foods may simultaneously change macronutrient 
intake and quality (Jenkins et al., 2005).  Individuals who consume low-fat diets also tend 
to increase intake of fruits, vegetables and whole grains (Jenkins et al., 2005).  Increased 
fruit and vegetable consumption can induce anti-inflammatory effects which may also 
lower CRP levels (Middleton E Jr, 1998).   
Meals that cause a rise in insulin and epinephrine output are associated with 
higher levels of CRP (Liu et al., 2002).  IL-6 release is also hypothesized to be stimulated 
by the amount of insulin and catecholamine in the bloodstream (McCarty, 2005).   Thus, 
meals that limit the increase in postprandial glucose may also reduce levels of cytokines 
and CRP in the bloodstream (Clifton, 2003).  In fact, consumption of meals which limit 
the rise in insulin and glucose, such as low glycemic diets, reduce CRP levels (Wolever 
et al., 2008).   
Low-Fat Dietary Interventions and CRP 
 
Epidemiological research has uncovered positive relationships between CRP and 
total lipid, saturated fat, and cholesterol intake (Bertran et al., 2005; Fredrikson et al., 
2004).  Low-fat dietary interventions decrease CRP levels as high as 32% (Clifton et al., 
2005; Heilbronn et al., 2001; O'Brien et al., 2005; Seshadri et al., 2004; Tchernof et al., 
2002) though the change in CRP is not always significant (Cardillo, Seshadri, & Iqbal, 
2006; Desroches et al., 2006; Jenkins et al., 2005; Koren et al., 2006).   
Inconsistencies with the results of low-fat diets on CRP may be due to small 
sample sizes (Koren et al., 2006; Jenkins et al., 2005; Tchernof et al., 2002) or 
interventions in a single gender (Desroches et al., 2006, Heilbronn et al., 2001; O’Brien 
et al., 2005; Tchernof et al., 2002).  Importantly, none of the above mentioned studies had 
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a control group for comparison.  One study which included a control group did not find 
changes in CRP between the low-fat group relative to the control group, providing 
evidence for a non-significant effect of low-fat diet on CRP (Erlinger et al., 2003).   
 Several low-fat diet interventions involved only obese individuals limiting the 
generalizability to normal and overweight individuals due to their higher overall CRP 
levels (Cardillo et al., 2006; Heilbronn et al., 2001; O'Brien et al., 2005; Seshadri et al., 
2004; Tchernof et al., 2002).  In order to account for the differences in CRP by weight 
status, many studies adjust for weight status in their statistical analysis by using body 
mass index (BMI).  Some research has found the relationship of physical activity and 
CRP independent of obesity as measured by BMI (Abramson & Vaccarino, 2002; Albert, 
Glynn, & Ridker, 2004; Geffken et al., 2001; King, Carek, Mainous, III, & Pearson, 
2003; Rawson et al., 2003; Reuben, Judd-Hamilton, Harris, & Seeman, 2003; 
Wannamethee et al., 2002), while other studies which adjust for BMI also attenuated this 
relationship (Pischon, Hankinson, Hotamisligil, Rifai, & Rimm, 2003; Rawson et al., 
2003; Verdaet et al., 2004; Elosua et al., 2005).  More accurate assessments for 
estimating body fat, utilizing percent body fat or visceral fat, found that CRP levels are 
not independent of adipose tissue (Colbert et al., 2004; Hammett et al., 2004; Manns, 
Williams, Snow, & Wander, 2003).  Thus, the relationship between physical activity and 
CRP may be dependent on an individual’s body fat. 
 Many dietary protocols include concomitant weight loss making it difficult to 
assess whether the low-fat diet or weight loss was the stimulus to change CRP (Clifton et 
al., 2005; Heilbronn et al., 2001; Koren et al., 2006; O’Brien et al., 2005; Seshadri et al., 
2004; Tchernof et al., 2002).  Weight reductions of 10% or more may induce CRP 
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changes which eliminates the ability to detect the independent effect of low-fat intake  
(Heilbronn et al., 2001; Tchernof et al., 2002).  When weight loss was unintentional 
through isocaloric or ad libitum intake, no significant changes in CRP were found 
(Desroches et al., 2006; Koren et al. 2006; Jenkins et al., 2005).  
 Therefore, in order to examine the independent effects of low-fat diet on CRP 
levels, future studies need randomized controlled trials, larger sample size and isocaloric 
intake.  Studies also need to account for the individual’s baseline body fat to eliminate the 
known influence on CRP.  Possible solutions include either including a more diverse 
distribution of body fat within the sample, adjusting the analysis by body fat, or 
stratifying the analysis by categories of weight status. 
Physical Activity Mechanisms for Reducing CRP 
 
Physical activity may modify inflammation through the IL-6 pathway.  IL-6 is 
released during a bout of exercise from various tissues including adipose tissue, skeletal 
muscle, mononuclear cells, and brain (Pedersen, 2006; Shephard, 2002).  Acutely, the 
increase in IL-6 increases CRP levels approximately 8-12 hours after the exercise bout 
(Petersen et al., 2005) and can remain elevated for 16 hours after exhaustive exercise 
(Castell et al., 1997). 
Despite the increase in IL-6 and CRP after an acute bout of exercise, IL-6 also 
acts to stimulate the release of anti-inflammatory agents (Pedersen, 2006; Shephard, 
2002).  Increase in IL-6 levels during the acute phase initiates also initiates a cascade 
response involving the secretion of anti-inflammatory markers such as interleukin-10 (IL-
10) and interleukin-1 receptor antagonist (IL-1ra) which downregulate the release of 
TNF-α (Pedersen, 2006; Petersen et al., 2005). The decrease in TNF-α may also inhibit 
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the release of IL-6, and ultimately, the release of CRP from the liver.  This negative 
feedback loop suggests that although the acute effect increases CRP, the chronic 
influence of exercise may decrease CRP.  It is hypothesized that the mechanism behind 
the decrease in inflammation with chronic activity is due to one or more of the following 
reasons 1) reduced adiposity, 2) reduced macrophage accumulation in adipose tissue, 3) 
increase in parasympathetic system due to training and/or 4) improved acute stress 
sensitivity from repeated exercise bouts and increased anti-oxidant activity (Woods, 
Vieira, & Keylock, 2006).     
Physical Activity Interventions and CRP 
 
 Epidemiological research has established an association of lower CRP levels in 
physically active men and women (Ford, 2002; Koenig et al., 1999; Panagiotakos, 
Pitsavos, Chrysohoou, Kavouras, & Stefanadis, 2005; Pitsavos et al., 2003), elevated 
cardiovascular risk adults (Pitsavos, Panagiotakos, Chrysohoou, Kavouras, & Stefanadis, 
2005), and older adults (Colbert et al., 2004; Geffken et al., 2001; Reuben et al., 2003; 
Taaffe, Harris, Ferrucci, Rowe, & Seeman, 2000).  Individuals with high 
cardiorespiratory fitness had 57-80% lower CRP values than their low fit counterparts in 
both men (Church et al., 2002; Kuo, Yen, Chen, Yu, & Bean, 2007) and women (Kuo et 
al., 2007; LaMonte, Ainsworth, & Durstine, 2005).   
While the association between physical activity/fitness and CRP in cross sectional 
studies is established, the effect of increasing physical activity levels and its effects on 
CRP levels has been variable.  Physical activity interventions significantly decreased 
CRP levels (Goldhammer et al., 2005; Kohut et al., 2006; Mattusch et al., 2000; Milani et 
al., 2004; Oberbach et al., 2006; Obisesan et al., 2004; Okita et al., 2004; Smith et al., 
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1999; Tisi, Hulse, Chulakadabba, Gosling, & Shearman, 1997).  The range for reductions 
for CRP through increasing physical activity and/or fitness are estimated to be between 
19-77% (Plaisance & Grandjean, 2006).  However, CRP differences with increasing 
physical activity have not always been statistically significant (Hammett et al., 2004; 
Huffman et al., 2006; Marcell, McAuley, Traustadottir, & Reaven, 2005; Rauramaa et al., 
2004; Nicklas et al., 2004).    
Many of these studies involved individuals with existing chronic diseases such as 
insulin resistance, type II diabetes or cardiovascular disease where the CRP baseline 
levels tend to be elevated (Goldhammer et al., 2005; Kohut et al., 2006; Milani et al., 
2004; Oberbach et al., 2006; Tisi et al., 1997).  Previous research has shown that only 
individuals with initially high CRP levels are able to significantly reduce CRP with 
increased physical activity/ fitness (Goldhammer et al., 2005; Lakka et al., 2005).  This 
may indicate that individuals with existing chronic disease, who have elevated CRP 
levels, may decrease their CRP levels to a greater extent than those who are healthy. 
Inconsistent effects for CRP from physical activity are found across gender.  
Some studies show consistent effects between genders for the changes in CRP (Hammett 
et al., 2004; Huffman et al., 2006; Lakka et al., 2005), while others show significantly 
greater change among men (Nicklas et al 2004).  Studies may include both men and 
women in their sample, and adjust their statistical analysis for gender (Goldhammer et al., 
2005; Kohut et al., 2006; Marcell et al., 2005; Milani et al., 2004; Oberbach et al., 2006; 
Obisesan et al., 2004).  However, since men and women have different baseline levels of 
CRP, they also may have a different response to exercise training.  Thus independent 
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statistical analyses by gender may reveal distinct responses in the CRP to increased 
physical activity.    
As previously mentioned, general weight loss can directly decrease CRP levels.  
However, weight loss specific from physical activity has shown inconsistent results 
between the relationship between physical activity and CRP.  Changes in CRP were 
independent from physical activity induced weight loss in one study (You et al., 2004), 
whereas another study attributed the weight loss as the major contributor to CRP change 
over the change in physical activity (Haffner et al., 2005).  
Most importantly, a number of interventions did not have control groups, limiting 
the inferences that can be made concerning the effect of the physical activity intervention 
on CRP levels (Lakka et al., 2005; Okita et al., 2004).  Interventions with a control group 
show inconsistent CRP results, where some studies show significant reductions 
(Mattusch et al., 2000; Milani et al., 2004), while others have had no effect on CRP 
(Hammett et al., 2004; Huffman et al., 2006).  Varying results for CRP in controlled trials 
may be due to an alternative CRP measurement technique (Mattusch et al., 2000), non-
randomized groups (Milani et al., 2004) or high variability in the CRP values (Hammett 
et al., 2004). 
In summary, to provide convincing evidence for the effects of physical activity 
interventions on CRP levels in both men and women, several issues need to be addressed:  
inclusion of randomized controlled design, controlling for weight loss in the statistical 




Combined Lifestyle Interventions on CRP 
 
 The physiological mechanisms theorized to be responsible for reductions in CRP 
from low-fat diet are distinct from mechanisms for increasing physical activity.  
Although not confirmed in research, it can be hypothesized that the combination of diet 
plus exercise may have an additive effect on lowering CRP levels, though other 
multidisciplinary interventions show sub-additive effects on traditional cardiovascular 
risk factors (Appel et al., 2003).   
 Multidisciplinary interventions which combine exercise and low-fat diet had 
positive reductions of CRP levels in both men and women (Dvorakova-Lorenzova et al., 
2006; Esposito et al., 2003; Haffner et al., 2005; Roberts et al., 2006; Wegge et al., 2004).  
However, the effect of combined lifestyle intervention on lowering CRP has not shown 
consistency between genders, where one study shows similar reductions in CRP (Haffner 
et al., 2005) and another shows a greater reduction in men (Nicklas et al., 2004).  
Furthermore, most combined diet and exercise interventions were limited to a single 
gender  (Dvorakova-Lorenzova et al., 2006; Esposito et al., 2006; Roberts et al., 2006; 
You, Berman, Ryan, & Nicklas, 2004) and obese only participants (Esposito et al., 2003;  
Roberts et al., 2006; You et al., 2004) limiting the generalizability of the results. 
 Combined dietary and exercise interventions without restricted caloric intake or 
intentional weight loss significantly reduced CRP levels between 30-45% (Bo et al., 
2007; Roberts et al., 2006; Wegge et al., 2004).  However, several of these interventions 
were in a single gender (Roberts et al., 2006;Wegge et al., 2004), did not adjust for 
gender (Bo et al., 2007) or did not include a control group for comparison (Roberts et al., 
2006;Wegge et al., 2004).  Several controlled trials also included hypocaloric intake to 
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induce weight loss which may have lowered levels of CRP beyond the contributions of 
low-fat diet and exercise alone (Haffner et al., 2005; Nicklas et al., 2004).  Weight loss, 
when combined with exercise showed greater reductions in CRP than exercise alone, 
making it difficult to distinguish whether it was weight loss, diet or exercise which 
caused the changes in CRP (Nicklas et al., 2004).  Reductions in CRP from the diet plus 
exercise group were independent of the change in body composition (You et al., 2004; 
Milani et al., 2004), however more controlled studies are needed which account for the 
weight loss within the analysis. 
Comparisons Between Low-Fat Diet, Exercise and Diet plus Exercise for CRP 
 A major limitation in the current diet plus exercise intervention research include 
the lack of controlled randomized design to compare CRP changes between control, diet, 
exercise and diet plus exercise.  Many studies examined the combination of diet plus 
exercise, making it difficult to discern the independent contributions of each (Bo et al., 
2007; Dvorakova-Lorenzova et al., 2006; Esposito et al., 2003; Haffner et al., 2005; 
Roberts et al., 2006).  Diet plus exercise has shown larger changes in CRP than diet 
alone, although none of these studies included a control group (You et al., 2004; Esposito 
et al., 2003; Esposito et al., 2004).  A randomized controlled trial which compared diet, 
exercise and diet plus exercise to a control group, found significant treatment effects in 
the diet only and diet plus exercise groups (Nicklas et al., 2004).  However, Nicklas et al., 
also incorporated resistance training, which can activates IL-6 to be released from the 
muscle tissues altering both the inflammatory and anti-inflammatory response (Petersen 
et al., 2005).  In addition, all of randomized controlled trials had concurrent weight loss 
which may have inflated the changes in CRP, masking the independent effects from 
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exercise or low-fat diet.  Therefore, systematic evaluation for the independent and 
combined effects of low-fat diet and increased physical activity on CRP levels needs to 
be examined.   
 In summary, the current research for the effects of increased physical activity and 
diet on CRP levels has not methodically determined the independent and combined 
contributions of each component in men and women, without the contribution of 
concurrent weight loss. 
 
Part II:  Metabolic Syndrome 
Metabolic syndrome is a constellation of elevated metabolic, lipid and non-lipid 
variables that tend to cluster in an individual.  The National Cholesterol Education 
Program Adult Treatment Panel III  (NCEP ATP III) developed a definition to identify 
metabolic syndrome in which an individual must have three of the following:  1) waist 
circumference over 102 cm men; 88 cm women, 2) triglycerides over 150 mg/dL, 3) high 
density lipoprotein cholesterol (HDL) under 40 mg/dL for men; 50 mg/dL for women, 4) 
blood pressure over 130/85 mmHg and 5) fasting glucose over 100 mg/dL (2001; 
Grundy, Brewer, Jr., Cleeman, Smith, Jr., & Lenfant, 2004a).  
The exact mechanisms responsible for the pathogenesis of metabolic syndrome 
remain unknown.  Early perspectives for the manifestation of metabolic syndrome 
involved insulin resistance (Reaven, 1988) and obesity (Grundy, 2004).  Recent theories 
attempting to explain the etiology of metabolic syndrome include chronic systemic 
inflammation, endothelial dysfunction, sympatho-adrenal irregularities, gene 
environment interactions, and lifestyle (Fowler, Moussouttas, & Mancini, 2005).  
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 Despite the unknown mechanisms, metabolic syndrome is intricately linked with 
the development of cardiovascular disease.  Individuals with metabolic syndrome have 
more advanced signs of atherosclerosis including plaque build-up in the lumen, greater 
intima-media thickness and increased stenosis of the arterial wall (Bonora et al., 2003; 
McNeill et al., 2004; Wallenfeldt, Hulthe, & Fagerberg, 2005).  Adults with metabolic 
syndrome also show greater progression of atherosclerosis over time (Bonora et al., 2003; 
Wallenfeldt et al., 2005).  Metabolic syndrome is associated with an increase in 
cardiovascular disease events and mortality in both men and women (Ford, 2004; Lakka 
et al., 2002; Scuteri, Najjar, Morrell, & Lakatta, 2005).  Metabolic syndrome may be able 
to predict cardiovascular disease events, mortality and morbidity better than any of its 
individual risk factors (Isomaa et al., 2001; Malik et al., 2004).  Thus, understanding the 
correlates of metabolic syndrome and finding appropriate treatments is paramount in 
order to curb the progression and development of cardiovascular disease. 
The prevalence of metabolic syndrome has increased over the past ten years.  The 
National Health and Nutrition Examination 1988-1994 Survey found prevalence was 
approximately 23% (Ford, Giles, & Dietz, 2002), which increased significantly in both 
men and women to 27% in 1999 (Ford, Giles, & Mokdad, 2004), and 35% in 2002 (Ford, 
2005).   
Prevalence of metabolic syndrome increases with aging, where it is six times 
more prevalent among elderly than in young adults (Ford, Giles, & Dietz, 2002).  
Metabolic syndrome prevalence is equal in men and women (Ford et al., 2003; Park et 
al., 2003), however, prevalence increases during menopause (Carr, 2003).  
Postmenopausal women on hormone replacement therapy (HRT) show reduced levels of 
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the individual components of metabolic syndrome (Carr, 2003; Dallongeville et al., 1995; 
Salpeter et al., 2006).  Finally, weight status is a major contributor to metabolic syndrome 
status.  As weight status increases from normal weight to obesity, prevalence of 
metabolic syndrome increases from 5% to 57% (Park et al., 2003).   
For management of the metabolic syndrome, the NCEP recommends the 
incorporation of positive lifestyle changes including the reduction in saturated fat and 
cholesterol, increasing physical activity and weight loss (2001).  Adults with metabolic 
syndrome have higher total dietary fat intake (Finley et al., 2006) and low-fat diet can 
reduce the individual components of metabolic syndrome (Yu-Poth et al., 1999).  
However, few studies have explored the influence of low-fat diet on the presence of 
metabolic syndrome, the condition in which an individual has clustering of the individual 
cardiovascular risk factors.  Men and women who are physically active are less likely to 
have or develop metabolic syndrome (Laaksonen et al., 2002; Irwin et al., 2002).  Thus, 
lower intake of dietary fat and higher levels of physical activity are associated with a 
lower prevalence of metabolic syndrome.  However, the influence of increasing physical 
activity and/or incorporating a low-fat diet on metabolic syndrome status is more 
complex.  The following literature review for metabolic syndrome briefly summarizes 
physiological mechanisms for the reduction in metabolic syndrome from low-fat and 
physical activity.  Then, evidence for reversal of metabolic syndrome from low-fat diet 
and physical activity is presented.  
Low-Fat Dietary Mechanisms for Reversing Metabolic Syndrome 
 
High fat diets can induce metabolic syndrome in animals (Barnard, Faria, 
Menges, & Martin, 1993), but can be reversed through incorporation of a low-fat diet 
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(Roberts, Vaziri, Liang, & Barnard, 2001).  Although the exact physiological mechanism 
to explain how fat reduction reverses the metabolic syndrome is unknown, it is 
hypothesized to be through weight loss and/or concurrent changes in dietary 
macronutrient quality intake (Feldeisen & Tucker, 2007).   
Low-fat diets can result in weight loss, even without intentionally lowering 
overall caloric intake (Astrup, Grunwald, Melanson, Saris, & Hill, 2000).  Weight loss 
can improve the overall cardiovascular risk profile (Yu-Poth et al., 1999) which may 
result in reversal of metabolic syndrome.   
Carbohydrate sources within low-fat diets may also be fiber-rich, which limits the 
increased postprandial glucose and insulin levels (Barnard, Scialli, Turner-McGrievy, 
Lanou, & Glass, 2005).  Since carbohydrate and lipid metabolism are intricately linked, 
decreasing the hyperinsulinemic response from a meal could lower plasma levels of 
glucose and lipoproteins.  Thus, a low-fat diet could ultimately decrease the presence of 
metabolic syndrome.  Evidence from a meta-analysis of low-fat diets promoting complex 
carbohydrate intake shows improvements for the cardiovascular risk factor profile (Yu-
Poth et al., 1999), possibly resulting in reversal of metabolic syndrome. 
Low-Fat Diet Interventions and Metabolic Syndrome  
 
The NCEP Step I and Step II diets were created to lower an individual’s risk of 
having cardiovascular related events and reduce the presence of abnormal cardiovascular 
risk factors (1993).  The major components of the NCEP diet are reduction of dietary fat 




Table 2.1.  National Cholesterol Education (NCEP) Program Dietary Guidelines  (1993). 
DIET PROGRAM SPECIFIC GUIDELINES 
NCEP Step I • Reduction of saturated fat < 10% 
• Reduction of total cholesterol <  300 mg/day 
NCEP Step II  
 
• Reduction of total fat < 30% of total caloric intake 
• Reduction of saturated fat < 7% of total caloric intake 
• Reduction of dietary cholesterol < 200 mg/day 
• Reduction of total caloric intake for weight loss if applicable 
 
In comparison to the NCEP Step I diet, the NCEP Step II diet demonstrates greater 
reductions in triglycerides, low density lipoprotein (LDL), and the ratio between total 
cholesterol and high density lipoprotein (HDL) (Yu-Poth et al., 1999).    
A reduced fat diet has shown resolution of the metabolic syndrome (Muzio et al., 
2005), though this intervention did not include a control group.  Low-fat dietary patterns, 
such as the DASH diet (low-fat dairy, increased fruits and vegetables, reduced sodium) 
have also shown success for reducing metabolic syndrome in comparison to a control 
condition (Azadbakht, Mirmiran, Esmaillzadeh, Azizi, & Azizi, 2005).  However, since 
the DASH diet has several dietary changes beyond incorporating low-fat foods, it is 
difficult to discern whether it is a single entity or the combination of a few components 
that make this diet successful in reducing presence of metabolic syndrome.    
 A major challenge in the existing literature for metabolic syndrome and low-fat 
diet, is that many dietary studies involve concomitant weight loss (Muzio et al., 2005; 
Azadbakht et al., 2005). Weight loss alone can independently improve many of the 
components of metabolic syndrome (Yu-Poth et al., 1999).  Due to the influential impact 
of weight loss on several metabolic and cardiac risk factors, it is difficult to discern the 
contributing effects of weight loss and the individual impact of the low-fat diet.   
 Clearly, randomized controlled trials are needed to evaluate the effects of low-fat 
diet on metabolic syndrome, independent from weight loss.   
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Physical Activity Mechanisms to Reverse Metabolic Syndrome 
 
 It is well established that physical activity has two major effects for prevention of 
cardiovascular disease: 1) it can effect cardiovascular disease through reductions in 
morbidity and mortality (Paffenbarger, Jr., Hyde, Hsieh, & Wing, 1986; Paffenbarger, Jr., 
Hyde, Wing, & Hsieh, 1986; Paffenbarger, Jr. et al., 1993) and 2) it can positively effect 
the biological cardiovascular risk factors associated with the disease (Grundy et al., 
2004b).  However, the exact mechanisms by which increases in physical activity result in 
the reduction of metabolic syndrome remain largely unexplored.  It is hypothesized that 
the reduction in metabolic syndrome from physical activity may be due to favorable 
changes in each of the individual components: triglycerides, HDL cholesterol, blood 
pressure, glucose and abdominal obesity, which in combination, result in decreased 
metabolic syndrome. 
 Theories to explain the decrease in plasma triglyceride concentrations with 
exercise training may be through alterations in lipid metabolism.  Triglycerides are 
broken down into free fatty acids that can be used for energy through fatty acid oxidation.  
Exercise training enhances free fatty acid oxidation and gluconeogenesis during rest and 
exercise, which can lower the presence of triglycerides in the blood (Martin, III, 1996; 
Bergman et al., 2000).  HDL cholesterol levels increase with overall energy expenditure 
possibly through an intricate relationship with lipid metabolism.  Increases in lipoprotein 
lipase activity also increase HDL formation while simultaneously reduce intramuscular 
triglycerides stores and decreases plasma triglycerides  (Thompson et al., 2001).  
Changes in blood pressure from increased physical activity are theorized to be from the 
adaptations in the sympathetic nervous system resulting in decreases in catecholamines, 
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total peripheral resistance, as well as alterations in the release of vasodilators and 
vasoconstrictors (Pescatello et al., 2004).  Improvements in glucose function from 
chronic exercise stem from increased GLUT4 transporters, capillary density, and muscle 
fiber conversion to type IIa and enzymes for fatty acid oxidation and gluconeogenesis 
(Houmard et al., 1991; Ivy, 1997).  These alterations increase glucose uptake into the 
muscle tissue which improves insulin resistance and utilization of glucose for energy.  
There is also evidence to suggest that increased physical activity decreases abdominal 
obesity even in the absence of weight loss (Kay & Fiatarone Singh, 2006).  Reduced 
visceral fat is associated with improved insulin and glucose homeostasis (Ross, Freeman, 
Hudson, & Janssen, 2002).  Increasing energy expenditure through increased physical 
activity can also result in weight loss which can indirectly but favorably change the 
individual cardiovascular risk factors (Dattilo & Kris-Etherton, 1992; Leenen et al., 1993; 
Chobanian et al., 2003; Yu-Poth et al., 1999). 
 In summary, increased physical activity can improve each of the individual 
components of metabolic syndrome, which may result in a reversal of metabolic 
syndrome status. 
Physical Activity Interventions and Metabolic Syndrome 
 
For every 3.3 individuals with metabolic syndrome who are treated with exercise, 
one participant successfully reverses the presence of metabolic syndrome (Katzmarzyk et 
al., 2003).  Physical activity interventions show reductions in magnitude between 15-37% 
for metabolic syndrome (Johnson et al., 2007; Katzmarzyk et al., 2003; Milani & Lavie, 
2003; Shubair, Kodis, McKelvie, Arthur, & Sharma, 2004) although this difference in 
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metabolic syndrome prevalence has not always been significant (Anderssen, Carroll, 
Urdal, & Holme, 2007; Stewart et al., 2005).   
Physical activity has reduced the prevalence of metabolic syndrome in studies 
which combine men and women (Katzmarzyk et al., 2003; Shubair et al., 2004).  One 
exercise intervention did not find differences between genders for the response of 
metabolic syndrome to exercise (Johnson et al., 2007).  However, results from cross 
sectional studies which explore the relationships between physical activity and gender are 
not consistent.  In one study, when men and women are separated for the statistical 
analysis, an inverse association between physical activity and metabolic syndrome was 
only significant in men (Zhu, St-Onge, Heshka, & Heymsfield, 2004; Liu et al., 2006), 
whereas another studies found it only significant in women  (Pitsavos et al., 2005).  Only 
one study separated genders for statistical analysis,  and found similar reductions in 
metabolic syndrome for both men and women (Shubair et al., 2004).  Thus, it appears the 
relationship between physical activity and metabolic syndrome among genders may need 
further study.  
Other explanations for the inconsistent results may be due to weight loss.  
Longitudinal studies indicate that after adjusting for changes in weight over time, the 
relationship between physical activity and metabolic syndrome is no longer significant 
(Carnethon et al., 2004).  This suggests that the changes in metabolic syndrome from 
physical activity may be explained by changes in body weight.  Meta-analyses suggests 
that long term physical activity, even in the absence of weight loss can improve 
cardiovascular risk factors, however, weight loss may provide further benefits (Carroll & 
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Dudfield, 2004; Yu-Poth et al., 1999).  Thus weight loss may contribute to decreased 
metabolic syndrome in addition to the increased physical activity and fitness.      
Many physical activity interventions do not include a control group for 
comparison  (Katzmarzyk et al., 2003; Stewart et al., 2005).  When an exercise group was 
directly compared to a control group post intervention, results were inconsistent, whereby 
decreases in metabolic syndrome prevalence were found in one study (Johnson et al., 
2007) and no differences in metabolic syndrome were found in another (Anderssen et al., 
2007).   
In summary, future studies for physical activity and their effects on metabolic 
syndrome should include more randomized controlled trials, analyze men and women 
separately, and control for change in weight in the statistical analysis to eliminate the 
effects of weight loss.   
Combined Lifestyle Interventions Effects on Metabolic Syndrome 
 
The combination of diet and exercise has improved several of the individual 
cardiovascular risk factors (Dengel, Hagberg, Pratley, Rogus, & Goldberg, 1998).  Diet  
plus exercise has also been successful in reducing the prevalence of metabolic syndrome 
(Bo et al., 2007; Esposito et al., 2004; Muzio et al., 2005; Orchard et al., 2005; Roberts et 
al., 2006). 
Diet plus exercise interventions involving the low-fat Mediterranean diet has 
reduced the presence of metabolic syndrome (Esposito et al., 2003; Esposito et al., 2004) 
though none of these interventions were randomized controlled trials.   
Many of the combined lifestyle interventions involved concomitant weight loss in 
addition to changing diet and physical activity habits (Bo et al., 2007; Esposito et al., 
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2004; Muzio et al., 2005; Orchard et al., 2005; Roberts et al., 2006).  The magnitude of 
the reduction in the individual cardiovascular risk factors appears to be dependent on the 
amount of  weight loss (Katzel, Bleecker, Rogus, & Goldberg, 1997; Watkins et al., 
2003; Dansinger, Gleason, Griffith, Selker, & Schaefer, 2005; Muzio, Mondazzi, 
Sommariva, & Branchi, 2005).   
Diet plus exercise interventions which examined metabolic syndrome as the 
outcome and either controlled for weight loss or allowed ad-libitum intake, still found 
significant reductions in metabolic syndrome status (Roberts et al., 2006; Esposito et al., 
2004).  However, none of the protocols which did not induce purposeful weight loss were 
randomized controlled trials. 
Comparisons Between Low-Fat Diet, Exercise and Diet plus Exercise on Metabolic  
Syndrome 
 
Understanding the independent and combined effects for diet and exercise is not 
able to be determined from previous research.  The combination of diet and exercise 
improves the individual cardiovascular risk factors for metabolic syndrome better than 
diet alone (Yu-Poth et al., 1999) though this result has not been consistent (Stefanick et 
al., 1998).  Not many intervention studies have systematically studied comparisons 
between the diet and exercise and control conditions for reductions in metabolic 
syndrome.  Diet plus exercise had more success for reversing metabolic syndrome than 
diet or exercise alone (Anderssen et al., 2007; Okura et al., 2007).  Anderssen et al., 
found that the combination of diet plus exercise reduced metabolic syndrome status 67% 
and also proved to be a better treatment than either diet or exercise alone, however, this 
study included purposeful weight loss.  Okura and colleagues found a 3.68 odds of 
decreasing metabolic syndrome with diet plus exercise over diet alone, though there was 
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no control group for comparison (Okura et al., 2007).  Many other existing diet plus 
exercise interventions also lacked a true control group for comparison (Roberts et al., 
2006; Muzio et al., 2005; Esposito et al., 2004; Okura et al., 2007).   
In conclusion, to examine the independent and combined contributions of diet 
plus exercise in men and women without the influence of the change in weight, 
randomized control designs need to statistically control for weight changes in the 
analysis. 
 
Part III:  C-Reactive Protein and Metabolic Syndrome 
 Individuals with the presence of metabolic syndrome also possess elevated levels 
of CRP (Ford, 2003; Pitsavos et al., 2005; Saltevo et al., 2007).  For every 1 pg/mL of 
CRP, there is a 37% increased risk of having metabolic syndrome (Hassinen et al., 2006).  
As risk factors for metabolic syndrome increase, CRP has been shown to add predictive 
and prognostic value to the risk of cardiovascular events, cardiovascular disease and type 
II diabetes (Ridker et al., 2003b; Sattar et al., 2003).  CRP and metabolic syndrome are 
each independent predictors of cardiovascular events  (Rutter et al., 2004; Sattar et al., 
2003).  Chronic inflammation has been suggested to be an actual feature of metabolic 
syndrome (Festa et al., 2000), and some recommend the addition of CRP to the clinical 
definition for identifying metabolic syndrome (Haffner, 2006).   
Physiological Connection Between Inflammation and Metabolic Syndrome 
 
 Despite evidence for the deleterious connection between CRP and metabolic 
syndrome, it is not known whether inflammation is the cause or effect of metabolic 
syndrome (Fernandez-Real & Ricart, 2003).  The etiology and pathogenesis of metabolic 
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syndrome has two theories which intimately link with the process of inflammation:  1) 
insulin resistance and 2) obesity.   
The release of TNF-α, one regulator of CRP release, can cause insulin resistance 
through the following pathways: inhibition of the GLUT4 transporter (Petersen et al., 
2005), and reduction in tyrosine, but not serine, phosphorylation of the insulin receptor 
(Goodyear & Kahn, 1998).  Ultimately , this results in a decrease in insulin released by 
the pancreas and an increase in glucose in the bloodstream (Petersen et al., 2005).  This 
increase in circulating cytokines can also decrease insulin’s natural anti-inflammatory 
properties (Dandona, Aljada, & Bandyopadhyay, 2004).   
The other physiological relationship between the inflammation and metabolic 
syndrome is through the amount of adipose tissue (Esposito & Giugliano, 2004).  The 
primary site for production and release of cytokines, such as TNF- α and IL-6, is directly 
from the adipose tissue (Petersen et al., 2005).  Since TNF- α and IL-6 control CRP 
release from the liver, an increase in adipose mass would increase CRP levels.  A positive 
relationship exists between higher BMI, fat mass, waist girth and visceral fat with CRP 
levels in adults (Ford, 1999; Lemieux et al., 2001).  Central obesity is considered the 
major determinant of CRP levels in those with the metabolic syndrome (Santos, Lopes, 
Guimaraes, & Barros, 2005).  Increased cytokine activity is also linked to abnormal lipid 
metabolism from excess adipose tissue, resulting in increased circulation of triglycerides 
and free-fatty acids (Guilherme, Virbasius, Puri, & Czech, 2008).  Increases in lipids 
within the bloodstream could also lead to metabolic syndrome.  Thus, obesity, can 
increase cytokine production, CRP and increase the individual components of the 
metabolic syndrome.  
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While it is not known whether obesity and/or insulin resistance is responsible for 
the pathogenesis of the metabolic syndrome, inflammation appears to be involved with 
both possible mechanisms. 
Lifestyle Effects on CRP Levels in Individuals with Metabolic Syndrome 
 
The influence of an individual’s metabolic syndrome status may attenuate or 
intensify the effects of diet and/or physical activity on CRP levels.  Evidence of CRP 
changes in healthy men and women show positive effects from low-fat diet (Clifton et al., 
2005; Heilbronn et al., 2001; O'Brien et al., 2005; Tchernof et al., 2002), exercise 
(Mattusch et al., 2000; Obisesan et al., 2004; Okita et al., 2004) and diet plus exercise 
(Dvorakova-Lorenzova et al., 2006; Esposito et al., 2003; Marfella et al., 2004; Nicklas et 
al., 2004; You et al., 2004).  However, only a few studies have examined the effects of 
lifestyle modification in men and women with metabolic syndrome. 
CRP Changes from Low-Fat Diet in Metabolic Syndrome 
 
Fat intake explains some of the variability in CRP levels in persons with 
dyslipidemia, however, the same relationship does not exist in healthy individuals 
(Ghayour-Mobarhan, Yaghootkar, Lanham-New, Lamb, & Ferns, 2007).  This cross-
sectional research suggests a different effect of lowering fat intake in high risk versus 
healthy individuals. 
Previous research has found low-fat diet was not successful in reducing CRP 
levels in hyperlipidemic subjects (Jenkins et al., 2005).  However, Seshadri et al., found 
significant changes in CRP with low-fat diet only when stratifying individuals by those 
who had high baseline values for CRP (Seshadri et al., 2004).  Neither Jenkins et al., or 
Seshadri et al., examined the effect of low-fat diet on CRP in individuals with metabolic 
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syndrome.  In addition, neither of these studies were randomized controlled trials.  The 
response of a low-fat diet may be different in individuals with metabolic syndrome due to 
their multiple lipid and metabolic abnormalities and higher CRP levels. 
Future studies need to examine low-fat diet in individuals with the metabolic 
syndrome using randomized controlled trials. 
CRP Changes from Physical Activity in Metabolic Syndrome 
Cross sectional research demonstrates that individuals with metabolic syndrome 
and high cardiorespiratory fitness have lower levels of CRP (Aronson et al., 2004a).  No 
physical activity interventions were identified that examine the changes in CRP in 
individuals with metabolic syndrome, however, several studies examine adults at 
increased cardiovascular risk.  Exercise training studies found significant reductions in 
CRP in adults with either normal glucose tolerance, insulin resistance or type II diabetes 
(Oberbach et al., 2006).  Oberbach et al., did observe a greater magnitude of CRP change 
in individuals with type II diabetes versus those with insulin resistance and normal 
glucose tolerance, however, neither of these groups were compared to a control group 
(2006).  In contrast, dyslipidemic adults did not show reductions in CRP in an exercise 
training controlled trial (Huffman et al., 2006).  While both of these studies involved 
elevated cardiovascular risk individuals, the presence metabolic syndrome status was not 
assessed. 
Exercise interventions reveal that only individuals with initially high CRP levels 
(whether healthy or with established chronic disease) significantly change CRP levels 
after increasing physical activity and fitness (Goldhammer et al., 2005; Lakka et al., 
2005), though neither of these studies were randomized controlled trials which examined 
 35
individuals with metabolic syndrome.  However, this research does imply individuals 
with metabolic syndrome may successfully lower CRP levels with exercise training due 
to higher baseline CRP values.   
 Future randomized controlled exercise training trials should examine the changes 
in CRP specifically in individuals with metabolic syndrome.   
CRP Changes from Combined Lifestyle Interventions in Metabolic Syndrome 
 
Combined diet plus exercise studies have had significant reductions in CRP in 
individuals with metabolic syndrome (Bo et al., 2007; Esposito et al., 2004; Roberts et 
al., 2006).  While Bo et al., did examine the CRP changes with a randomized controlled 
trial, weight loss also occurred which may have further influenced the changes.  Another 
diet plus exercise intervention cites weight loss as the more important contributor to the 
reduction in CRP than change in physical activity (Haffner et al., 2005).  One diet plus 
exercise study adjusted their statistical analysis for weight loss and significant 
improvements were still found in CRP adults with metabolic syndrome (Esposito et al., 
2004).   
Although studies that examined CRP changes without purposeful weight loss 
were not identified for individuals with metabolic syndrome, interventions in 
dyslipidemic adults revealed significant CRP reductions in men and women (Roberts et 
al., 2006; Wegge et al., 2004).  However, dyslipidemia is only part of the metabolic 
syndrome and the clustering of multiple risk factors in metabolic syndrome, may alter 
CRP in response to diet plus exercise. 
Diet plus exercise interventions often combine men and women in the statistical 
analysis but do not account for possible gender differences (Bo et al., 2007; Esposito et 
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al., 2004).  As CRP levels do differ by gender, these analyses are unable to account for 
the possible gender interactions with diet plus exercise, and may have influenced the 
results (Ford et al., 2003; Ford et al., 2004b).  Separate gender analysis has been 
performed in insulin resistant men and women, and revealed similar magnitudes of CRP 
change (Haffner et al., 2005), however these results are not necessarily generalizable to 
individuals with metabolic syndrome who have multiple lipid and metabolic disorders.   
In conclusion, future studies in individuals with metabolic syndrome need to 
incorporate weight randomized controlled trials that allow men and women to be 
analyzed independently for the changes of CRP.  Furthermore, systematic study for the 
independent and combined effects for low-fat diet and increased physical activity in 











 This dissertation project is a secondary data analysis.  This methods section 
presents a detailed account of the original methodology and protocol for the Diet and 
Exercise for Elevated Risk Trial (DEER) study, which is the data set used for this work.  
The new laboratory analysis for CRP and retrospective analysis of metabolic syndrome 
are detailed in Chapters 4 and 5, respectively. 
 DEER began in 1992 as a year-long, single-center randomized controlled clinical 
trial.  DEER was performed at Stanford University as a project within the Stanford 
Medical School’s Stanford Center for Research in Disease Prevention.  Funding was 
provided by National Heart, Lung and Blood Institute.  The Principal Investigator for the 
study was Dr. Peter D. Wood, with Co-Principal Investigators Dr. Marcia L. Stefanick 
and William L. Haskell.  The original results of the intervention trial were published in 
1998 (Stefanick et al., 1998). 
 DEER’s primary objective was to investigate the effects of diet and exercise 
interventions for men and postmenopausal women with elevated LDL cholesterol and 








Table 3.1.  DEER Study Objectives. 
Primary Objective Examine the effects of diet, exercise, alone or in 
combination on the changes in HDL cholesterol 
Secondary Objective Describe the differences of physiological factors 
between the groups concerning:  
• Cardiovascular Risk Factors:  Total cholesterol, 
LDL, HDL2, HDL3, apolipoproteins A-I, 
apolipoprotein B 
• Glucose Metabolism Factors:  Fasting and two 
hour post-load plasma glucose and insulin 
• Body Composition Variables:  BMI, percent 
body fat and WHR 
• Cardiovascular Variables:  Resting heart rate, 
systolic and diastolic blood pressure 
• Aerobic Physical Fitness Variables:  Maximal 
oxygen uptake, time to exhaustion on treadmill 
• Dietary Intake Components 





 Beginning in the year 1992, postmenopausal women between the ages of 45-64 
years and men between the ages of 30-64 years were recruited from the surrounding area 
of Stanford University in Palo Alto, California.  A variety of mass media methods were 
utilized to recruit including: worksite contacts, posted flyers, handouts, brochures to area 
physician offices and clinics, newsletters, mailings to past participants, Stanford Blood 
Bank, Peninsula Blood Bank and paid advertisements.  Table 3.2 presents the eligibility 
criteria.  Table 3.3 presents the exclusion criteria. 
Table 3.2.  Eligibility criteria for DEER. 
 MEN WOMEN 
Age (yrs) 30-64 45-64 
HDL cholesterol (mg/dL) < 45 <60 
LDL cholesterol (mg/dL) 126-189 126-209 
Triglycerides (mg/dL) <500 <500 
Glucose, fasting (mg/dL) <140 <140 
Blood pressure (mmHg) <160/95 <160/95 
BMI (kg/m2) ≤ 34 ≤ 32 
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Table 3.3.  Exclusion criteria for DEER 
EXCLUSION 
CRITERIA 
SPECIFIC DETAILS  
History of Heart Disease 
 
       
 
 
Abnormal Response to 
Symptom-    Limited 
Treadmill Exercise Test 
 



















Judgment of a Physician 
Myocardial infarction, coronary artery bypass graft    (CABG), 
percutaneous transluminal coronary angioplasty (PTCA), current 
use of cardiac medications, current use of anti-hypertensive 
medications 
 
Angina, ST depression > 1mm, complex arrhythmias, inadequate 
systolic blood pressure response (failure to increase with 
exercise) 
 
Current use of insulin or other medications for diabetes, fasting 
glucose > 140 mg/L on repeat test with first test > 140 mg/L, 2 
hour glucose > 200 mg/L on repeat test, first test > 200 mg/L 
 
 
Any condition that would limit moderate intensity physical activity, 
especially walking or jogging 
 
Any other medical condition that may influence survival during the 
next 18 months significantly decrease exercise capacity or modify 
lipoprotein metabolism such as cancer diagnosed within five 
years, other than skin cancer, severe obstructive pulmonary 
disease (COPD), etc. 
 
As prescribed by physician or niacin > 500 mg/day or fish oils in 
doses > 2 capsules/day 
 
On stable thyroid medication (for at least three months) 









Adherence & Participation 
Smoking more than nine cigarettes/day (self-report) 
 
Consuming more than four alcoholic drinks per day (self-report) 
 
Lives or works beyond easy access of Stanford University or plans 
to move  out of the area within the next 18 months 
 
Unwilling to attend 10 weekly nutrition classes and make changes in 
current      eating habits 
Unwilling to add a minimum of three 30 minute sessions of aerobic 
activity per week to current activity 
Refusal to sign informed consent 
At the discretion of the clinic staff 
Menopausal Status 
 
Bilaterial oophorectomy before age 40 or hysterectomy less than 2 
months before recruitment 
Last menstrual period less than 12 months prior (if uterus is present) 
Unwilling to make no changes in current Hormone Replacement 






Enrollment Screening & Sequence of Events 
 
 Subjects underwent telephone screening where exclusionary criteria were 
identified.  Interested participants were then scheduled for various screening tests 
including laboratory blood analysis, dietary screening, exercise habits and physical 
examination.  Four clinic visits and five telephone interviews were necessary to collect 
the baseline data.    
 
DEER Methods and Measurement 
 
 All measures were taken at baseline prior to randomization and then repeated at 
one year follow-up.  DEER measurement staff were blinded to the treatment of the 
subjects.  All data were double key entered to ensure accurate data entry.  Table 3.4 
summarizes all measures taken during baseline and follow-up.   
Table 3.4.  Measurements for DEER at Baseline and Follow-up. 









Resting Heart Rate 




Diet Assessment 24 Hour Dietary Recall 
Psychological Assessment 
 
Stages of Change 
Profile of Mood States 
Physical Activity Status Physical Activity Diaries 
General Exercise Habits 
Godin Leisure Time Physical Activity Questionnaire 
Physical Fitness Maximal Oxygen Consumption  








 Dietary intake assessment included five unannounced 24 hour dietary recalls.  The 
questionnaire was administered over the phone with Nutrient Data Systems (NDS), a 
computer assisted interviewing and data entry program developed by the University of 
Minnesota Nutrition Coordinating Center.  Diet recalls captured one weekend day and 
four weekdays on non-consecutive days.  Nutrient intake was calculated with Food 
database software Version 5a & 6a.  Data included mean from the four weekdays and one 
weekend recall.  
Physical activity assessment 
 
 Physical activity was assessed with the Godin Leisure Time Exercise 
Questionnaire (Godin) (Godin & Shephard, 1985).  The Godin instrument has been 
shown to be valid and reliable against maximal oxygen consumption testing in men and 
women (Godin et al., 1985; Jacobs, Jr., Ainsworth, Hartman, & Leon, 1993).  The 
questionnaire asks “Considering a seven day period (a week), how many times on 
average do you do the following kinds of exercises for more than 15 minutes during your 
free time?”.  Activities assessed include 1) strenuous exercise (heart beats rapidly), 2) 
moderate exercise (not exhausting) and 3) mild exercise (minimal effort).  Total weekly 
15 minute bouts for strenuous, moderate and mild exercise were multiplied by 3, 5 and 9, 
respectively to convert to MET-weighted units.  The total MET-weighted units are then 




Physical fitness assessment  
 
 Physical fitness was measured by oxygen consumption from a graded exercise 
treadmill test using a semi-automated metabolic analysis system (Savin, Haskell, 
Schroeder, & Stinson, 1980).  Oxygen uptake was measured every 30 seconds during the 
test.  Speed started at 2 miles per hour at 2.5% grade for 3 minutes.  The stages 
progressed to 3 miles an hour with an increase in grade 2.5% every 3 minutes.  Subjects 
exercised to volitional fatigue and maximal oxygen consumption (VO2max) was an 
average of the highest two measures during the final minutes of exercise. 
Physiological Measures 
 
Body composition measurement 
 
 Body weight was measured with a standard medical beam balance scale.  Height 
was measured using a Harpenden stadiometer.  Body mass index (BMI) was calculated 
by dividing the subject’s body weight in kilograms into their height squared (kg/m2). 
 Waist circumference was taken at the narrowest circumference of the torso when 
viewed from the front.  Waist circumference measures were taken three times and 
averaged. 
 Skinfolds were taken using the three site method as identified by Jackson and 
Pollack (Jackson & Pollock, 1978; Jackson, Pollock, & Ward, 1980).  Men were 
measured at the chest (diagonal fold at the midpoint between axillary line and nipple), 
abdomen (vertical fold one cm to the right of the umbilicus), and the thigh (vertical fold 
at the midpoint between inguinal fold and the superior patella).  Women were measured 
at the thigh (identical to male site), suprailiac (diagonal fold superior to the iliac crest), 
and triceps (vertical fold midway between the olecranon process and the acromion 
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process).  Three measurements were taken and averaged.  Jackson-Pollock gender 
specific formulas were applied to calculate body density (Jackson et al., 1978; Jackson et 
al., 1980) and then the Siri equation was applied to calculate percent body fat (Siri, 
1961). 
 Cardiovascular parameters 
 Resting heart rate, systolic and diastolic blood pressure were taken in duplicate 
after five minutes of quiet rest in the morning.  A standard mercury sphygmomanometer 
and stethoscope was utilized to estimate blood pressure from the brachial artery.  First 
and fifth phase Korotkoff were noted as systolic and diastolic blood pressure readings in 
millimeters of mercury (Fortmann, Haskell, & Wood, 1988).  The two systolic and 
diastolic blood pressure readings were averaged. 
 Prior to the venous blood collection, subjects were asked to fast with no food or 
drink, except water, for at least 12 hours.  Smoking was not allowed during the hour prior 
to blood collection.  Participants also abstained from alcohol consumption and vigorous 
activity for at least 24 hours prior to blood collection.  Blood samples were taken in the 
morning on two different visits at baseline.  All collected blood was mixed with 1.5 
mg/mL of EDTA.  Standard methods were used:  serum was allowed to clot for 30-60 
minutes, centrifuged, put on ice, and then transferred to the freezer where aliquots of 
plasma were stored at -80° C. 
 Both fasting blood samples were analyzed for lipoproteins and then averaged.  
Total cholesterol and triglycerides were measured using enzymatic procedures (Allain, 
Poon, Chan, Richmond, & Fu, 1974; Sampson, Demers, & Krieg, 1975).  High density 
lipoprotein (HDL) was measured using dextran sulfate – magnesium precipitation 
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(Warnick, Benderson, & Albers, 1982) as well as enzymatic measurement of non-
precipitated cholesterol (Allain et al., 1974).  Very low density lipoprotein (VLDL) was 
calculated as triglycerides divided by five (Friedewald, Levy, & Fredrickson, 1972).  If 
triglyceride levels were over 400 mg/dL enzymatic methods were used to measure VLDL 
according to Friedewald methods (Friedewald et al., 1972).  Low density lipoprotein 
(LDL) was calculated as total cholesterol minus the sum of HDL + VLDL (Friedewald et 
al., 1972).   








 Randomization was done by the Efron procedure in which subjects were assigned 
to one of four groups:  control, low-fat diet, exercise, diet plus exercise.  The Efron 
procedure uses a computer algorithm to weight the probability of group assignment to 
balance individual groups for sample size, average HDL cholesterol and LDL cholesterol 
(Efron, 1971).   
 The final number of participants for men and women within each intervention 
group are presented in Table 3.5.   DEER enrolled nine cohorts to complete data 
collection. 
Table 3.5.  Deer Subject Sample Size For Each Intervention Arm. 
INTERVENTION ARM MEN WOMEN TOTAL 
Control 47 46 93 
Diet 49 47 96 
Exercise 50 44 94 
Diet + Exercise 51 43 94 








 The control group was instructed to maintain their usual diet and exercise habits 
until tests were completed one year post randomization.  The diet and/or exercise 







 Participants followed the dietary goals set by the National Cholesterol Education 
Program (NCEP) Step II Guidelines (1993).  Components of the guidelines are outlined 
below in Table 3.6.  It is important to note that the NCEP Step II Guidelines which 
focused on cholesterol dietary changes were emphasized, not total caloric reduction or 
weight loss. 
Table 3.6.  National Cholesterol Education (NCEP) Program Dietary Guidelines  (1993). 
 SPECIFIC GUIDELINES 
NCEP Step II  
 
Reduction of total fat to < 30% of calories 
 
Reduction of saturated fat to < 7% of calories 
 
Reduction of dietary cholesterol < 200 mg/day 
 
Encouragement to decrease total fat and saturated fat 
below recommended levels 
 
Reduction of total calories (if needed) to achieve ideal 
body weight* 
 
Weight reduction as applicable* 
* Not an intervention target for DEER 
 
Post randomization visit 
 
 The 12 week adoption phase began with an individualized appointment for each 
subject with a dietitian.  The main goals of the visit were to establish a baseline dietary 
intake history and weight history.  The information was integrated into individualized 
dietary recommendations to meet the NCEP dietary goals.  
Major intervention phase  
 
 Eight weekly group sessions comprised the major intervention phase for the 
dietary treatment arm.  Dietary class content was based on the NCEP Step II Guidelines 
which included information concerning the rationale and behavioral approaches to 
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positively change dietary habits.  The dietary class content used a six-step approach for 
behavioral change included 1) identifying the problem, 2) making a commitment and 
building confidence, 3) increasing awareness, 4) developing and implementing an action 
plan, 5) evaluating the action plan and 6) maintaining changes.  The one hour nutrition 
classes were held for approximately 15 mixed gender participants.  Each session included 
a short lecture and discussion, practical demonstration, or hands-on activity with 
homework to complete before the next class.  Participants could bring a family member 
or guest to promote adherence.  Nutrition class topics and titles are listed below in Table 
3.7. 
Table 3.7.  Nutrition Class Topics for Diet Intervention. 
SESSION NUMBER NUTRITION SESSION CLASS TITLE 
I Getting Started.  Where are we going and how are we 
going to get there?  Fat Demonstration 
II Meat, Fish, and Poultry…Choosing and Using the Best 
for Health 
III Workshop of Using Less Meat 
IV The Dairy Case…Finding your “Whey” 
V Fats, Oils, Salad Dressing, and Nuts 
VI Let’s Do Lunch.  Strategies for Managing Breakfast, 
Lunch and Snacks 
VII More Strategies…For Dinners and Desserts 
VIII Getting Ready for Minor Intervention:  Making More 
Dietary Changes and  Maintaining the Ones We’ve 
Already Made 
 
 Each participant received The New American Diet System as a textbook for the study 
(Connor & Connor W.E., 1986).  Participants also received fat gram booklets to assist fat 
gram counting.  
Minor intervention phase 
 
 Following the major intervention phase, participants were contacted every other 
month via individual appointments, group sessions, telephone calls and/or mailings.  The 
 49
major goal of the minor intervention phase was to prevent relapse and encourage other 
positive dietary behavioral changes over the course of the following six to eight months. 
Individuals were given contact information of dietary interventionists for questions and 
were able to make private appointments as needed. 
 Once all measures were completed at follow-up, all subjects in the diet only group 
were given the option to participate in the exercise program.  
Exercise Intervention 
 
Post randomization visit 
 
 Immediately following randomization, individuals assigned to the exercise only 
group met with a member of the exercise intervention team.  Physical activity and 
exercise history was obtained to individualize the exercise intervention materials.  
Participants were taught how to monitor their pulse for monitoring intensity, and received 
an individualized exercise prescription for their appropriate training range based on the 
results from their maximal graded treadmill test.   
 Participants in the exercise group received the following books to act as guides 
for the intervention, The Stanford Heart Disease Prevention Project Walking Kit or 
Jogging Kit, The Exercise Book For People Who Do Not Exercise, and/or a handout 
entitled, “The How Do I Begin?  Exercise Workshop:  A Complete Guide to Fitness 
Master”.  These materials were originally created for the Stanford Weight Control 
Project.  Individuals who were already active were told to continue their current programs 
and add more minutes to their existing routines, not replace their current routines with the 
DEER program recommendations. 
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  Adoption phase 
 The initial six weeks of exercise training consisted of three days a week of one 
hour supervised aerobic sessions by exercise intervention staff.  The exercise adoption 
program consisted of three days a week of 45-60 minute exercise sessions for both men 
and women together.   
Major intervention phase 
 
After completion of the adoption phase, participants engaged in supervised 
training sessions led by trained exercise intervention staff.  Intensity recommendations 
were to achieve 60-85% maximum heart rate for 20 minutes three times a week for the 
first six weeks.  Participants increased duration over the course of a year.  Any 
individuals who were already active upon randomization were asked to add 20 minutes 
three times a week to their existing physical activity programs.  
Encouragement was given for activities outside of the exercise sessions one day a 
week including biking, swimming, dancing etc to engage participants in four days a week 
of physical activity.  Exercise participants were also encouraged to further increase their 
activity by using the stairs, walking instead of driving and increase recreational 
opportunities.  The exercise program progression is outlined below in Table 3.8. 







Table 3.8.  DEER Exercise Intervention Details. 
EXERCISE COMPONENT EXERCISE PROGRAM DETAILS 
Exercise Adoption Phase Duration:  Initial 6 weeks 
Type:  Aerobic training 
Frequency:  3 days/week 
Main Intervention Exercise Phase Supervised training sessions 
Duration:  3 months 
Type:  Walking or jogging 
Frequency: 3 days/week 
Intensity: 60-85% maximum heart rate 
Time: 20 minutes for the first 6 weeks; Increased duration 
throughout program to 45-60 minutes 
Note:  Already active participants added 20 more minutes to 
existing exercise routine 3x/week 
 
Encouragement for Recreational Exercise 
Frequency:  1 day/week 
Type:  biking, swimming, dancing, etc 
 
Encouragement for Lifestyle habits 
Type:  taking the stairs, parking further away, walking for 
transportation 
 
Minor Exercise Intervention Phase Duration:  7-8 months 
Individualized counseling session for identifying future exercise 
goals 
 
Either supervised training sessions or adopted home program 
Duration:  10-12 miles per week 
Type:   Brisk walking/jogging/running  
 
Attendance at supervised exercise sessions was monitored by the exercise intervention 
staff and intervention and counseling was given when appropriate. 
Minor intervention phase 
 
 An individualized meeting was scheduled at the completion of the major 
intervention phase to identify exercise goals and develop future exercise plans.  
Participants continued with three days a week of supervised activity or were encouraged 
to adopt a home program for the following 7-8 months.  Weekly exercise programs 
consisted of a minimum of 10 miles of brisk walking, jogging, or running each week.  
Monthly special group exercise activities were held including races, par courses, special 
track games, introducing new routes/trails etc.  A “Mileage Plus” program was initiated 
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to promote adherence.  Participants who accumulated the appropriate mileage received 
small gifts.  Newsletters providing training tips, injury prevention and local activities 
were provided throughout the minor intervention phase. 
 Once all measures for the intervention were completed at follow-up, all subjects 
in the exercise only group were given the option to participate in the diet intervention 
program. 
Diet Plus Exercise Intervention 
 
 Participants randomized into the diet plus exercise group received both 
interventions as individual treatments.  Nutritionists made no reference to physical 
activity and the exercise intervention group made no references to dietary changes.  
Classes were scheduled in a coordinated manner to promote adherence for the diet plus 
exercise group.  All dietary classes and exercise sessions were held separately for diet, 
exercise and diet plus exercise participants. 
 
Promotion of Adherence 
 
 Special events and rewards were integrated into the dietary and exercise treatment 
arms to further promote adherence and attendance.  Participants who displayed poor 
adherence to either dietary or exercise interventions were contacted and given private 
sessions to discuss strategies to prevent or minimize the problems.  Six attempts were 
made to contact participants who had major adherence issues.  Individuals who did not 
communicate with the intervention staff were mailed a letter to reiterate the goals of the 




The Effects of Low-Fat Diet and/or Exercise on C-Reactive Protein:  




 Chronic inflammation, a novel cardiovascular risk factor, is an increase in 
circulating pro-inflammatory cytokines such as C-reactive protein (CRP).  CRP is an 
acute phase reactant which is released from the liver and is considered a downstream 
marker of chronic inflammation.  CRP increases with aging (Rumley et al., 2006), body 
mass index (Ford, 1999) and is 35% higher in women than in men (Ford et al., 2003; 
Ford et al., 2004b).  It is estimated that approximately 25% of adults have elevated levels 
of CRP (Pearson et al., 2003) which is linked to mortality (Harris et al., 1999), 
cardiovascular disease (Ridker, 2003b; Ridker, 2003a; Ridker et al., 2003a), type II 
diabetes (Pradhan et al., 2003) and metabolic syndrome (Das, 2002; Ridker et al., 2003b).  
 The incorporation of positive lifestyle changes such as a low-fat diet and exercise 
has reduced cardiovascular risk and improved overall health (Blair et al., 1989; 
Paffenbarger, Jr. et al., 1993; Pate et al., 1995; Yu-Poth et al., 1999; Elmer et al., 2006).  
Lower CRP levels are associated with lower consumption of total fat, saturated fat and 
cholesterol intake (Bertran et al., 2005; Fredrikson et al., 2004).  Lower CRP levels are 
also correlated with higher physical activity in both healthy adults (Ford, 2002; Koenig et 
al., 1999; Panagiotakos et al., 2005; Pitsavos et al., 2003) and in adults with high 
cardiovascular risk (Colbert et al., 2004; Geffken et al., 2001; Pitsavos et al., 2005; 
Reuben et al., 2003; Taaffe et al., 2000).  Individuals who have high levels of 
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cardiorespiratory fitness also demonstrate lower levels of CRP (Aronson et al., 2004b; 
Church et al., 2002; Kuo et al., 2007; LaMonte et al., 2002).  
 Despite the robust cross sectional relationships between CRP and positive 
lifestyle habits, low-fat diet and exercise interventions have not convincingly lowered 
CRP.  Few randomized controlled trials have attempted to examine the independent and 
combined responses of CRP to diet, exercise and diet plus exercise.  The independent 
effects of low-fat diet and/or exercise on CRP change have been inconsistent.  Low-fat 
dietary interventions have shown reductions of CRP levels as high as 32% (Clifton et al., 
2005; Heilbronn et al., 2001; O'Brien et al., 2005; Seshadri et al., 2004; Tchernof et al., 
2002), however, these changes in CRP were not significant in comparison to a control 
group in another study (Erlinger et al., 2003).  Exercise trials have shown varying results 
for changes in CRP, where some studies show significant reductions in comparison to a 
control group (Mattusch et al., 2000; Milani et al., 2004), while other studies show no 
effect on CRP levels (Hammett et al., 2004; Huffman et al., 2006).   
Combined low-fat diet and exercise interventions have significantly reduced CRP 
levels between 30-45% (Bo et al., 2007; Roberts et al., 2006; Wegge et al., 2004), though 
control groups were not always included for comparison (Roberts et al., 2006;Wegge et 
al., 2004).  In addition, many lifestyle interventions only examine the combination of diet 
plus exercise, making it difficult to discern the independent contributions of each (Bo et 
al., 2007; Dvorakova-Lorenzova et al., 2006; Esposito et al., 2003; Haffner et al., 2005; 
Roberts et al., 2006).   
 Comparisons between low-fat diet and diet plus exercise have shown that the 
combination results in larger changes in CRP than diet alone, although none of these 
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studies included a control group (You et al., 2004; Esposito et al., 2003; Esposito et al., 
2004).  These randomized trials also induced concurrent weight loss which can increase 
the magnitude of changes in CRP (You et al., 2004; Esposito et al., 2003; Esposito et al., 
2004).  The release of CRP is controlled, in part, by cytokines which can be stored and 
released from adipose tissue (Petersen et al., 2005).  Therefore, the amount of body fat 
(Visser et al., 1999) and the change in body fat (Selvin et al., 2007) are directly related to 
the circulating levels of CRP.  Thus, comparisons between the independent and combined 
effects of low-fat diet and exercise on CRP are difficult to distinguish from the influence 
of fat loss. 
 Another challenge with the present low-fat diet plus exercise interventions is that 
many only include a single gender, limiting the generalizability of the results 
(Dvorakova-Lorenzova et al., 2006; Esposito et al., 2003; Roberts et al., 2006; You et al., 
2004; Wegge et al., 2004).  Since CRP baseline levels are consistently higher in women, 
it is important to account for this difference within the analysis (Ford et al., 2003; Ford et 
al., 2004b).  Diet plus exercise interventions which include both genders, have not 
accounted for the differences in CRP levels between men and women in their analysis 
(Bo et al., 2007; Esposito et al., 2004).  Furthermore, it is possible that due to the higher 
CRP baseline value among women, the magnitude of change for CRP from lifestyle 
interventions may differ by gender.  
 The purpose of this study was to examine the changes in CRP, separately in men 
and women, between control, low-fat diet, exercise and diet plus exercise from a 
randomized controlled trial.  We hypothesized that diet plus exercise would be the most 
efficacious for reducing CRP levels in both men and women.   
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Methods 
 The Diet and Exercise for Elevated Risk Trial (DEER) was a year-long, single-
center randomized controlled clinical trial.  DEER began in 1992 at Stanford Medical 
School’s Center for Research in Disease Prevention.  The original objective was to 
examine the response of lipoproteins to a low-fat diet and/or exercise in individuals with 
elevated cardiovascular disease risk.  This project utilizes the existing data set and stored 
blood samples to retrospectively examine the effect of the diet and exercise programs for 
the change in CRP. 
 Specific eligibility criteria for men were: age between 30-64 years, high density 
lipoprotein cholesterol (HDL) < 45 mg/dL, low density lipoprotein cholesterol (LDL) 
126-189 mg/dL and body mass index (BMI) ≤  34 kg/m2.  Eligibility criteria for women 
were: age between 45-64 years, postmenopausal, HDL < 60 mg/dL, LDL 126-209 mg/dL 
and BMI ≤ 32 kg/m2.  In addition, men and women had to have blood pressure below 
160/95 mmHg, triglycerides under 500 mg/dL, fasting glucose under 140 mg/dL and a 
normal maximal exercise treadmill test.  Exclusion criteria included history of heart 
disease, abnormal response to symptom-limited treadmill exercise test, insulin dependent 
diabetes mellitus, neuromuscular/orthopaedic disability, use of lipid medication, non-
euthyroid, low hematocrit, excessive smoking or alcohol consumption, inability to attend 
sessions, or by judgment of a physician.  
 Recruitment was from the Stanford University area in Palo Alto, California.  
Recruiting methods consisted of mass media including: worksite contacts, posted flyers, 
handouts, brochures to area physician offices and clinics, newsletters, mailings and paid 
advertisements.     
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Measurement 
Participant eligibility was assessed with telephone screening, blood analysis, 
dietary analysis, exercise history and physical examination.  Baseline measures were 
taken prior to randomization and then repeated at the end of the one year intervention.  
DEER clinic staff performing testing and measurement at baseline and follow-up were 
blinded to the participants’ intervention group assignment.   
Body composition  
 Body weight was measured with a standard medical beam balance scale.  Height 
was measured using a Harpenden stadiometer.  BMI was calculated by dividing the 
participant’s body weight in kilograms into their height squared (kg/m2).  BMI categories 
were determined using the guidelines presented by the National Institutes of Health 
(NIH) (1998).  Waist circumference was taken at the narrowest circumference of the 
torso when viewed from the front.  Calculation of body density and body composition 
were made using skinfold measurements.  Skinfold measures were made in triplicate on 
the right side of the body and averaged.  For males, the locations of the skinfolds were 
chest, abdomen, thigh. For women, the locations were triceps, suprailiac and thigh.  Body 
density was estimated using generalized equations (Jackson et al., 1978; Jackson et al., 
1980) and percent body fat was calculated using the Siri equation (Siri, 1961). 
 Blood collection 
Prior to venous blood collection, participants were asked to abstain from any 
smoking for the hour prior, fast with no food or drink (except water) for at least 12 hours, 
as well as refrain from alcohol consumption and vigorous physical activity for at least 24 
hours.  Blood samples were taken in the morning on two different visits at baseline.  All 
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collected blood was mixed with 1.5 mg/mL of EDTA.  Standard methods were used for 
the blood samples:  serum clotted for 30-60 minutes, centrifuged, put on ice, and then 
plasma was transferred to the freezer for storage at -80° C. 
 C-Reactive Protein  
 
 Plasma high sensitivity CRP concentrations were determined from randomly 
choosing one of the two stored plasma samples.  Immunoturbidimetric assay was 
performed on the Hitachi 917 analyzer (Roche Diagnostics - Indianapolis, IN), using 
reagents and calibrators from DiaSorin (Stillwater, MN).  The immunoturbidimetric 
method creates an antigen-antibody reaction between CRP and an anti-CRP antibody that 
has been sensitized to latex particles, resulting in agglutination.  This antigen-antibody 
complex causes an increase in light scattering, which is detected spectrophotometrically, 
with the magnitude of the change being proportional to the concentration of CRP in the 
sample.  Since the photomultiplier tube is directly across from the light source, there is a 
decrease in the transmitted light due to scattering, reflectance and absorption.  Values of 
density and absorption are read at 570 nm with a background subtract of 800 nm.  Five-
point calibration curves were constructed and standardized against CRM470.  This assay 
has a sensitivity of 0.03 mg/L.  The day-to-day variability of the assay at concentrations 
of 0.91, 3.07 and 13.38 mg/L are 2.81, 1.61 and 1.1%, respectively. 
Dietary intake 
 
 Dietary intake assessment included five unannounced 24 hour dietary recalls.  
Recalls captured one weekend day and four weekdays on non-consecutive days.  Data 
were collected utilizing Nutrient Data Systems (NDS), a computer assisted telephone 
interview developed by the University of Minnesota Nutrition Coordinating Center.  
 59
Nutrient intake was calculated as the mean of the five data collections, with use of Food 
database software Version 5a & 6a.   
Physical activity  
 
 Physical activity was assessed with the Godin Leisure Time Exercise 
Questionnaire (Godin) (Godin et al., 1985).  The Godin questionnaire is valid and reliable 
against maximal oxygen consumption (Godin et al., 1985; Jacobs, Jr. et al., 1993).  The 
questionnaire specifically asks “Considering a seven day period (a week), how many 
times on average do you do the following kinds of exercises for more than 15 minutes 
during your free time?”.  Intensities assessed include: 1) strenuous exercise (heart beats 
rapidly), 2) moderate exercise (not exhausting) and 3) mild exercise (minimal effort).  
Total weekly 15 minute bouts for strenuous, moderate and mild exercise were multiplied 
by 3, 5 and 9, respectively to convert to MET-weighted units.  The total MET-weighted 
units were summed to identify a physical activity score. 
Physical fitness  
 
 Physical fitness was measured from a graded exercise treadmill test using a semi-
automated metabolic system (Savin et al., 1980).  Oxygen uptake was measured every 30 
seconds during the test.  Speed started at two miles per hour at 2.5% grade for three 
minutes.  The stages progressed to three miles an hour with an increase in grade 2.5% 
every three minutes.  Subjects exercised to volitional fatigue and maximal oxygen 
consumption (VO2max) was the average of the highest two oxygen measures during the 






Eligible subjects were randomized into intervention groups by the Efron 
procedure.  This procedure is based on a computer algorithm which balances groups for 
sample size, HDL and LDL cholesterol measures (Efron, 1971).  The four intervention 
groups were: 1) control, 2) diet, 3) exercise and 4) diet plus exercise. 
Control 
 
 The control group was instructed to maintain their usual lifestyle habits for the 
duration of the intervention. 
Low-fat diet  
 
 The dietary goals of the DEER were based on the National Cholesterol Education 
Program (NCEP) Step II Guidelines (1993):  1) reduce total fat to less than 30% of total 
calories, 2) reduce saturated fat to less 7% of total calories and 3) reduce dietary 
cholesterol to less than 200 mg/day.  Each participant met with a dietician to 
individualize dietary recommendations and attended eight group sessions about the 
NCEP Step II Guidelines.  After completion of the group dietary sessions, participants 
were contacted every other month by individual appointments, group sessions, telephone 
calls and/or mailings.   
Exercise  
 
 Exercise participants met with a member of the exercise intervention team to 
individualize the exercise prescription based on the results of the maximal exercise test.  
All exercise participants began with six weeks of aerobics sessions three days a week for 
one hour.  After the adoption phase, participants were instructed to perform 20 minutes 
three times a week at 60-85% maximum heart rate, increasing duration over the course of 
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the year to 45-60 total minutes.  Any individuals who were already active upon 
randomization were asked to add 20 minutes three times a week to their existing physical 
activity programs.  Participants had the option of continuing supervised training or 
adopting a home program for the remaining eight months.  The typical exercise program 
involved a minimum of ten miles per week of brisk walking, jogging, or running.   
Diet plus exercise  
 
 Participants in the diet plus exercise group received both the diet and exercise 
interventions as individual treatments.  Project staff involved with nutrition made no 
reference to physical activity and the exercise intervention staff made no references to 
diet.  Diet plus exercise had separate nutrition and exercise sessions from the other 
groups to prevent contamination.   
 It is important to note that the diet, exercise and diet plus exercise groups did not 
emphasize weight loss as an intervention goal. 
Statistical Analysis 
 
All statistical analyses were performed by using SAS software version 9.1 (SAS 
Institute, Cary, NC).  Participants with CRP levels at baseline or follow-up over 10 mg/L 
were removed from the analysis to eliminate the acute effects of infection (n=9) (Myers 
et al., 2004).  Values were rounded to one decimal point to standardize CRP reporting 
(Myers et al., 2004).  Since the DEER demographic eligibility criteria varied for men and 
women, all analyses were stratified by gender. 
 An analysis of covariance (ANCOVA) was used to test the effects of low-fat diet 
and exercise on CRP changes between intervention groups.  Change was calculated as a 
difference between the follow-up value and the baseline value.  Differences for the 
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change in CRP between intervention groups were compared for:  1) control versus diet, 
2) control versus exercise, 3) control versus diet plus exercise, 4) diet versus diet plus 
exercise and 5) exercise versus diet plus exercise.  An α level of 0.01 was adopted to 
control for type I error and to account for the multiple statistical comparisons.  ANCOVA 
analyses controlled baseline CRP, cohort, baseline body fat percentage, change in body 
fat, cigarettes per day, alcoholic drinks per day and age.  For women, hormone 
replacement therapy (HRT) status was also included as a covariate.  Analyses controlled 
for the change in body fat in an attempt to eliminate the influence on the change in CRP.  
Models were also analyzed without including the change in body fat as a covariate.   
 Repeated measures generalized linear modeling assessed changes in CRP within 
each intervention group between baseline and follow-up with adjustments for the same 
covariates as previously described.  CRP values at baseline and follow-up did not have a 
normal distribution, and were skewed to the right of the mean.  Thus to satisfy the 
normality assumptions for ANCOVA, a log transformation was made.  Results for within 
group differences were quantified as ∆ log CRP and were considered statistically 
significant if p < 0.05.  
The CDC/AHA established categories to identify individuals at increased risk for 
cardiovascular disease based on their level of CRP:  low risk (less than 1 mg/L), average 
risk (1-3 mg/L), and high risk (above 3.0 mg/L) (Myers et al., 2004).  Logistic regression 
analyzed the change in distribution for high risk individuals between intervention groups, 








 Of the total 377 DEER participants who were randomized for the study, 278 
participants (74%, 149 men and 129 women) were analyzed for changes in CRP.  
Participants were not included in the analysis due to incomplete data which was assumed 
to be missing at random.  
Men and women had an average age of 49.0 ± 8.83 and 57.6 ± 5.05 years, 
respectively.  Participants were mostly Caucasian (~85%), non-smokers (~ 98%) and 
consumed less than one alcoholic drink per day (~ 95%).  Men and women were highly 
educated: 61% of men and 42% of women had a college degree or greater.  The mean 
BMI for men was approximately 26 kg/m2 and 26% were normal weight, 58% were 
overweight and 16% were obese.  In women, mean BMI was approximately 26 kg/m2, 
and 37% were normal weight, 49% were overweight and 13% were obese.  
Approximately 45% of women were on HRT.  Table 4.1 shows the baseline study 
variables by intervention groups for men and women. 
Data from the original DEER study indicate adherence to the assigned treatment 
groups for men and women: the change in fitness (VO2max) from baseline was 
significantly greater in the exercise group and diet plus exercise groups relative to 
controls.  Furthermore, the changes in total fat, saturated fat and cholesterol were 
significantly different within the diet group and diet plus exercise groups relative to the 
control group, in both men and women (Table 4.2).  There was little loss to follow-up for 
data collection, and retention was 98% and 96% in men and women, respectively 
(Stefanick et al., 1998).    
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Table 4.1 Baseline Characteristics in Men and Women (mean ± SD). 
___________________________________________________________________________________________________________ 
Men (n=149)    Control   Diet    Exercise   Diet plus Exercise  
N     33   39   35   42 
Age      48.8 ± 9.79  49.3 ± 9.17   49.5 ± 8.67   48.5 ± 8.12 
Caucasian (%)    91   79.5   91   81 
Non-Smokers (%)   97   100   100   100 
≤1 Alcoholic Drink per day (%) 88   92   91   95 
Waist Circumference (cm)  95.3 ± 9.39  95.9 ± 10.15  95.4 ± 7.85  94.8 ± 8.52 
Body Fat (%)      21.1 ± 3.60  21.3 ± 4.48  22.3 ± 4.96  21.6 ± 4.13 
BMI (kg/m2)    26.7 ± 3.19  26.9 ± 3.10  26.9 ± 2.64  26.6 ± 2.63 
CRP (mg/L)       1.4 ± 1.47    1.0 ± 1.16    1.3 ± 1.26    1.4 ± 1.34 
High CRP (>3mg/L) n(%)    3(9)     2(5)     5(14)     5(12) 
__________________________________________________________________________________________________________ 
Women (n=129)   Control   Diet    Exercise   Diet plus Exercise 
N     34   32   30   33 
Age      58.4 ± 4.84  57.9 ± 5.36   57.1 ± 5.36  56.8 ± 4.80 
Caucasian (%)    85   91   89   90 
Non-Smokers (%)   100   100   100   91 
≤1 Alcoholic Drink per day (%) 94   97   90   100 
Waist Circumference (cm)  85.4 ± 11.60  85.3 ± 7.83  83.3 ± 7.11  83.7 ± 9.19 
Body Fat (%)      31.7 ± 5.73  31.8 ± 4.77  31.6 ± 5.30  32.8 ± 5.25 
BMI (kg/m2)    26.0 ± 3.88  26.6 ± 2.82  25.6 ± 2.51  26.3 ± 3.42 
CRP (mg/L)      2.2 ± 2.19    1.9 ± 1.60    1.8 ± 1.55    1.9 ±1.75 
High CRP (>3mg/L) n(%)    9(25)     7(21)     5(16)     5(14) 
 






Table 4.2.  Baseline Values and Changes in Body Fat, Physical Activity, Physical Fitness, Dietary Fat, Saturated Fat and Cholesterol 
Intake.+ 
____________________________________________________________________________________________________________ 
Men    Baseline  ∆ Control  ∆ Diet   ∆ Exercise   ∆ Diet plus  
                Exercise____ 
Body Fat (%)     21.6 ± 0.35    0.5 ± 0.59  -1.5 ± 0.55*  -0.5 ± 0.67  -2.0 ± 0.51* 
Physical Activity Score    27.8 ± 1.69  -4.4 ± 3.46   1.9 ± 3.25  13.3 ± 3.02*  21.3 ± 4.53*  
VO2max (mL/kg/min)    37.7 ± 0.56  -0.9 ± 0.60   1.0 ± 0.61    1.9 ± 0.77*    4.8 ± 0.77* 
Fat (% of total intake)    30.5 ± 0.59  -1.1 ± 1.13  -8.7 ± 1.35*   -0.9 ± 0.99   -8.3 ± 0.93* 
Saturated Fat (% of total intake)   10.0 ± 0.26           -0.13 ± 0.45  -3.8 ± 0.52*   -0.3 ± 0.38   -3.9 ± 0.42* 
Cholesterol intake (mg)  261.4 ± 10.41            -15.4 ± 22.84         -115.5 ± 20.79*               -5.2 ± 15.90          -110.3 ± 17.24* 
_____________________________________________________________________________________________________________________ 
Women   Baseline  ∆ Control  ∆ Diet   ∆ Exercise   ∆ Diet plus  
                Exercise____ 
Body Fat (%)     32.1 ± 0.46     1.4 ± 0.62   -1.4 ± 0.77*  0.09 ± 0.70      -2.2 ± 0.79* 
Physical Activity Score    23.0 ± 2.11      14.1 ± 7.30    2.3 ± 2.91  17.0 ± 6.53  12.5 ± 6.30 
VO2max (mL/kg/min)    26.0 ± 0.41    -1.0 ± 0.45    0.5 ± 0.77*    2.2 ± 0.59*    3.6 ± 0.64* 
Fat (% of total intake)    28.1 ± 0.63    -0.1 ± 1.12   -5.9 ± 1.31*    1.4 ± 1.05   -8.5 ± 1.07* 
Saturated Fat (% of total intake)     9.0 ± 0.25                0.1 ± 0.46   -2.3 ± 0.52*    0.3 ± 0.54   -3.2 ± 0.42* 
Cholesterol intake (mg)  174.6 ± 7.23     7.4 ± 15.34            -67.2 ± 12.58*  17.3 ± 16.53            -67.7 ± 14.34* 
____________________________________________________________________________________________________________ 
Adapted from Stefanick et al., 1998 
+ Means ± standard error 
* p < 0.05 for the change in the variable between intervention group and control group  
(Change in body fat, physical activity and VO2max adjusted for age and baseline values; Fat, saturated fat and cholesterol adjusted for 
baseline values)
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CRP Changes Between Intervention Groups 
 
 There were no baseline CRP differences between control, diet, exercise or diet 
plus exercise groups in either men or women.  CRP changes from baseline to follow-up 
between control, diet, exercise and diet plus exercise groups were not different in men (p 
= 0.99) (Figure 4.1).  CRP changes were significantly different between intervention 
groups in women (p = 0.036).  Reductions in CRP in women were significantly greater 
when comparing diet plus exercise to the control group (-0.7 ± 0.33 mg/L, p = 0.04) and 
exercise group (-0.9 ± 0.32 mg/L, p = 0.004) (Figure 4.2).  
CRP Changes Within Intervention Groups 
 
   In men, CRP did not change from baseline to follow-up within the control, 
exercise, diet or diet plus exercise groups.  In women, only the diet plus exercise group 
had a difference in CRP from baseline to follow-up (∆ log CRP 0.2 ± 0.035 mg/L; p = 
0.0002).    
Change Between Intervention Groups for CRP Category 
 
 Approximately 10% of men and 19% of women were classified in the high CRP 
risk category (> 3 mg/L) at baseline.  At follow-up, approximately 6% of men and 17% 
of women remained classified as high CRP risk.  Logistic regression for the high risk 
category at follow-up did not reveal differences for the distribution of individuals 
between intervention groups either in men (p = 0.74) or women (p = 0.38).     
 No differences in statistical significance were noted after removing the change in 























Figure 4.1. CRP change in men between groups (n = 149).  Adjusted changes in CRP 
(mg/L) ± standard error are presented.  ANCOVA statistical comparisons between 
intervention groups adjusted for the following covariates:  baseline CRP, baseline body 
fat percentage, change in body fat, cohort, cigarettes per day, alcoholic drinks per day and 
age.  In men, no differences existed between or within control, diet, exercise or diet plus 































† significant difference for CRP change between intervention groups 
‡ significant change in CRP from baseline to follow-up within intervention group  
 
Figure 4.2. CRP change in women between groups (n = 129).  Adjusted changes in CRP 
(mg/L) ± standard error are presented.  ANCOVA statistical comparisons between 
intervention groups adjusted for the following covariates:  baseline CRP, baseline body 
fat percentage, change in body fat, cohort, cigarettes per day, alcoholic drinks per day, 
age and hormonal therapy status.  In women, differences for the change in CRP were 
found between the control versus diet plus exercise group (p = 0.04); exercise versus diet 
plus exercise group (p = 0.0043).  In women, CRP changes from baseline to follow-up 







 In postmenopausal women, CRP was significantly different from low-fat diet plus 
exercise in comparison to both the control and exercise only groups.  In contrast, men did 
not show significant differences for the CRP change between control, diet, exercise or 
diet plus exercise.   
These findings for women revealed that a low-fat diet plus exercise intervention 
was more efficacious than exercise alone, which was also confirmed in other research 
(Nicklas et al., 2004).  In contrast to our findings, previous research indicated that diet 
plus exercise was more effective at reducing CRP than diet alone (You et al., 2004; 
Esposito et al., 2003; Esposito et al., 2004).  However, none of these studies included a 
control group for comparison, and weight loss was also induced through hypocaloric 
intake (You et al., 2004; Esposito et al., 2003; Esposito et al., 2004).  The change in CRP 
is directly related to weight loss  (Due et al., 2005) and the change in weight (Clifton et 
al., 2005).  For each one kilogram of diet or exercise induced weight loss, CRP is reduced 
-0.13 mg/L  (Selvin et al., 2007).  Therefore, from previous research, it is difficult to 
discern the exact stimulus for CRP change: weight loss, low-fat diet and/or exercise.  Our 
intervention did not include purposeful weight loss and an adjustment for the changes in 
body fat were also made.  Results from our study suggest that changes in CRP are no 
different between diet plus exercise and diet when compared to control. 
Reductions for CRP for women between diet plus exercise and control were 
comparable to other low-fat diet plus exercise programs in which weight loss was 
unintentional (Bo et al., 2007).  However, Bo et al., included both men and women 
together in the same analysis without adjustment for gender despite known differences in 
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CRP levels at baseline (2007).  Thus, our findings in women suggest that CRP levels can 
be reduced from the incorporation of a low-fat diet combined with exercise, even while 
controlling for the change in body fat. 
Men in the DEER trial did not significantly reduce their CRP levels in the diet 
plus exercise group when compared to a control group.  Contrary to our findings, a diet 
plus exercise intervention in men significantly reduced CRP levels (Roberts et al., 2006).  
However the Roberts et al., study involved a three week residential diet and exercise 
program which may not be entirely generalizable to the DEER community dwelling one 
year intervention (2006).  The Roberts et al., dietary protocol involved fat restriction to 
12-15% of total intake, which is a more stringent reduction than the DEER goal of less 
than 30% total fat intake.  Roberts et al., also included only obese men, and did not adjust 
CRP values for baseline weight status or the possible change in weight (2006).  The 
release of CRP is controlled, in part, by TNF-α and IL-6, which can be located and 
released from the adipose tissue (Petersen et al., 2005).  Thus, the more body fat a person 
has, the higher the release of CRP (Visser et al., 1999).  Therefore, it is imperative to 
control for body fat in order to eliminate the effect of excess adipose tissue on CRP 
levels.  Most importantly, Roberts et al., did not have a control group for comparison 
(2006).  Our results imply that when controlling for baseline body fat, and possible 
changes in body fat, low-fat diet plus exercise may not decrease CRP in men when 
compared to a control group. 
 The current study did not find significant independent effects of low-fat diet alone 
or exercise alone in comparison to a control group, in either men or women.  Other low-
fat diet interventions, which did not attempt to induce concurrent weight loss, either 
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through isocaloric or ad-libitum consumption, agree with our findings (Koren et al., 
2006; Desroches et al., 2006; Jenkins et al., 2005), though none of these were compared 
to a control condition.  Our null findings for exercise versus control are also confirmed 
with other training interventions (Hammett et al., 2004; Huffman et al., 2006; Marcell et 
al., 2005; Rauramaa et al., 2004; Smith et al., 1999).  Thus, our results suggest that the 
independent effects of both low-fat diet and exercise are not effective for changing CRP 
levels in men and women compared to a control group.  
 Possible explanations for the lack of effect either between or within interventions 
groups for changes in CRP may be due to a lower than expected mean value for CRP.  
Since CRP and dyslipidemia are positively associated (Medina-Urrutia et al., 2008; 
Wisse, 2004), we expected CRP values above the United States population median (Ford 
et al., 2003; Ford et al., 2004).  Other studies with dyslipidemic subjects have had similar 
mean values to those we hypothesized (Festa et al., 2000).  However, the DEER means 
were 1.3 ± 1.30 mg/L for men and 1.9 ± 1.73 mg/L in women, which were lower than the 
age and gender matched national median values.  This discrepancy in CRP could be due 
to the DEER participants average levels of body fat (2006).  It is possible that although 
the subjects had dyslipidemia, the subjects were mostly normal weight and overweight, 
which could have resulted in the lower baseline CRP levels.  The lower CRP mean may 
have not provided enough power to detect differences between groups for the change in 
CRP.   
 We did not directly compare men and women for CRP response to lifestyle 
intervention in the current study.  Due to eligibility criteria for the enrollment of the 
present study, women were an average of ten years older than the male participants.  As 
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previously mentioned, CRP levels are higher in women and also increase with aging 
(Ford et al., 2003; Ford et al., 2004; Rumley et al., 2006).  Therefore, we performed our 
statistical analysis separately within the genders, to avoid bias from age and/or gender.  
Stratified gender analyses make it challenging to distinguish whether the reduction in 
CRP from diet plus exercise in women was due to gender, age, or higher overall CRP 
levels.  Future studies should continue to analyze men and women separately and explore 
possible biological mechanisms to explain the possible gender discrepancy for the 
response of CRP to lifestyle intervention. 
 Several physiological mechanisms exist to explain the changes in CRP from low-
fat diet and exercise.  Low-fat foods may simultaneously change macronutrient intake 
and quality (Jenkins et al., 2005).  IL-6, which controls the release of CRP, is 
hypothesized to also be stimulated by the amount of insulin in the bloodstream (McCarty, 
2005).  Meals that limit postprandial glucose and hyperinsulinemia, such as fruits, 
vegetables and whole grains, may reduce levels of CRP in the bloodstream (Clifton et al., 
2003).  Increased fruit and vegetable consumption can also induce an anti-inflammatory 
response which may also lower CRP levels (Middleton E Jr, 1998).  During a bout of 
exercise, IL-6 is released from muscle tissue.  An increase in IL-6 levels initiates the 
secretion of anti-inflammatory markers such as interleukin-10 (IL-10) and interleukin-1 
receptor antagonist (IL-1ra) which downregulate the pro-inflammatory effects of TNF-α  
(Pedersen, 2006; Petersen et al., 2005).  This negative feedback loop suggests that 
chronic exercise decreases CRP levels.  While the mechanisms that describe low-fat diet 
and physical activity and their relationship to CRP reduction appear to be independent, 
one could theorize that physiological effects could be additive.  However, the exact 
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physiological mechanism relating the decrease in CRP from diet plus exercise is poorly 
understood.   
Since most of our subjects were Caucasian, highly educated, and highly 
motivated, our results may be limited to persons with similar characteristics.  
Furthermore, all of the women were postmenopausal which also reduces the 
generalizability.    
Despite the limitations in the present study, this report eliminated many of 
shortcomings from previous research.  Our study included a randomized controlled 
design which examined the independent and combined effects of low-fat diet and 
exercise.  Our analysis also adjusted for baseline body fat and changes in body fat, which 
have known influences on the level of circulating CRP.  Finally, our separate analyses in 
men and women removed the possible gender bias. 
 In conclusion, CRP levels decreased for women in the diet plus exercise group 
compared to exercise and control groups.  These results suggest that CRP levels can be 


















The Effects of a Low-Fat Diet and Exercise on Metabolic Syndrome:  




 Metabolic syndrome is a clustering of abnormal metabolic, lipid and non-lipid 
variables.  The National Cholesterol Education Program (NCEP) has operationally 
defined metabolic syndrome as meeting at least three of the following criteria:  1) 
abdominal obesity, 2) elevated triglycerides, 3) low high density lipoprotein cholesterol 
(HDL), 4) hypertension and 5) high fasting glucose (2001).     
The prevalence of metabolic syndrome has increased over the past ten years.  
Data from the 1988-1994 National Health and Nutrition Examination Survey estimated 
the prevalence of metabolic syndrome to be approximately 23% (Ford et al., 2002), 
which increased to 27% by 1999 (Ford et al., 2004a).  Metabolic syndrome prevalence 
among Americans from the 2002 National Health and Nutrition Survey (NHANES) was 
35% (Ford, 2005).  The presence of metabolic syndrome may predict cardiovascular 
disease mortality and morbidity better than any of its individual components (Isomaa et 
al., 2001).  In fact, individuals with the presence of metabolic syndrome are two to three 
times more likely to die from cardiovascular disease (Ford, 2004; Lakka et al., 2002).  
Therefore, it is paramount to find effective treatments to reverse metabolic syndrome in 
order to curb the progression of cardiovascular disease. 
 Recommendations for treatment for reversing metabolic syndrome from the 
NCEP Adult Treatment Panel emphasize changing negative lifestyle behaviors such as 
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reducing intake of saturated fat and cholesterol, increasing physical activity and 
achieving weight loss (2001).  While these lifestyle modifications have shown benefits 
for individual risk factors (Grundy et al., 2004b), evidence for improving metabolic 
syndrome prevalence with low-fat diet and/or physical activity without intentional weight 
loss has not been consistent.  
Few randomized controlled trials have systematically examined the individual and 
combined effects of low-fat diet and exercise on metabolic syndrome.  Diet plus exercise 
demonstrates more success for reversing metabolic syndrome than diet or exercise alone 
(Anderssen, et al., 2007; Okura et al., 2007), however these interventions also included 
concomitant weight loss.  Weight loss can improve many of the individual metabolic and 
lipid components of metabolic syndrome (Yu-Poth et al., 1999), making it difficult to 
identify the successful component(s) of the intervention.  Another challenge within the 
current lifestyle research for metabolic syndrome is the absence of a control group for 
comparison, which may limit the interpretation of results (Roberts et al., 2006; Muzio et 
al., 2005; Esposito et al., 2004; Okura et al., 2007). 
Interventions that examined the independent effects of low-fat diet or exercise on 
metabolic syndrome status have also been limited.  Low-fat dietary patterns, such as 
Mediterranean and DASH, have reduced metabolic syndrome prevalence (Azadbakht et 
al., 2005; Marfella et al., 2004), however, these low-fat diets also included purposeful 
weight loss.  Furthermore, both the Mediterranean and DASH diets have multiple dietary 
alterations beyond reducing fat intake, which also may decrease the presence of 
metabolic syndrome.  While exercise interventions have reduced the presence of 
metabolic syndrome (Katzmarzyk et al., 2003; Milani & Lavie, 2003; Shubair et al., 
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2004), studies which included a control group for comparison have been inconsistent 
(Anderssen et al., 2007; Johnson et al., 2007; Stewart et al., 2005).  Combined diet plus 
exercise interventions which either controlled for weight loss in the statistical analysis 
(Esposito et al., 2004) or allowed ad-libitum intake (Roberts et al., 2006), found 
significant reductions in the prevalence of metabolic syndrome.  However, none of these 
combined diet plus exercise studies incorporated a randomized controlled design.   
The purpose of this study was to examine the effects of low-fat diet and exercise 
on metabolic syndrome prevalence with a randomized controlled trial.  Based on the 
previous literature, we hypothesized that exercise alone will show no change in metabolic 
syndrome prevalence when compared to a control.  We also hypothesized that low-fat 
diet and diet plus exercise will show significant decreases in metabolic syndrome 




 The Diet and Exercise for Elevated Risk Trial (DEER) began in 1992 as a year-
long, single-center randomized controlled clinical trial within the Stanford Medical 
School’s Center for Research in Disease Prevention.  The original primary objective was 
to examine the effects of low-fat diet and exercise, alone and together, on plasma 
lipoproteins in men and postmenopausal women (Stefanick et al., 1998).  The present 
secondary data analysis retrospectively determined the effects of low-fat diet and exercise 
on metabolic syndrome status. 
 Specific eligibility criteria for men were: age 30-64 years, HDL < 45 mg/dL, low 
density lipoprotein cholesterol (LDL) 126-189 mg/dL and body mass index (BMI) ≤  34 
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kg/m2.  Eligibility criteria for women were: postmenopausal, age 45-64 years, HDL < 60 
mg/dL, LDL 126-209 mg/dL and BMI ≤  32 kg/m2.  In addition, men and women had 
blood pressure below 160/95 mmHg, triglycerides under 500 mg/dL, fasting glucose 
under 140 mg/dL and a normal maximal exercise treadmill test.  Exclusion criteria 
included history of heart disease, abnormal response to symptom-limited treadmill 
exercise test, insulin dependent diabetes mellitus, neuromuscular/orthopaedic disability, 
use of lipid medication, non-euthyroid, low hematocrit, excessive smoking or alcohol 
consumption, inability to attend sessions or by judgment of a physician.  
 A variety of mass media was utilized for recruitment from the community 
surrounding Stanford University in Palo Alto, California.  Recruiting strategies included 
worksite contacts, posted flyers, handouts, brochures to area physician offices and clinics, 
newsletters, mailings and paid advertisements.     
Measurement 
 Participants underwent telephone screening and a number of tests including 
laboratory blood analysis, dietary screening, exercise habits and physical examination.  
All measures were taken at baseline prior to randomization and then repeated at one year 
follow-up. Clinic staff who performed the measures were blinded to participants’ 
treatment status.  
 Body composition 
 Body weight was measured with a standard medical beam balance scale.  Height 
was measured using a Harpenden stadiometer.  BMI was calculated by dividing the 
participant’s body weight in kilograms by height squared (kg/m2).  BMI categories were 
determined using the guidelines presented by the National Institutes of Health (NIH) 
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(1998).  Waist circumference was taken in triplet and average from the narrowest 
circumference of the torso when viewed from the front.  Estimation of body composition 
was made utilizing skinfold measurements.  All skinfold measures were taken three times 
on the right side of the body and averaged.  For males, the locations of the skinfolds were 
chest, abdomen, thigh.  For women, the skinfold locations were triceps, suprailiac and 
thigh.  Body density was estimated using generalized equations (Jackson et al., 1978; 
Jackson et al., 1980).  Percent body fat was calculated using the Siri equation (Siri, 1961). 
 Cardiovascular risk factors 
A mercury sphygmomanometer estimated blood pressure from the brachial artery.  
Averages of two readings of the first and fifth phase Korotkoff were noted as systolic and 
diastolic blood pressure readings in millimeters of mercury (Fortmann et al., 1988). 
 For the venous blood collection, participants were asked to refrain from smoking 
for the hour prior, fast with no food or drink (except water) for at least 12 hours, and 
abstain from alcohol consumption and vigorous activity for at least 24 hours.  Blood 
samples were taken in the morning on two different visits at baseline.  All collected blood 
was mixed with 1.5 mg/mL of EDTA.  Standard methods were used:  serum was allowed 
to clot for 30-60 minutes, centrifuged, put on ice, and then plasma was transferred to the 
freezer at -80° C. 
 Both fasting blood samples were analyzed for lipoproteins.  Total cholesterol and 
triglycerides were measured using enzymatic procedures (Allain et al., 1974; Sampson et 
al., 1975).  HDL was measured using dextran sulfate – magnesium precipitation 
(Warnick et al., 1982) as well as enzymatic measurement of non-precipitated cholesterol 
(Allain et al., 1974).  Very low density lipoprotein (VLDL) was calculated as 
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triglycerides divided by five (Friedewald et al., 1972).  If triglyceride levels were over 
400 mg/dL enzymatic methods were used to measure VLDL according to Friedewald 
methods (Friedewald et al., 1972).  LDL was calculated as total cholesterol minus the 
sum of HDL + VLDL (Friedewald et al., 1972).  Lipoprotein values were averaged 
between the two fasting blood samples. 
Metabolic syndrome definition 
 
 Metabolic syndrome prevalence was determined using the NCEP’s Adult 
Treatment Panel III definition (NCEP-ATPIII) (2001).  Clinical identification of the 
metabolic syndrome involves an individual having at least three or more abnormal 
cardiovascular risk factors including abdominal obesity, dyslipidemia, hypertension and 
abnormal glucose metabolism.  Details of the definition are provided in Table 5.1. 
Table 5.1.  Clinical Identification of the Metabolic Syndrome NCEP-ATP III 
 
Diagnosis is established when ≥ 3 of the following risk factors are present: 
RISK FACTOR DEFINING LEVEL 
FOR MEN 
 




      Waist Circumference 
 
 
> 102 cm 
 
> 88 cm 
Dyslipidemia 
      Triglycerides 
 
 
≥ 150 mg/dL 
 
≥ 150 mg/dL 
      High Density Lipoprotein 
 
< 40 mg/dL < 50 mg/dL 
Hypertension 
       Blood Pressure 
 
≥ 130 / ≥ 85 mmHg 
 
≥ 130 / ≥ 85 mmHg 
Metabolism  
       Fasting Glucose 
 
≥ 100 mg/dL* 
 
≥ 100 mg/dL* 
*This definition is updated to reflect the current American Diabetes Association fasting 








 Five unannounced 24 hour dietary recalls were administered using Nutrient Data 
Systems (NDS), a computer assisted telephone interview developed by the University of 
Minnesota Nutrition Coordinating Center.  Interviews included one weekend day and 
four weekdays on non-consecutive days.  Nutrient intake was calculated as the mean of 
the five recalls with use of food database software Version 5a & 6a.   
Physical activity  
 
 Physical activity was assessed with the Godin Leisure Time Exercise 
Questionnaire (Godin) (Godin et al., 1985).  The Godin questionnaire is valid and reliable 
against maximal oxygen consumption testing (Godin et al., 1985; Jacobs, Jr. et al., 1993).  
The specific questionnaire asks “Considering a seven day period (a week), how many 
times on average do you do the following kinds of exercises for more than 15 minutes 
during your free time?”.  Intensities assessed include: 1) strenuous exercise (heart beats 
rapidly), 2) moderate exercise (not exhausting), and 3) mild exercise (minimal effort).  
Total weekly 15 minute bouts for strenuous, moderate and mild exercise are multiplied 
by 3, 5 and 9, respectively to convert to MET-weighted units.  The total MET-weighted 
units are then summed to identify a physical activity score. 
Physical fitness  
 
 A maximal graded exercise test was administered to measure physical fitness by 
oxygen consumption.  A semi-automated metabolic analysis system measured oxygen 
consumption every 30 seconds (Savin et al., 1980).  Speed started at two miles per hour 
at 2.5% grade for three minutes.  The stages progressed to three miles an hour with an 
increase in grade 2.5% every three minutes.  Subjects exercised to volitional fatigue and 
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maximal oxygen consumption (VO2max) was the average of the highest two measures 
during the final minutes of exercise. 
Randomization  
Individuals were randomized into four intervention groups:  1) control, 2) diet, 3) 
exercise and 4) diet plus exercise.  Randomization was done by the Efron procedure in 
which participants were assigned to one of the four groups by a computer algorithm 
which balanced groups for sample size,  average HDL cholesterol, and LDL cholesterol 
(Efron, 1971). 
Control  
 The control group was asked to maintain their usual diet and exercise habits until 
tests were completed one year after randomization.     
Low-fat diet  
 Participants were instucted to achieve the dietary goals set by the NCEP Step II 
Guidelines (1993):  1) reduce total fat to less than 30% of total calories, 2) reduce 
saturated fat to less 7% of total calories and 3) reduce dietary cholesterol to less than 200 
mg/day.  Each participant met with a dietitian to establish individualized dietary 
recommendations and attended eight weekly group sessions.  After completion of group 
sessions, participants were contacted every other month via individual appointments, 
group sessions, telephone calls and/or mailings.   
Exercise  
 
 Individuals in the exercise group met with a member of the exercise intervention 
team in order to individualize the exercise prescription.  The adoption phase for exercise 
training consisted of six weeks of three days a week of one hour supervised aerobics 
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training.  After the adoption period, participants began with 20 minutes duration, three 
times a week and proceeded to increase duration to 45-60 minutes total over the course of 
a year.  Initial intensity recommendations were to achieve 60-85% maximum heart rate 
which was determined from the maximal graded treadmill test.  Any individuals who 
were already active upon randomization were asked to add 20 minutes three times a week 
to their existing physical activity programs.  After three months, participants continued 
with supervised activity or were encouraged to adopt a home program for the remaining 
7-8 months.  Weekly exercise programs consisted of a minimum of ten miles of brisk 
walking, jogging or running each week.   
Diet plus exercise  
 
 Participants randomized into the diet plus exercise group received both 
interventions as individual treatments.  Dietitians made no reference to physical activity 
and the exercise interventionists made no references to dietary changes.  The diet plus 
exercise group had separate nutrition and exercise sessions from the other groups to 
prevent contamination.   
 It is important to note that the diet, exercise and diet plus exercise groups did not 
emphasize weight loss as an intervention goal. 
Statistical Analysis 
 
 All statistical analyses were performed by using SAS software version 9.1 (SAS 
Institute, Cary, NC).  Since enrollment criteria for cardiovascular risk factors were 






 Metabolic syndrome  
 
Logistic regression was used to compare between intervention groups for 
metabolic syndrome prevalence at follow-up.  Specific comparisons were between: 1) 
control versus diet, 2) control versus exercise, 3) control versus diet plus exercise, 4) diet 
versus diet plus exercise and 5) exercise versus diet plus exercise.  A conservative α level 
of 0.01 was chosen to protect against type I error.  All models controlled for baseline 
metabolic syndrome prevalence, age and change in body fat percent.  For women, 
hormone replacement therapy (HRT) was added as a covariate.  All statistical models for 
metabolic syndrome were adjusted for the change in percentage body fat in an attempt to 
eliminate its effect on metabolic syndrome status.  All models were also analyzed without 
the adjustment for the change in body fat to note any changes in significance. 
Repeated measures generalized linear modeling assessed within intervention 
group prevalence for metabolic syndrome from baseline to follow-up.  The binary 
distribution was adjusted for age and change in body fat percent.  Results were 
considered statistically significant if p < 0.05.  
 Finally, intervention groups were combined within gender to explore whether the 
changes in individual cardiometabolic risk factors predicted the presence of metabolic 
syndrome at follow-up.  Specifically, logistic regression examined the changes in the 
following predictors for metabolic syndrome: fasting glucose, HDL, waist circumference, 
systolic and diastolic blood pressure, and triglycerides.  Each analysis controlled for the 
covariates as described previously.  Among individuals with baseline metabolic 
syndrome, t-tests were conducted to determine differences for the mean values of the 
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individual cardiometabolic risk factors in those who reversed or maintained metabolic 
syndrome at follow-up. 
Number of abnormal risk factors 
 
 The number of abnormal risk factors was defined as the mean number of criteria 
from the metabolic syndrome definition that each participant met.  For example, if a 
participant had blood pressure above the threshold for the metabolic syndrome definition, 
but did not meet any of the other criteria, then the number of abnormal risk factors would 
be 1.  Change was calculated as the difference between the follow-up and baseline values 
for the number of abnormal risk factors.  Differences between the intervention groups for 
the change in the number of abnormal risk factors were compared using general linear 
modeling.  Statistical comparisons were made between intervention groups as described 
previously, also adopting a conservative α level of 0.01 to protect against type I error. 
Repeated measures generalized linear modeling assessed within intervention group 
changes for the number of abnormal risk factors from baseline to follow-up.  Results 
were considered statistically significant if p < 0.05.  All models with the number of 
abnormal risk factors as the outcome were controlled for baseline number of abnormal 




 Of the total 377 DEER participants who were randomized for the study, 325 
participants (86%, 179 men and 146 women) had sufficient data for determining 
metabolic syndrome prevalence at both baseline and follow-up.  The average age in years 
for men and women was 48.6 ± 8.70 and 57.8 ± 5.08, respectively.  Participants were 
mostly Caucasian (~85%) and 61% of men and 42% of women had completed a college 
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degree.  Men (Table 5.2) and women (Table 5.3) had elevated LDL cholesterol, low HDL 
cholesterol, normal blood pressure and normal fasting glucose levels.  Approximately 
46% of women were on HRT.  The mean BMI was approximately 26 kg/m2 for both men 
and women.  BMI classifications in men were 28% normal weight, 58 % overweight and 
15% obese.  BMI classifications in women were 37% were normal weight, 48% 
overweight and 14% obese.  Baseline characteristics and demographics for men are 
presented in Table 5.2 and for women in Table 5.3. 
 Data from the original DEER study indicate adherence to the assigned treatment 
groups for men and women: fitness (VO2max) from baseline was significantly greater in 
the exercise group and diet plus exercise groups relative to controls.  Changes in total fat, 
saturated fat and cholesterol were significantly different within the diet group and diet 
plus exercise groups relative to the control group, in both men and women (Table 5.4).  
There was little loss to follow-up for data collection, and retention was 98% and 96% in 





Table 5.2. Baseline Characteristics in Men (mean ± SD).  
___________________________________________________________________________________________________ 
Men (n=179)    Control   Diet    Exercise  Diet plus Exercise  
N(%)       44(25)   47(26)     42(23)    46(26) 
LDL (mg/dL)     158.0 ± 17.72  156.5 ± 18.70  155.0 ± 16.37  156.5 ± 17.18 
HDL (mg/dL)      34.2 ± 5.32    35.3 ± 5.24    35.1 ± 4.26    34.6 ± 4.65 
Systolic Blood Pressure (mmHg)  112.5 ± 10.40  113.2 ± 11.73  113.1 ± 12.64  113.2 ± 11.25 
Diastolic Blood Pressure (mmHg)    76.0 ± 7.62    75.4 ± 8.40    75.7 ± 6.34    75.4 ± 8.34 
Triglycerides (mg/dL)   175.0 ± 87.18  183.5 ± 94.43  178.9 ± 63.37  160.3 ± 63.66 
Fasting Glucose (mg/dL)    93.0 ± 9.01    96.9 ± 6.46    97.9 ± 10.54    95.3 ± 8.05 
Waist Circumference (cm)    94.9 ± 8.74    95.3 ± 10.04    94.9 ± 7.81    95.4 ± 8.51 
Percent Body Fat (%)       21.0 ± 3.77    21.4 ± 4.45    22.0 ± 4.88    22.0 ± 4.07 
BMI (kg/m2)      26.7 ± 2.89    26.8 ± 3.10    26.7 ± 2.65    26.8 ± 2.63 
Metabolic Syndrome n(%)      9(20)    15(32)    13(31)    16(35) 
Number of Abnormal Risk Factors     1.8 ± 1.11      2.1 ± 1.12      2.0 ± 0.99      2.2 ± 1.03 
____________________________________________________________________________________________________ 
Key:  LDL:  low density lipoprotein cholesterol; HDL:  high density lipoprotein cholesterol 
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Table 5.3. Baseline Characteristics in Women (mean ± SD).  
___________________________________________________________________________________________________ 
Women (n=146)   Control  Diet   Exercise  Diet plus Exercise  
N(%)       37(25)    40(27)    33(23)    36(25) 
LDL (mg/dL)     163.9 ± 17.46  163.9 ± 23.93  168.6 ± 23.98  165.0 ± 21.43 
HDL (mg/dL)      44.9 ± 7.06    45.1 ± 7.33    44.8 ± 7.17    45.3 ± 6.85 
Systolic Blood Pressure (mmHg)  113.3 ± 12.59  116.1 ± 15.67  114.0 ± 13.49  112.5 ± 12.40 
Diastolic Blood Pressure (mmHg)    72.2 ± 7.67    73.7 ± 8.77    71.5 ± 7.91    71.7 ± 7.83 
Triglycerides (mg/dL)   161.2 ± 68.1  155.3 ± 78.58  159.6 ± 77.92  150.7 ± 70.9 
Fasting Glucose (mg/dL)    92.9 ± 8.76    92.8 ± 7.40    94.2 ± 10.52    93.9 ± 10.63 
Waist Circumference (cm)    85.1 ± 11.65    84.9 ± 7.68    83.5 ± 9.33    83.7 ± 9.19 
Percent Body Fat (%)       31.6 ± 5.71    31.9 ± 4.69    33.1 ± 5.21    32.8 ± 5.25 
BMI (kg/m2)      25.9 ± 3.94    26.5 ± 2.92    26.4 ± 3.42    26.3 ± 3.42 
Metabolic Syndrome n(%)    10(27)    12(30)    11(33)     14(39) 
Number of Abnormal Risk Factors     1.9 ± 1.17      1.9 ±1 .22      2.0 ± 1.12      1.9 ± 1.20  
____________________________________________________________________________________________________ 
Key:  LDL:  low density lipoprotein cholesterol; HDL:  high density lipoprotein cholesterol 
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Table 5.4.  Baseline Values and Changes in Body Fat, Physical Activity, Physical Fitness, Dietary Fat, Saturated Fat and Cholesterol.+ 
____________________________________________________________________________________________________________ 
Men    Baseline  ∆ Control  ∆ Diet   ∆ Exercise  ∆ Diet plus    
                Exercise____ 
Body Fat (%)     21.6 ± 0.32     0.6 ± 0.49    -1.6 ± 0.48*   -0.6 ± 0.58    -1.9 ± 0.48* 
Physical Activity Score    28.1 ± 1.51               -3.7 ± 2.79                4.4 ± 3.62  13.3 ± 3.23*   21.7 ± 4.17*  
VO2max (mL/kg/min)    37.6 ± 0.51    -0.8 ± 0.53     0.4 ± 0.58    2.0 ± 0.67*     4.8 ± 0.71* 
Fat (% of total intake)    30.4 ± 0.53    -0.7 ± 0.90    -8.2 ± 1.19*   -0.7 ± 0.90    -8.4 ± 0.86* 
Saturated Fat (% of total intake)   10.1 ± 0.23  -0.02 ± 0.37    -3.6 ± 0.46*   -0.2 ± 0.41    -3.9 ± 0.39* 
Cholesterol intake (mg)  257.2 ± 9.11      -7.0 ± 18.65           -106.3 ± 19.09*   -9.2 ± 15.22           -111.6 ±15.82* 
_____________________________________________________________________________________________________________________ 
Women   Baseline  ∆ Control  ∆ Diet   ∆ Exercise  ∆ Diet plus  
                Exercise____ 
Body Fat (%)   32.2 ± 0.42     1.2 ± 0.64  -1.1 ± 0.63*    0.1 ± 0.67   -1.9 ± 0.73* 
Physical Activity Score  23.3 ± 1.93   12.4 ± 6.53   1.2 ± 2.48  16.0 ± 5.97  13.6 ± 6.02 
VO2max (mL/kg/min)  26.1 ± 0.40    -0.9 ± 0.41   0.2 ± 0.68    2.4 ± 0.63*    3.5 ± 0.68* 
Fat (% of total intake)  28.2 ± 0.58     0.3 ± 1.05  -5.8 ± 1.13*    1.6 ± 1.14   -8.4 ± 1.01* 
Saturated Fat (% of total intake)   8.9 ± 0.23     0.1 ± 0.43  -2.4 ± 0.44*    0.5 ± 0.56   -3.1 ± 0.39* 
Cholesterol intake (mg)            176.3 ± 6.75   12.2 ± 14.66           -74.4 ± 10.92*  22.2 ± 16.5            -57.0 ± 11.84* 
____________________________________________________________________________________________________________ 
Adapted from Stefanick et al., 1998 
+ Means ± standard error 
* p < 0.05 for the change in the variable between intervention group and control group  
(Change in body fat, physical activity and VO2max adjusted for age and baseline values; Fat, saturated fat and cholesterol adjusted for 
baseline values) 
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Metabolic Syndrome Prevalence 
 
At baseline, prevalence of metabolic syndrome was 30% and 32% in men and 
women, respectively.  In men at follow-up, the prevalence of metabolic syndrome was 
20% in the controls, 17% in the diet group, 14% in the exercise group and 15% in the diet 
plus exercise group.  For women at follow-up, the prevalence of metabolic syndrome at 
follow-up was 27% in the controls, 8% in the diet group, 21% in the exercise group and 
22% in the diet plus exercise group.   
Differences in metabolic syndrome prevalence between intervention groups 
 
Comparisons for the odds of having metabolic syndrome at follow-up between 
intervention groups revealed no differences in men (p = 0.87) (Figure 5.1) or women (p = 
0.12) (Figure 5.2). The difference in the log odds for having metabolic syndrome between 
diet and control groups approached statistical significance in women (OR: 2.0, 95% CI: 
0.37-3.59; p = 0.0157).  
Differences in metabolic syndrome prevalence within intervention groups 
 
 Differences in the odds ratio for metabolic syndrome from baseline to follow-up 
were found within the diet plus exercise groups in men (OR: 3.5, 95% CI: 1.14-10.56; p 
= 0.029) and the diet only group in women (OR:  5.9, 95% CI: 1.38-24.84; p = 0.018).  
Thus, for men in the diet plus exercise group, the odds of having metabolic syndrome at 
baseline, was 3.5 times of that at follow-up.   
 No changes in significance were noted after removing body fat change as a 
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‡ significant difference in metabolic syndrome within intervention group from baseline to 
follow-up 
 
Figure 5.1.  Changes in metabolic syndrome prevalence in men (n = 179).  Unadjusted 
prevalence (%) at baseline and follow-up is shown.  Logistic regression was utilized to 
compare metabolic syndrome prevalence at follow-up between intervention groups, 
controlling for baseline metabolic syndrome prevalence, change in body fat and age.  No 
differences between control, diet, exercise and diet plus exercise were found for 
metabolic syndrome prevalence at follow-up in men.  The diet plus exercise group had 



















































‡ significant difference in metabolic syndrome within intervention group from baseline to 
follow-up 
 
Figure 5.2.  Changes in metabolic syndrome prevalence in women (n = 146).  Unadjusted 
prevalence (%) at baseline and follow-up is shown.  Logistic regression compared 
metabolic syndrome prevalence at follow-up between intervention groups while adjusting 
for baseline metabolic syndrome prevalence, change in body fat, HRT and age.  No 
differences were found between control, diet, exercise and diet plus exercise for 
metabolic syndrome prevalence at follow-up in women.  The diet group had a significant 
decrease in metabolic syndrome prevalence from baseline to follow-up (p = 0.018).  
‡ 
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Predictors of Metabolic Syndrome  
 
 Since no differences between intervention groups existed for metabolic syndrome 
prevalence at follow-up, intervention groups were combined by gender to examine 
possible predictors for metabolic syndrome at follow-up.  The change in glucose, systolic 
blood pressure and diastolic blood pressure predicted the presence of metabolic syndrome 
at follow-up in men (Table 5.5).  For women, the change in waist circumference, systolic 
blood pressure, diastolic blood pressure, triglycerides and glucose predicted the presence 
of metabolic syndrome at follow-up (Table 5.5).  For a one unit change in a specific 
predictor, the odds for the presence of metabolic syndrome are expected to change by the 
odds ratio estimate.  For example, in men, the odds ratio of metabolic syndrome at 
follow-up was predicted by the change in glucose as 1.1 (CI:  1.03-1.14), which indicates 
that there is increase in the odds of having the metabolic syndrome for each mg/dL 
increment change in glucose levels. 
Table 5.5.  Cardiometabolic Predictors of Metabolic Syndrome at Follow-up for Men and 
Women. 
________________________________________________________________________ 
Men         OR  95% CI   p-value 
Total Men (n=179) 
Change in Waist Circumference (cm)    1.1        0.99-1.20     0.08 
Change in Triglycerides (mg/dL)   1.0        1.00-1.01  0.08 
Change in HDL cholesterol (mg/dL)    0.9        0.85-1.02  0.11 
Change in Systolic Blood Pressure (mmHg)    1.1        1.01-1.12  0.02 
Change in Diastolic Blood Pressure (mmHg)  1.1        1.03-1.17   0.005 
Change in Glucose (mg/dL)          1.1        1.03-1.14  0.001  
Women      OR  95% CI   p-value 
Total Women (n=146) 
Change in Waist Circumference (cm)   1.2         1.05-1.31  0.005 
Change in Triglycerides (mg/dL)   1.0         1.01-1.02  0.002 
Change in HDL cholesterol (mg/dL)    1.0         0.94-1.04   0.33 
Change in Systolic Blood Pressure (mmHg)     1.1         1.01-1.09  0.01 
Change in Diastolic Blood Pressure (mmHg)  1.1         1.04-1.21  0.002 
Change in Glucose (mg/dL)     1.1         1.01-1.14   0.03 
Abbreviations:  CI:  Confidence Intervals; HDL:  high density lipoprotein 
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In men who had metabolic syndrome at baseline, significant differences for the 
changes in triglycerides, HDL, diastolic blood pressure and fasting glucose were found 
between those who maintained versus reversed metabolic syndrome status (Table 5.6).  In 
women, significant differences in the mean values existed between those who reversed or 
maintained metabolic syndrome status for waist circumference, triglycerides, and 
diastolic blood pressure (Table 5.6). 
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Table 5.6. Differences in Cardiometabolic Risk Factors Between Individuals Who Maintained or Reversed Metabolic Syndrome.  
__________________________________________________________________________________________________________________________________________ 
     Men              Women  ______________  
     Mean Change+   p-value*  Mean Change+  p-value* 
Waist Circumference (cm)   
 Total     -3.3 ± 0.35     -3.1 ±  0.42  
 Reverse    -5.6 ± 0.77     -5.3 ±  0.72  
 Maintain    -2.8 ± 1.28    0.06    0.4 ± 0.88    <0.0001 
Triglycerides (mg/dL)   
 Total     -2.5 ± 6.04         -5.7 ± 5.52     
 Reverse             -45.2 ± 14.28               -46.9 ± 12.40 
 Maintain    21.0 ± 19.77    0.009              16.1 ± 16.41         0.003       
HDL cholesterol (mg/dL)   
 Total      0.3 ± 0.38     1.5 ± 0.64 
 Reverse     3.0 ± 1.01     2.4 ± 1.67   
 Maintain              -0.3 ± 0.87     0.02   1.3 ± 1.15           0.58       
Systolic Blood Pressure (mmHg)        
 Total    -0.5 ± 0.64       -2.1 ± 1.04     
 Reverse   -3.6 ± 2.54     -4.6 ± 3.16 
 Maintain    0.2 ± 2.54    0.19    2.0 ± 2.29           0.11         
Diastolic Blood Pressure (mmHg)  
 Total    -0.4 ± 0.54        -1.8 ± 0.59        
 Reverse   -4.0 ± 1.15     -5.1 ± 1.58 
 Maintain    0.5 ± 1.84    0.04    3.5 ± 1.44        0.0003 
Fasting Glucose (mg/dL)   
 Total     -6.5 ± 0.68          -6.3  ± 0.93   
 Reverse              -11.9 ±1.44     -9.7  ± 1.41   
 Maintain    -5.8 ±2.44    0.03    0.05± 4.73          0.059 
+ unadjusted means ± SE 
* p-value:  t-tests between mean values for individual cardiometabolic risk factors for reverse versus maintain  
Total:  men n =179; women n = 146 
Reverse:  Baseline metabolic syndrome, Follow-up no metabolic syndrome (men n = 35; women n = 26) 
Maintain:  Baseline metabolic syndrome, Follow-up metabolic syndrome (men n = 18; women n = 21) 
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Number of Abnormal Cardiometabolic Risk Factors   
 
 No differences were found between intervention groups for the number of 
abnormal risk factors at baseline in either men or women.  Figures 5.3 and 5.4 display the 
adjusted changes in the number of abnormal cardiometabolic risk factors in men and 
women for each intervention group. 
Changes in cardiometabolic risk factors between intervention groups 
 There were no differences for the change in abnormal risk factors between 
control, diet, exercise or diet plus exercise groups in men (p = 0.53) or women (p = 0.42).  
Changes in cardiometabolic risk factors within intervention groups 
 In men, decreases in the number of abnormal risk factors between baseline and 
follow-up were found for the diet group (-0.4 ± 0.19; p = 0.02), exercise group (-0.4 ± 
0.15; p = 0.006) and diet plus exercise group (-0.7 ± 0.13; p < 0.0001).  In women, 
decreases in the number of abnormal risk factors were significant for diet group (-0.6 ± 
0.22; p = 0.006), exercise (-0.4 ± 0.11; p = 0.003) and diet plus exercise (-0.4 ± 0.20; p = 
0.045).  
 No changes in significance were noted when removing body fat change as a 
covariate, either between or within intervention groups, for the number of abnormal 




























‡significant change in the number of abnormal risk factors within intervention group 
between baseline and follow-up 
 
Figure 5.3.  Change in the number of abnormal risk factors in men (n = 179).  Adjusted 
means for the change ± standard error are shown.  Comparisons between groups adjusted 
for baseline number of risk factors, change in body fat, cohort and age.  No differences 
were found for the change in abnormal risk factors between control, diet, exercise and 
diet plus exercise groups in men.  Decreases within intervention group from baseline 
were found within the diet group (p = 0.02), exercise group (p = 0.006) and diet plus 





































‡significant change in the number of abnormal risk factors within intervention group 
between baseline and follow-up 
 
Figure 5.4. Change in the number of abnormal risk factors in women (n = 146).  Adjusted 
means ± standard error are shown.  Comparisons between intervention groups controlled 
for baseline number of abnormal risk factors, change in body fat, cohort, hormone 
therapy status and age.  No differences were found between control, diet, exercise or diet 
plus exercise for the change in the number of risk factors.  Decreases within intervention 
group from baseline were significant within diet (p = 0.01), exercise (p = 0.003) and diet 


























 To our knowledge, our study is the first to systematically compare the 
independent and combined effects of low-fat diet and exercise on metabolic syndrome 
prevalence from a randomized controlled trial.  A one-year lifestyle intervention did not 
result in any significant differences for metabolic syndrome prevalence between the low-
fat diet, exercise and diet plus exercise in either men or postmenopausal women relative 
to control.  Despite the null findings for between intervention group differences, there 
were large net reductions for metabolic syndrome prevalence within groups for men (diet 
plus exercise: -57%) and women (diet: -76%).  Furthermore, decreases in the number of 
abnormal risk factors were found within low-fat diet, exercise and diet plus exercise from 
baseline to follow-up, though none of these changes were significantly different from the 
control group.  These results suggest that in comparison to a control group, low-fat diet, 
exercise and diet plus exercise are ineffective for lowering metabolic syndrome in men or 
women.   
The low-fat diet and exercise program in the current study did not appear to have 
additive effects as hypothesized.  Despite our own null findings, several studies found 
that diet plus exercise was more successful at reversing metabolic syndrome status over 
diet alone (Anderssen et al., 2007; Okura et al., 2007) or exercise alone (Anderssen et al., 
2007).  Importantly, Okura and colleagues did not have a control condition to compare 
the effects of diet alone or diet plus exercise (2007).   Other discrepancies between our 
findings and Andersen et al., (2007) and Okura et al., (2007) may be due to their 
recruitment of only obese individuals, limiting generalizability to DEER’s mostly normal 
weight and overweight men and women.  Furthermore, both Okura et al., (2007) and 
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Anderssen et al., (2007) also restricted energy intake to promote weight loss.  Weight loss 
can also favorably change the individual components of metabolic syndrome (Dansinger 
et al., 2005; Yu-Poth et al., 1999), whereby the greater the weight loss, the larger the 
magnitude of change in cardiovascular risk factors (Muzio et al., 2005).  Our intervention 
did not promote weight loss, and weight loss was controlled for in the statistical analysis.  
Thus, our results from a diet plus exercise randomized controlled trial suggest that 
changing lifestyle in normal weight/overweight individuals, without an emphasis on 
weight loss may be insufficient for reversing metabolic syndrome status. 
Another explanation for our findings may be due to the baseline characteristics of 
our study participants.  One study suggests that diet plus exercise interventions are more 
successful for reducing metabolic syndrome prevalence in adults with abdominal obesity 
and hypertension compared with individuals with lipid abnormalities (Orchard et al., 
2005).  Our group of men and women were dyslipidemic at baseline, but did not exceed 
the abdominal obesity threshold or hypertension criteria for defining the metabolic 
syndrome.  Thus, lifestyle intervention may have been less effective in resolving the 
metabolic syndrome in this specific group of participants.   
Our non-significant findings for the independent effects of exercise for reducing 
metabolic syndrome prevalence for men and women are confirmed in other controlled 
studies (Stewart et al., 2005; Anderssen et al., 2007).  However, our findings for the 
independent effects of low-fat diet on metabolic syndrome are not in agreement with 
previous research.  Low-fat diet interventions have significantly decreased the presence 
of metabolic syndrome (Muzio et al., 2005), even in comparison to a control group 
(Azadbakht et al., 2005).  However, Azadbakht et al., also induced weight loss and 
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included the DASH diet which modifies multiple dietary components beyond reducing 
fat intake (2005).  Our findings suggest that reducing only fat intake, while controlling 
for the change in body fat, is not efficacious for reducing metabolic syndrome in men or 
women.  
Previous interventions for low-fat diet plus exercise resulted in a decrease in 
metabolic syndrome prevalence (Esposito et al., 2004; Muzio et al., 2005; Orchard et al., 
2005; Roberts et al., 2006).  However, many of the combined diet plus exercise studies 
lacked a true control condition for comparison (Esposito et al., 2004; Muzio et al., 2005; 
Roberts et al., 2006), included significant weight loss (Esposito et al., 2004; Muzio et al., 
2005; Orchard et al., 2005), or incorporated several dietary changes besides reducing fat 
intake (Esposito et al., 2003; Esposito et al., 2004).   Our low-fat diet plus exercise 
intervention changed only dietary fat intake and controlled for weight loss, however no 
significant improvements in metabolic syndrome prevalence were found when compared 
to a control condition in either men or women. 
A possible explanation for the lack of independent effects of diet, exercise and 
diet plus exercise versus the control group may be the nature of the control group. 
Eligibility criteria did not include sedentary individuals and the control group was not 
screened for high physical activity or low-fat dietary intake.  While the control group did 
not adopt a dietary or fitness protocol, they were asked to continue their current daily 
routines.  Therefore, this control group was not necessarily a sedentary, unfit or higher 
dietary fat consuming group.  For example, as reported in Stefanick et al (1998), the total 
fat intake for men at baseline was approximately 30% and for women was 28%, which 
was already very close to the intervention goal of less than 30%.  Therefore, the control 
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group was essentially meeting the dietary requirements for the intervention and there may 
not have been a sufficient change between controls and intervention groups to provide 
statistical power to detect differences between intervention groups. 
Regardless of the addition of low-fat diet and/or exercise, metabolic syndrome 
status at follow-up was predicted by the change in blood pressure and glucose in men and 
women.  Changes in waist circumference, and triglycerides were also factors for women.  
Bo and colleagues demonstrated that the changes in metabolic syndrome in adults are 
mostly related to the changes in triglycerides, glucose and waist circumference (2007).  
While the mechanism causing metabolic syndrome remains unknown,  insulin resistance 
and adiposity are thought to be the main components (Eckel, Grundy, & Zimmet, 2005).  
Predictors of metabolic syndrome at follow-up for both men and women included 
surrogate measures of adiposity and insulin resistance.      
Although the sample was considered at high cardiovascular risk due to their 
dyslipidemia, only approximately 30% had metabolic syndrome at baseline.  It was 
hypothesized that metabolic syndrome would be closer to 55%, as evidenced in other 
studies of high cardiovascular risk adults (Orchard et al., 2005).  The lower prevalence 
most likely reduced statistical power to detect significant differences between 
intervention groups for metabolic syndrome.  
Men and women in this study were analyzed separately in order to account for the 
gender differences in recruitment and eligibility criteria concerning age and 
cardiovascular risk factors.  Since metabolic syndrome is directly assessed from these 
variables, we felt that it was more appropriate to stratify genders for analyses.  It is 
possible that separating the genders reduced power to explore between intervention group 
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differences.  An additional statistical analysis was done which utilized the entire sample 
of men and women while controlling for age and gender.  Gender was not significant in 
the overall model, which agrees with previous research for the response to exercise 
(Katzmarzyk et al., 2003) and diet plus exercise (Bo et al., 2007).  Even with the larger 
sample size, there were no significant differences in metabolic syndrome prevalence at 
follow-up between control, diet, exercise and diet plus exercise.   
Women in the current study were all postmenopausal, which places these women 
at an increased risk for metabolic syndrome (Park et al., 2003).  While postmenopausal 
status does eliminate certain hormonal differences from men, it also reduces the 
generalizability of results of this study to premenopausal women.  Also, it is important to 
consider that the sample is mostly Caucasian, highly educated, highly motivated and had 
high retention to measurement at follow-up, which further limits the generalizability of 
our findings.   
Future work is needed to identify the ideal combination of diet and physical 
activity to successfully reduce metabolic syndrome in men and women.  Low-fat dietary 
patterns such as the DASH and Mediterranean diet need to confirm findings for reversal 
of metabolic syndrome status without purposeful weight loss.  Larger doses of physical 
activity have resulted in significant reductions in metabolic syndrome prevalence in 
elevated cardiovascular risk subjects (Johnson et al., 2007), and future studies should 
continue to examine the appropriate threshold of physical activity, also in combination 
with low-fat diet or dietary pattern. 
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 In conclusion, no differences in metabolic syndrome were found in either men or 
women between a control group and a low-fat diet, exercise and diet plus exercise 


































Changes in C-Reactive Protein from Low-Fat Diet and/or Exercise in 
Men and Women With and Without Metabolic Syndrome:  Results 




The process of atherosclerosis leading to cardiovascular disease has been 
hypothesized to be controlled through inflammation (Bhagat et al., 1997; Libby, 2002; 
Ross, 1999).  Chronic inflammation is characterized by elevated levels of C-reactive 
protein (CRP), an acute phase reactant released from the liver in response to various 
cytokines such as interleukin-6 (IL-6) and tumor necrosis factor (TNF-α).  CRP is also 
theorized to be an actual feature of metabolic syndrome, precursor to cardiovascular 
disease involving a clustering of multiple metabolic and lipid abnormalities (Festa et al., 
2000).  
Individuals with metabolic syndrome also possess elevated levels of inflammatory 
cytokines and CRP (Ford, 2003; Pitsavos et al., 2005; Saltevo et al., 2007).  For every 1 
pg/mL of CRP, there is a 37% increased risk of having metabolic syndrome (Hassinen et 
al., 2006).  CRP and metabolic syndrome are each independent predictors of 
cardiovascular events (Rutter et al., 2004; Sattar et al., 2003) and the combination of both 
adds predictive and prognostic value to the estimation of cardiovascular disease and type 
II diabetes risk (Ridker et al., 2003b; Sattar et al., 2003).   
Prevalence of metabolic syndrome among Americans is approximately 35% 
(Ford, 2005) while 25% of adults have elevated CRP levels (Pearson et al., 2003).  For 
 105
management of metabolic syndrome, The National Cholesterol Education Program 
(NCEP) recommends weight loss, reduction in dietary fat intake and increased physical 
activity (2001).  Diet or exercise induced weight loss can independently improve the 
individual components of metabolic syndrome (Yu-Poth et al., 1999) and CRP levels 
(Clifton et al., 2005; Due et al., 2005; Selvin et al., 2007).  However, determining the 
most effective lifestyle treatment to lower CRP levels in individuals with metabolic 
syndrome without the contribution of weight loss is unknown.  Few studies have 
compared the independent and combined effects of low-fat diet and exercise in 
individuals with metabolic syndrome. 
Combined diet plus exercise studies show significant reductions in CRP in 
individuals with metabolic syndrome (Bo et al., 2007; Esposito et al., 2004; Roberts et 
al., 2006), even when weight loss was not an intervention goal (Bo et al., 2007; Roberts 
et al., 2006).  However, these studies are either in a single gender (Roberts et al., 2006) or 
combine gender in the statistical analyses (Bo et al., 2007; Esposito et al., 2004).  It is 
well established that women have higher levels of CRP than their age-matched male 
counterparts (Ford et al., 2003; Ford et al., 2004b).  Research suggests that higher CRP 
values at baseline can result in larger decreases in CRP with both low-fat diet (Seshadri et 
al., 2004) and exercise (Goldhammer et al., 2005; Lakka et al., 2005).  Thus, analyses of 
CRP from lifestyle intervention should be kept gender separate.  Separate gender analysis 
revealed similar magnitudes of CRP change in insulin resistant men and women from a 
diet plus exercise intervention (Haffner et al., 2005), however these results may not be 
generalizable to individuals with metabolic syndrome who have multiple lipid and 
metabolic disorders.   
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The independent effects of low-fat diet and exercise have not been specifically 
examined for changes in CRP in individuals with metabolic syndrome.  However, several 
lifestyle interventions have explored the results of lifestyle interventions in other high 
cardiovascular risk adults.  Low-fat diet interventions have not shown success in reducing 
CRP in hyperlipidemic subjects (Jenkins et al., 2005) or hypertensive subjects in 
comparison to a control group (Erlinger et al., 2003).  While exercise training lowered 
CRP in adults with normal glucose tolerance, insulin resistance and type II diabetes 
(Oberbach et al., 2006), these changes were not significant in dyslipidemic adults when 
compared to a control group (Huffman et al., 2006).  Dyslipidemia and hypertension are 
only part of the metabolic syndrome, and the clustering of multiple risk factors may alter 
changes in CRP in response to low-fat diet or exercise. 
 The purpose of this study was to explore CRP changes resulting from a low-fat 
diet and /or exercise intervention, relative to controls, in men and women with and 
without metabolic syndrome.  We hypothesized that the combined intervention of low-fat 
diet and exercise would be the most effective treatment for reducing CRP in both men 
and women.  We also hypothesized that men and women with metabolic syndrome would 
benefit most from diet plus exercise, due to their higher overall CRP levels.   
 
Methods 
 The Diet and Exercise for Elevated Risk Trial (DEER) was a one year single-
center randomized controlled clinical trial which began in 1992 at Stanford Medical 
School.  The original DEER objective was to examine the effects of diet and exercise on 
plasma lipoproteins in men and postmenopausal women (Stefanick et al., 1998).  The 
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present secondary data analysis incorporated a new laboratory test for CRP and a 
retrospective analysis of metabolic syndrome to compare the effects of low-fat diet and 
exercise. 
 Specific eligibility criteria for men were: age 30-64 years, high density lipoprotein 
cholesterol (HDL) < 45 mg/dL, low density lipoprotein cholesterol (LDL) 126-189 
mg/dL and body mass index (BMI) ≤  34 kg/m2.  Eligibility criteria for women were: 
postmenopausal, age 45-64 years, HDL < 60 mg/dL, LDL 126-209 mg/dL and BMI ≤  32 
kg/m2.  In addition, men and women had blood pressure under 160/95 mmHg, 
triglycerides under 500 mg/dL, fasting glucose under 140 mg/dL and a normal maximal 
exercise treadmill test.  Exclusion criteria included history of heart disease, insulin 
dependent diabetes mellitus, neuromuscular/orthopaedic disability, use of lipid 
medication, not euthyroid, low hematocrit, excessive smoking or alcohol consumption, 
inability to attend sessions or by judgment of a physician.  
 A variety of mass media was used for recruiting strategies from the Stanford 
University area in Palo Alto, California.  Recruitment methods included worksite 
contacts, posted flyers, handouts, brochures to area physician offices and clinics, 
newsletters, mailings and paid advertisements.     
Measurement  
 
 Potential participants had telephone screening, laboratory blood analysis, dietary 
screening, exercise habits assessment and a physical examination.  Baseline measures 
were taken before randomization and then repeated at one year follow-up.  Clinic staff 
were blinded to the specific treatment of the participants. 
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 Body composition 
 Body weight was measured with a standard medical beam balance scale.  Height 
was measured using a Harpenden stadiometer.  Waist circumference was taken three 
times and averaged from the narrowest circumference of the torso when viewed from the 
front.  BMI was calculated by dividing the participant’s body weight in kilograms into 
their height squared (kg/m2).  BMI categories were determined using the guidelines 
presented by the National Institutes of Health (NIH) (1998).  Body density and body 
composition estimates were made from skinfold measurements.  Skinfolds were  
measured on the right side of the body in triplicate and averaged.  For males, the 
locations of the skinfolds were chest, abdomen and thigh.  For women, the skinfold 
locations were triceps, suprailiac and thigh.  Body density was estimated using 
generalized equations (Jackson et al., 1978; Jackson et al., 1980) and percent body fat 
was calculated using the Siri equation (Siri, 1961). 
 Cardiovascular risk factors 
 Blood pressure was measured from the brachial artery utilizing a mercury 
sphygmomanometer and stethoscope.  Averages for two readings of the first and fifth 
phase Korotkoff were recorded as systolic and diastolic blood pressure readings in 
millimeters of mercury (Fortmann et al., 1988).  
 Prior to venous blood collection, participants abstained from alcohol consumption 
and vigorous activity for at least 24 hours, food or drink for 12 hours and refrained from 
smoking for the hour prior.  Blood samples were taken in the morning in duplicate at 
baseline.  All blood specimens were mixed with 1.5 mg/mL of EDTA.  Serum was 
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allowed to clot for 30-60 minutes, centrifuged, put on ice, and then plasma was 
transferred to the freezer for storage at -80° C. 
 Both fasting blood samples were analyzed for lipoproteins.  Total cholesterol and 
triglycerides were measured using enzymatic procedures (Allain et al., 1974; Sampson et 
al., 1975).  HDL was measured using dextran sulfate–magnesium precipitation (Warnick 
et al., 1982) as well as enzymatic measurement of non-precipitated cholesterol (Allain et 
al., 1974).  Very low density lipoprotein (VLDL) was calculated as triglycerides divided 
by five (Friedewald et al., 1972).  If triglyceride levels exceeded 400 mg/dL, enzymatic 
methods were used to measure VLDL according to Friedewald methods (Friedewald et 
al., 1972).  LDL was calculated as total cholesterol minus the sum of HDL + VLDL 
(Friedewald et al., 1972).  Lipoprotein values were averaged between the two baseline 
fasting values. 
 C-Reactive Protein  
 
 Plasma high sensitivity CRP concentrations were measured utilizing one of the 
two stored bloods chosen at random.  CRP concentration was determined with an 
immunoturbidimetric assay on the Hitachi 917 analyzer (Roche Diagnostics - 
Indianapolis, IN) using reagents and calibrators from DiaSorin (Stillwater, MN).  In this 
assay, an antigen-antibody reaction occurs between CRP and an anti-CRP antibody that 
has been sensitized to latex particles, resulting in agglutination.  This antigen-antibody 
complex causes an increase in light scattering, which is detected spectrophotometrically, 
with the magnitude of the change being proportional to the concentration of CRP in the 
sample.  Five-point calibration curves were constructed and standardized against 
CRM470.  Values of density and absorption were read at 570 nm with a background 
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subtract of 800 nm.  This assay has a sensitivity of 0.03 mg/L.  The day-to-day variability 
of the assay at concentrations of 0.91, 3.07 and 13.38 mg/L are 2.81, 1.61 and 1.1%, 
respectively.  
 Metabolic syndrome definition 
 
The National Cholesterol Education Program Adult Treatment Panel III (NCEP–
ATP III) developed a definition to identify metabolic syndrome in which an individual 
must have three of the following:  1) waist circumference greater than 102 cm in men; 88 
cm women, 2) triglycerides greater than or equal to 150 mg/dL, 3) HDL cholesterol less 
than 40 mg/dL for men; 50 mg/dL for women, 4) blood pressure greater than or equal to 
130/85 mmHg and 5) fasting glucose greater than or equal to 100 mg/dL (2001; Grundy 
et al., 2004a).  
Dietary intake 
 
 Five unannounced 24 hour dietary recalls captured one weekend day and four 
weekdays on non-consecutive days.  The diet recalls utilized a computer assisted 
telephone interview by Nutrient Data Systems (NDS), developed by the University of 
Minnesota Nutrition Coordinating Center.  Food database software Version 5a & 6a 
calculated nutrient intake as the mean from the five recalls.  
Physical activity  
 
 Physical activity was assessed with the Godin Leisure Time Exercise 
Questionnaire (Godin) (Godin et al., 1985).  The Godin questionnaire is both valid and 
reliable against maximal oxygen consumption testing in men and women (Godin et al., 
1985; Jacobs, Jr. et al., 1993).  The specific questions ask, “Considering a seven day 
period (a week), how many times on average do you do the following kinds of exercises 
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for more than 15 minutes during your free time?”.  Intensities assessed include 1) 
strenuous exercise (heart beats rapidly), 2) moderate exercise (not exhausting), and 3) 
mild exercise (minimal effort).  Total weekly 15 minute bouts for strenuous, moderate 
and mild exercise are multiplied by 3, 5 and 9, respectively to convert to MET-weighted 
units.  The total MET-weighted units are then summed to identify a physical activity 
score. 
Physical fitness  
 
 Physical fitness was measured by oxygen consumption with a maximal graded 
exercise treadmill test.  A semi-automated metabolic analysis system was used whereby 
oxygen uptake was measured every 30 seconds (Savin et al., 1980).  Speed started at two 
miles per hour at 2.5% grade for three minutes and progressed to three miles an hour with 
an increase in grade 2.5% every three minutes.  Subjects exercised to volitional fatigue 
and maximal oxygen consumption (VO2max) was an average of the highest two measures 
during the final minutes of exercise. 
Randomization 
 
 Individuals were randomized into four treatment groups:  1) control, 2) diet, 3) 
exercise and 4) diet plus exercise by the Efron procedure.  Participants were assigned to a 
group by a computer algorithm which balanced groups for sample size, HDL and LDL 
cholesterol (Efron, 1971). 
 Figure 6.1 displays the intervention program details for the control, diet, exercise 
and diet plus exercise groups.  The control group was advised to maintain their usual diet 
and exercise habits for one year.  The dietary group followed the dietary goals set by the 
National Cholesterol Education Program NCEP Step II Guidelines (1993) to reduce total 
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fat, saturated fat, and dietary cholesterol.  The exercise group engaged in a minimum of 
ten miles of walking/jogging each week at a moderate to vigorous intensity.  Diet plus 
exercise participants received both interventions as individualized treatments.  The 
individuals in the diet plus exercise group had separate nutrition and exercise sessions 
from the other groups to prevent contamination.  
  It is important to note that the diet, exercise and diet plus exercise groups did not 
emphasize weight loss as an intervention goal. 




All statistical analyses were performed by using SAS software version 9.1 (SAS 
Institute, Cary, NC).  Participants with CRP levels over 10 mg/L were removed from the 
 113
analysis to eliminate the acute effects of infection (n=9) (Myers et al., 2004).  Values 
were rounded to one decimal point to standardize CRP reporting (Myers et al., 2004).  
Since the DEER eligibility criteria were different for men and women, all analyses are 
done separately within gender. 
 Wilcoxon rank sum tests were used to compare CRP baseline level between 
metabolic syndrome status groups.  χ-square examined differences in the distribution of 
individuals in baseline high risk CRP categories.  Change was calculated as a difference 
between the follow-up value and the baseline value.  Analysis of covariance (ANCOVA) 
compared the treatment effects on CRP changes separately for individuals with and 
without metabolic syndrome.  Comparisons were made between intervention group 
differences for the change in CRP from baseline to follow-up:  1) control versus diet, 2) 
control versus exercise, 3) control versus diet plus exercise, 4) diet versus diet plus 
exercise and 5) exercise versus diet plus exercise.  All models were adjusted for the 
change in percentage body fat to eliminate its known effect on the change in CRP, as well 
as baseline CRP, baseline body fat percentage, cohort, change in body fat, cigarettes per 
day, alcoholic drinks per day and age.  Women had an additional covariate of hormonal 
replacement therapy status (HRT).  All models were also analyzed without including the 
change in body fat as a covariate to note any change in significance.  An α level of 0.01 
was adopted to control for type I error and account for the multiple statistical 
comparisons. 
 Repeated measures generalized linear modeling, with the above mentioned 
covariates, assessed changes in CRP within each intervention group for those with and 
without metabolic syndrome.  CRP values at baseline and follow-up were positively 
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skewed to the right, thus to satisfy the normality assumptions, a log transformation was 
made.  Results for within group differences were quantified as ∆ log CRP and were 




 Of the total 377 DEER participants who were randomized for the study, 274 
participants (73%, 149 men and 125 women) had sufficient data for determining CRP 
changes and metabolic syndrome status.  Participants were excluded from the current 
analysis due to incomplete data, which was assumed to be missing at random.   
 Men and women were mostly Caucasian (men: 85%; women: 88%), non-smokers 
(men: 99% women: 98%) and consumed one or less alcoholic drink per day (men: 92%; 
women: 95%).  Men and women were highly educated:  61% of men and 42% of women 
had a college degree or greater.  Approximately 44% of women were on HRT.   
Table 6.1 and Table 6.2 show baseline study characteristics stratified by 
metabolic syndrome status for men and women, respectively.  Classification of obesity 
according to the National Institutes of Health (NIH) (1998) was 32% in men with 
metabolic syndrome, while prevalence of obesity in men without metabolic syndrome 
was 7%.  Classification of obesity in women with metabolic syndrome was 33%, whereas 
obesity prevalence in women without metabolic syndrome was 5%.  Baseline CRP was 
1.5 ± 1.43 mg/L in men with metabolic syndrome and 1.2 ± 1.24 mg/L in men without 
metabolic syndrome (p = 0.24).  Baseline CRP was 2.4 ± 1.66 mg/L in women with 
metabolic syndrome and 1.7 ± 1.84 mg/L in women without metabolic syndrome (p = 
0.008).  According to the Centers for Disease Control and American Heart Association 
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classification (Myers et al., 2004), approximately 15% of men with metabolic syndrome 
and 8% of men without metabolic syndrome were considered to have high CRP at 
baseline (p = 0.18) Approximately 36% of women with metabolic syndrome and 13% of 
women without metabolic syndrome were considered to have high CRP at baseline (p = 
0.003). 
 Changes in body fat, physical activity, fitness (VO2max), total fat, saturated fat, 
and cholesterol intake are presented in men with and without metabolic syndrome (Table 
6.3), and in women with and without metabolic syndrome (Table 6.4).  There was little 
loss to follow-up for data collection, and retention was 98% and 96% in men and women, 




Table 6.1.  Baseline Characteristics in Men With and Without Metabolic Syndrome (mean ± SD). 
___________________________________________________________________________________________________________ 
With Metabolic Syndrome 
Men (n=47)    Control   Diet    Exercise   Diet plus    
              Exercise_______ 
N(%)       9(19)     13(28)    11(23)    14(30) 
Age        52.7 ± 11.27    52.4 ± 8.81     49.5 ± 10.07    48.7 ± 9.04 
Waist Circumference (cm)  104.2 ± 10.50  102.2 ± 9.96  100.9 ± 7.75  100.4 ± 7.83 
Body Fat (%)        22.3 ± 4.11    22.8 ± 4.37    22.9 ± 5.58    22.9 ± 5.58 
BMI (kg/m2)      29.0 ± 3.32    28.6 ± 3.05    28.2 ± 2.57    27.8 ± 2.81 
CRP (mg/L)        1.8 ± 1.57      0.8 ± 0.29      1.6 ± 1.56      1.9 ± 1.74 
 
 
Without Metabolic Syndrome 
Men (n=102)    Control   Diet    Exercise   Diet plus    
              Exercise_______ 
N(%)     24(24)   26(25)   24(24)   28(27) 
Age      47.3 ± 9.00  47.7 ± 9.11   49.5 ± 8.19  48.5 ± 7.80 
Waist Circumference (cm)  91.9 ± 6.47  92.8 ± 8.83  92.8 ± 6.60  92.0 ± 7.50 
Body Fat (%)      20.6 ± 3.36  20.5 ± 4.42  22.0 ± 4.75  20.9 ± 3.97 
BMI (kg/m2)    25.8 ± 2.72  26.1 ± 2.81  26.4 ± 2.52  26.0 ± 2.33 
CRP (mg/L)      1.3 ± 1.44    1.1 ± 1.40    1.1 ± 1.11    1.2 ± 1.05 
 








Table 6.2.  Baseline Characteristics in Women With and Without Metabolic Syndrome (mean ± SD). 
____________________________________________________________________________________________________________ 
With Metabolic Syndrome 
Women (n=39)   Control   Diet    Exercise   Diet plus    
              Exercise______ 
N(%)       9(23)     9(23)     9(23)   12(31) 
Age      57.4 ± 5.94  59.7 ± 4.18  56.9 ± 5.56  58.1 ± 3.60 
Waist Circumference (cm)  95.4 ± 10.15  91.6 ± 2.14  86.2 ± 4.37  93.4 ± 6.86 
Body Fat (%)      33.8 ± 5.90  33.3 ± 5.22  31.2 ± 4.13  36.9 ± 2.74 
BMI (kg/m2)    28.8 ± 2.96  28.2 ± 2.87  26.1 ± 1.94  29.7 ± 1.77 
CRP (mg/L)      2.6 ± 1.75    2.3 ± 1.83    2.2 ± 2.03    2.4 ± 1.40 
 
 
Without Metabolic Syndrome 
Women (n=86)   Control   Diet    Exercise   Diet plus    
              Exercise_______ 
N(%)     25(29)   23(27)   19(22)   19(22) 
Age      58.8 ± 4.47  57.2 ± 5.69   57.7 ± 5.40  55.7 ± 5.12 
Waist Circumference (cm)  81.8 ± 10.51  82.6 ± 7.88  82.5 ± 7.79  77.7 ± 5.50 
Body Fat (%)      30.9 ± 5.75  31.0 ± 4.60  32.2 ± 5.21  30.1 ± 4.78 
BMI (kg/m2)    25.0 ± 3.86  25.9 ± 2.57  25.7 ± 2.60  24.3 ± 2.58 
CRP (mg/L)      2.0 ± 2.41    1.6 ± 1.45    1.6 ± 1.35    1.7 ± 2.08 
 








Table 6.3.  Baseline Values and Changes in Body Fat, Physical Activity, Physical Fitness, Dietary Fat, Saturated Fat and Cholesterol 
Intake in Men With and Without Metabolic Syndrome.+ 
 
With Metabolic Syndrome  
    Baseline    ∆ Control     ∆ Diet  ∆ Exercise            ∆ Diet plus  
                Exercise 
N      47       9       13     11     14  
Body Fat (%)     22.8 ± 0.65     1.9 ± 1.04               -1.7 ± 1.15*    -0.9 ± 1.10           -1.92 ± 1.09* 
Physical Activity Score    21.6 ± 2.94  -10.6 ± 8.71                3.1 ± 1.84    16.9 ± 5.75*  21.1 ± 3.83*  
VO2max (mL/kg/min)    35.1 ± 0.86    -1.2 ± 0.79                1.0 ± 1.13     1.3 ± 1.40    4.7 ± 1.32* 
Fat (% of total intake)    32.4 ± 0.93    -4.0 ± 2.00    -7.2 ± 2.46    -4.7 ± 1.60   -9.3 ± 1.69 
Saturated Fat (% of total intake)   10.9 ± 0.48    -1.1 ± 0.85               -3.8 ± 1.22    -1.2 ± 0.78   -3.9 ± 0.87* 
Cholesterol (mg)  291.9 ± 18.86  -60.8 ± 45.01           -107.7 ± 32.74   -36.7 ± 39.14          -129.9 ± 23.81 
_____________________________________________________________________________________________________________________ 
Without Metabolic Syndrome  
    Baseline  ∆ Control  ∆ Diet   ∆ Exercise            ∆ Diet plus  
                Exercise 
N    102   24   26    24    28   
Body Fat (%)     21.0 ± 0.41           -0.02 ± 0.69             -1.4 ± 0.62   -0.3 ± 0.85  -2.0 ± 0.54* 
Physical Activity Score    30.6 ± 2.01  -2.2 ± 3.58    1.4 ± 4.70  11.6 ± 3.57*  21.5 ± 6.57* 
VO2max (mL/kg/min)    38.8 ± 0.69             -0.8 ± 0.80    0.9 ± 0.73    2.2 ± 0.94*               4.9 ± 0.97* 
Fat (% of total intake)    29.7 ± 0.73            0.02 ± 1.32   -9.4 ± 1.62    0.9 ± 5.37*              -7.8 ± 1.12* 
Saturated Fat (% of total intake)     9.7 ± 0.31              0.2 ± 0.53   -3.8 ± 0.50*    0.2 ± 0.41              -3.9 ± 0.46* 
Cholesterol (mg)  247.4 ± 12.30             1.7 ± 26.22          -119.4 ± 26.96*               9.2 ± 14.5          -100.5 ± 23.02* 
____________________________________________________________________________________________________________ 
Adapted from Stefanick et al., 1998 
+ Means ± standard error 
* p < 0.05 for the change in the variable between intervention group and control group 
(Change in body fat, physical activity and VO2max adjusted for age and baseline values; Fat, saturated fat and cholesterol adjusted for 
baseline values)  
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Table 6.4.  Baseline Values and Changes in Body Fat, Physical Activity, Physical Fitness, Dietary Fat, Saturated Fat and Cholesterol 
Intake in Women With and Without Metabolic Syndrome.+ 
 
With Metabolic Syndrome  
    Baseline  ∆ Control  ∆ Diet   ∆ Exercise            ∆ Diet plus  
                Exercise 
N     39   9   9   9    12 
Body Fat (%)    34.0 ± 0.77    2.3 ± 1.54             -0.6 ± 1.40  -0.7 ± 1.25   -2.0 ± 1.08 
Physical Activity Score   21.2 ± 3.08  31.7 ± 19.87    3.8 ± 8.47*  32.3 ± 17.57   16.6 ± 5.90  
VO2max (mL/kg/min)   24.5 ± 0.61   -1.5 ± 1.35    2.0 ± 2.63    2.0 ± 1.15     3.6 ± 0.67* 
Fat (% of total intake)   29.9 ± 1.24    0.6 ± 2.18   -4.2 ± 2.33*   -0.7 ± 1.59    -8.7 ± 2.00* 
Saturated Fat (% of total intake)    9.8 ± 0.53    0.3 ± 0.91   -1.2 ± 0.92   -0.4 ± 0.74    -3.3 ± 0.70* 
Cholesterol intake (mg)             176.9 ± 11.15  10.5 ± 25.86            -73.2 ± 21.99*   -4.6 ± 27.37  -40.9 ± 20.33* 
 
Without Metabolic Syndrome  
    Baseline  ∆ Control  ∆ Diet   ∆ Exercise            ∆ Diet plus 
                Exercise 
N      86   25   23   19   19 
Body Fat (%)     31.1 ± 0.55   1.1 ± 0.64  -1.7 ± 0.94*    0.6 ± 0.92   -2.1 ± 1.20* 
Physical Activity Score    24.4 ± 2.86   7.2 ± 6.37    1.7 ± 2.50  10.5 ± 4.95    8.6 ± 10.32 
VO2max (mL/kg/min)    26.7 ± 0.53  -0.9 ± 0.42  0.02 ± 0.53    2.2 ± 0.78*    3.4 ± 1.04* 
Fat (% of total intake)    27.3 ± 0.75  -0.1 ± 1.33   -6.6 ± 1.58*    2.3 ± 1.46   -8.5 ± 1.39* 
Saturated Fat (% of total intake)     8.6 ± 0.29  0.04 ± 0.54   -2.7 ± 0.61*    0.5 ± 0.77   -3.2 ± 0.58* 
Cholesterol intake (mg)  168.9 ± 8.75    6.3 ± 18.96            -64.8 ± 15.51*  20.5 ± 22.08            -68.4 ± 14.17* 
____________________________________________________________________________________________________________ 
Adapted from Stefanick et al., 1998 
+ Means ± standard error 
* p < 0.05 for the change in the variable between intervention group and control group  
(Change in body fat, physical activity and VO2max adjusted for age and baseline values; Fat, saturated fat and cholesterol adjusted for 
baseline values) 
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CRP Changes in Men and Women With Metabolic Syndrome 
CRP changes between intervention groups  
No significant differences existed for CRP changes between intervention groups 
in the men with metabolic syndrome (p = 0.77) (Figure 6.2).  Differences for the change 
in CRP were found between intervention groups in women with metabolic syndrome (p < 
0.01) (Figure 6.3).  Women with metabolic syndrome had differences for the CRP change 
between the diet versus control group (-1.2 ± 0.43 mg/L; p = 0.009) as well as the diet 
plus exercise versus control group (-1.3 ± 0.43 mg/L; p = 0.006).  Women with metabolic 
syndrome in the diet plus exercise group also had differences in the CRP change when 
compared to exercise alone (-1.1 ± 0.44 mg/L; p = 0.02).   
CRP changes within intervention groups 
 
 For men with metabolic syndrome, the CRP changes from baseline within the 
dietary, exercise, or diet plus exercise groups from baseline to follow-up were not 
significant.  In women with metabolic syndrome, only the change in CRP from baseline 
within the diet plus exercise group was significant (∆ log CRP 0.2 ± 0.039 mg/L; 
p=0.0008). 
 Removing the change in body fat as a covariate did not alter the significance 
between or within intervention groups for the response in CRP in either men or women 





























Figure 6.2.  Change in CRP for men with metabolic syndrome (n = 47).  Adjusted means 
± standard error are shown for CRP changes from baseline to follow-up.  ANCOVA 
statistical comparisons between intervention groups adjusted for the following covariates:  
baseline CRP, baseline body fat percentage, cohort, change in body fat, cigarettes per 
day, alcoholic drinks per day, and age. No differences existed for the change in CRP 




































† significant difference in CRP change between intervention groups 
‡ significant reduction in CRP from baseline to follow-up within intervention group  
 
Figure 6.3. Change in CRP for women with metabolic syndrome (n = 39).  Adjusted 
means ± standard error are shown for CRP changes from baseline and follow-up.  
ANCOVA statistical comparisons between intervention groups adjusted for the following 
covariates:  baseline CRP, baseline body fat percentage, cohort, change in body fat, 
cigarettes per day, alcoholic drinks per day, age and HRT.  CRP changes were different 
between the control and diet groups (p = 0.009), control and diet plus exercise groups (p 
= 0.006) and exercise and diet plus exercise groups (p = 0.02).  CRP was reduced from 




















CRP Changes in Men and Women Without Metabolic Syndrome 
 
CRP changes between intervention groups  
 
No significant differences were found for the CRP changes between intervention 
groups in the men without metabolic syndrome (p = 0.79) (Figure 6.4) or women without 
metabolic syndrome (p = 0.31) (Figure 6.5).   
CRP changes within intervention groups  
 
In men without metabolic syndrome, the diet group showed a reduction in CRP 
from baseline to follow-up (∆ log CRP: 0.1 ± 0.045 mg/L; p = 0.03).  For women without 
metabolic syndrome, reductions in CRP from baseline to follow-up were significant 
within the diet plus exercise group (∆ log CRP: 0.1 ± 0.054 mg/L; p = 0.02). 
Removing the change in body fat as a covariate did not alter the significance 



































‡ significant reduction in CRP from baseline to follow-up within intervention group  
 
Figure 6.4. Change in CRP for men without metabolic syndrome (n = 102).  Adjusted 
means ± standard error are shown for CRP changes from baseline to follow-up.  
ANCOVA statistical comparisons between intervention groups adjusted for the following 
covariates:  baseline CRP, baseline body fat percentage, cohort, change in body fat, 
cigarettes per day, alcoholic drinks per day, and age.  No differences existed for the 
change in CRP between intervention groups for the men without metabolic syndrome.  
CRP change from baseline in men without metabolic syndrome was significant within the 































‡ significant reduction in CRP from baseline to follow-up within intervention group  
 
Figure 6.5.  Change in CRP in women without metabolic syndrome (n = 86).  Adjusted 
means ± standard error are shown for CRP changes from baseline to follow-up.  
ANCOVA statistical comparisons between intervention groups adjusted for the following 
covariates:  baseline CRP, baseline body fat percentage, cohort, change in body fat, 
cigarettes per day, alcoholic drinks per day, age and HRT.  No differences existed 
between intervention groups for the changes in CRP in women without metabolic 
syndrome.  CRP was reduced from baseline within the diet plus exercise group (p = 0.02) 






















 To our knowledge, this is the first paper to explore CRP changes in a low-fat diet 
and/or exercise intervention in men and postmenopausal women with and without the 
metabolic syndrome.  When compared to the control group, women with metabolic 
syndrome had significant reductions in CRP for the low-fat diet and diet plus exercise 
group.  In addition, women with metabolic syndrome had significant reductions for CRP 
in diet plus exercise when compared to the exercise group.  In men with metabolic 
syndrome, no differences were found between CRP changes for control, low-fat diet, 
exercise and diet plus exercise.  For both men and women without metabolic syndrome, 
no significant changes in CRP were found between the intervention and control 
conditions.   
Explanations for why we only found significant results in women with metabolic 
syndrome may be due to their elevated baseline CRP values.  In the present study, 
women with metabolic syndrome had significantly higher CRP levels than women 
without metabolic syndrome at baseline.  Some low-fat diet and exercise interventions 
have found decreased CRP levels only in individuals who initially had elevated levels of 
CRP at baseline (Goldhammer et al., 2005; Lakka et al., 2005; Seshadri et al., 2004).  
CRP levels in men with metabolic syndrome were not significantly elevated above their 
healthy counterparts, which may have weakened the CRP response to low-fat diet and/or 
exercise.  Future studies are needed to clarify whether the significant CRP reductions 
were an influence of gender or a result of higher baseline values. 
Women with metabolic syndrome reduced their CRP levels with low-fat diet and 
diet plus exercise, however, no differences were found between these two groups.  In 
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addition, no independent effects for exercise on CRP were found.  These results suggest 
that low-fat diet may be the most important component for reducing CRP levels in 
women with metabolic syndrome.  Our findings are supported by work from Nicklas et 
al., who also found significant reductions for CRP from low-fat diet and diet plus 
exercise, but not from exercise (2004).  However, Nicklas et al., involved a group of 
elderly, arthritic, obese adults with purposeful weight loss (2004).  Thus our study is the 
first to confirm the benefits of low-fat diet alone and in combination with exercise, while 
controlling for the change in body fat, on CRP levels in individuals with the metabolic 
syndrome.   
The independent success of low-fat diet was also confirmed in a study of 
dyslipidemic adults (Jenkins et al., 2005), though a portfolio diet was utilized 
(combination of cholesterol lowering foods: viscous fibers, plant sterols, soy foods and 
almonds), making it difficult to distinguish the successful factor or factors.  Our null 
findings for the independent changes in CRP from exercise training in comparison to 
control are confirmed by Huffman et al., who also studied the CRP response in 
dyslipidemic adults (Huffman et al., 2006).  Our study supports previous low-fat diet and 
exercise work in dyslipidemic adults, while translating these findings to individuals with 
multiple metabolic and lipid abnormalities.    
Combined diet and exercise interventions show decreases in CRP in insulin 
resistant adults (Haffner et al., 2005), women with multiple cardiovascular risk factors 
(Wegge et al., 2004) and in adults with metabolic syndrome (Esposito et al., 2004).  
However, several diet plus exercise interventions also incorporated weight loss (Haffner 
et al., 2005; Esposito et al., 2004) which has been suggested as the most important 
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contributor for changes in CRP for a combined intervention (Haffner et al., 2005).  Even 
after controlling for changes in body fat (Esposito et al., 2004) or allowing ad-libitum 
dietary consumption (Wegge et al., 2004; Roberts et al., 2006), CRP reductions were still 
significant within the diet plus exercise group which is consistent with our research.   
In contrast to our findings in individuals without metabolic syndrome, evidence 
for CRP changes in healthy men and women have shown positive effects from a low-fat 
diet (Clifton et al., 2005; Heilbronn et al., 2001; O'Brien et al., 2005; Tchernof et al., 
2002), exercise (Mattusch et al., 2000; Obisesan et al., 2004; Okita et al., 2004) and diet 
plus exercise (Dvorakova-Lorenzova et al., 2006; Esposito et al., 2003; Marfella et al., 
2004; Nicklas et al., 2004; You et al., 2004).  However, Lakka et al., found that only 
healthy adults with initially high CRP values were able to lower their CRP with exercise 
and weight loss (Lakka et al., 2005).  Since our individuals without metabolic syndrome 
did not have an overall elevated mean, and the intervention did not emphasize weight 
loss, there may not have been the appropriate stimulus for CRP change.  In order to 
clarify the ideal treatment for lowering CRP in individuals with and without metabolic 
syndrome, future studies should clarify the added effect of weight loss, and more 
specifically fat loss, with low-fat diet and exercise.   
The underlying physiological mechanisms to explain the reduction of CRP 
through low-fat diet and exercise remain unknown.  Low-fat meals may increase intake 
of naturally anti-inflammatory foods (Middleton E Jr, 1998) and limit the postprandial 
glucose response (McCarty, 2005).  These alterations may inhibit the cytokine release 
into the bloodstream (McCarty, 2005) and CRP release from the endothelium (De, Liao, 
& Libby, 2000).  Increased physical activity increases the release of IL-6, which initiates 
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a negative feedback loop for secretion of anti-inflammatory cytokines (Pedersen, 2006; 
Petersen et al., 2005).  Future studies are needed to uncover the biological mechanisms to 
explain the additive effects of low-fat diet and exercise for the changes in CRP for 
individuals with metabolic syndrome. 
 Limitations of the present study include a highly educated, highly motivated, and 
mostly Caucasian group of men and postmenopausal women which limits overall 
generalizability.  The statistical analysis to determine differences in CRP between 
intervention groups for individuals with metabolic syndrome had a reduced sample size, 
which may have reduced statistical power.  Therefore, although significant findings were 
found, these analyses were exploratory, and further study is warranted. 
 In conclusion, men with metabolic syndrome showed no changes in CRP levels 
within and between control, diet, exercise and diet plus exercise.  In contrast, women 
with metabolic syndrome successfully reduced CRP levels with low-fat diet and diet plus 
exercise programs in comparison to control.  Men and women without metabolic 




















Summary, Conclusions and Future Directions 
 
 Few randomized controlled clinical trials have compared the response of a low-fat 
diet and increased physical activity, on CRP and metabolic syndrome.  In this 
dissertation, we compared:  1) the effects of a low-fat diet and exercise, alone and in 
combination, on CRP levels in a high risk adult population, 2) the effects of a low-fat diet 
and exercise, alone and in combination, on metabolic syndrome, and 3) the changes in 
CRP in men and women with and without metabolic syndrome in response to a low-fat 
diet and/or exercise.  This chapter serves as an executive summary of the findings from 
all three studies with recommendations for future research. 
 
Comparisons Between Low-Fat Diet, Exercise and Diet Plus Exercise on CRP 
 In postmenopausal women, CRP was significantly reduced within the low-fat diet 
plus exercise from baseline (∆ log CRP 0.2 ± 0.035 mg/L; p = 0.0002).  The change in 
CRP for the diet plus exercise group was significantly different in comparison to the 
control group (-0.7 ± 0.33 mg/L, p = 0.04) and the exercise group (-0.9 ± 0.32 mg/L, p = 
0.004).  The independent effects of low-fat diet alone and exercise alone, while 
controlling for the change in body fat, appear to be ineffective for lowering CRP levels in 
women.  Men did not show differences for CRP between control, diet, exercise or diet 
plus exercise.   
 This dissertation provides evidence for the combination of diet plus exercise 
changes, in order to reduce CRP in postmenopausal women.  Future studies are also 
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needed to elucidate the response of CRP to lifestyle intervention in men and explore 
possible biological mechanisms to explain the possible gender discrepancy.     
 
Comparisons Between Low-Fat Diet, Exercise and Diet Plus Exercise on Metabolic 
Syndrome 
 
 No differences were found in metabolic syndrome prevalence between control, 
low-fat diet, exercise and diet plus exercise in either men or postmenopausal women.  
There were also no differences between intervention groups for the change in number of 
abnormal cardiometabolic risk factors in either men or women.  Despite the null findings 
between groups, there were:  1) significant net reductions for metabolic syndrome 
prevalence from baseline within the diet plus exercise group in men (-57%), 2) significant 
net reductions for metabolic syndrome prevalence within the diet group in women (-
76%), 3) decreases in the number of abnormal risk factors within the diet, exercise and 
diet plus exercise groups in both men and women.   
This dissertation clarifies recommendations from the NCEP for treating metabolic 
syndrome.  Our research implies that after controlling for the changes in body fat, there 
are no differences between control, diet, exercise and diet plus exercise for reversing 
metabolic syndrome in men and women.  Low-fat dietary patterns such as the DASH and 
Mediterranean diet need to replicate findings for reversal of metabolic syndrome without 
concurrent weight loss.  Future studies should continue to explore the effect of varying 
dose of physical activity on metabolic syndrome (Johnson et al., 2007).  Further research 
is needed to identify the ideal combination of lifestyle treatment for reversing metabolic 
syndrome.       
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Comparisons Between Low-Fat Diet, Exercise and Diet Plus Exercise on CRP in Adults 
with and without Metabolic Syndrome 
 
 To our knowledge, this is the first paper to explore CRP changes in a low-fat diet 
and/or exercise intervention in men and postmenopausal women with and without 
metabolic syndrome.  In women with the metabolic syndrome, the change from baseline 
to follow-up CRP within the diet plus exercise group was significant (∆ log CRP 0.2 ± 
0.039 mg/L; p=0.0008).  The difference between the change in CRP between the diet plus 
exercise group and control group was significant (-1.3 ± 0.43 mg/L; p = 0.006), as well as 
between the diet plus exercise group and exercise only group (-1.1 ± 0.44 mg/L; p = 
0.02).  Finally, women with metabolic syndrome had a significant difference for the 
change in CRP between the low-fat diet and control groups (-1.2 ± 0.43 mg/L; p = 0.009).  
Our study confirms the benefits of low-fat diet alone and in combination with exercise, in 
women with metabolic syndrome.   
 For men with metabolic syndrome, CRP changes were not different between 
control, low-fat diet, exercise and diet plus exercise.  Furthermore, in both men and 
women without metabolic syndrome, no significant changes in CRP were found between 
any of the intervention and control conditions.   
Replication of these findings is needed to explain whether the significant CRP 
reductions were an influence of metabolic syndrome, gender or a result of higher baseline 
CRP values.   
 
In summary, this dissertation describes the change of CRP and metabolic 
syndrome prevalence utilizing a randomized controlled trial of low-fat diet, exercise and 
diet plus exercise.  Weight loss was not a major intervention focus, and all changes in 
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body fat were controlled for in the statistical analysis, eliminating a known influence on 
both CRP and metabolic syndrome.  All analyses were gender stratified in order to 
characterize the results from low-fat diet and exercise independently in men and women.  
Finally, changes in CRP from lifestyle interventions were characterized separately in 
adults with and without the presence of metabolic syndrome.  This dissertation provides 
evidence for the effectiveness of diet and diet plus exercise for reducing CRP in women 

































Appendix I:  Definitions of Common Terms 
Body Composition:  Body composition refers to a component of fitness that relates to the 
proportion of metabolically active and inactive tissues of the body which may include 
muscle, adipose tissue, bone and fluids. 
 
Exercise:  Exercise is a term used to describe a planned and structured approach to 
repetitive bodily movement done to improve or maintain components of physical fitness.  
 
Intervention:  Intervention studies are research in which subjects are enrolled into a 
specific exercise program, measured at baseline and then at follow-up to ascertain the 
changes in various variables. 
 
MET:  A MET indicates a unit of resting metabolic rate and is an indication of exercise 
intensity (1-3 – light; 4-6 – moderate; 6+ - heavy) (Pate et al., 1995). 
 
Physical Activity:  Physical activity will be operationally defined as “any bodily 
movement produced by skeletal muscle that results in energy expenditure” (pg. 126) 
(Caspersen, Powell, & Christenson, 1985).  Physical activity is a complex behavior that 
can be categorized into many subgroups including formal, informal, planned, unplanned, 
voluntary or involuntary.  Physical activity is usually characterized in an “amount” of 
frequency, intensity and duration of activity.  Frequency refers to the number of times the 
activity is performed while duration is the total amount of time in a specified time period.   
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Examples of intensity for physical activity can be described as light, moderate and/or 
vigorous.  Physical activity can also be stratified into types including but not limited to 
leisure time, housework/yardwork, work-related.       
 
Physical Fitness:  Physical fitness is a set of attributes that people have or achieve that 
relate to the ability to perform physical activity (Caspersen et al., 1985).  Being 
physically fit is defined as “the ability to carry out daily tasks with vigor and alertness 
without undue fatigue and with ample energy to enjoy leisure time pursuits and to meet 
unforeseen emergencies” (1971).  Physical fitness can be thought of an objective and 
current assessment of physical activity levels.  Physical fitness health-related components 
include cardiorespiratory aerobic endurance, muscular strength, muscular endurance, 
flexibility and body composition.  
 
VO2max:  Cardiorespiratory endurance is a specific component of physical fitness that 
relates to the ability of the circulatory and respiratory systems to supply fuel during 
sustained physical activity.  The volume of oxygen utilized by various body tissues per 
unit of time will be referred to as VO2max.  Ideally, VO2max is measured by a treadmill 







Appendix II:  Limitations of the Study 
 
 
1. This dissertation was a secondary and retrospective data analysis.  The original 
DEER study was not designed for the outcomes for CRP change or metabolic 
syndrome prevalence. 
2. The diet protocol from DEER has been updated by the National Cholesterol 
Education Program in 2001 to: 
• 25-35% total fat per day of total caloric intake 
• < 7% saturated fat per day of total caloric intake 
• < 200 mg/day cholesterol 
• 50-60% carbohydrate intake of total caloric intake 
• 20-30g/day fiber 
• ~ 15% protein intake of total caloric intake 
3. Baseline values for CRP and metabolic syndrome prevalence were lower than 
expected which reduced statistical power to examine differences between 
groups. 
4. Participants were limited to the Stanford University area of Palo Alto, California  
 which included a high socioeconomic status, mostly Caucasian and highly  
 educated study sample.   
5. All study participants had to meet the study inclusion criteria: be between the ages 
of 30 and 64 years for men; and 45 and 64 years for postmenopausal women.  
All participants had high LDL between 126-189 mg/dL for men, and between 
126-209 mg/dL for women.  All participants also had low HDL below 45 
mg/dL for men and below 60 mg/dL for women.  All participants were non-
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diabetic and without any history of cardiovascular disease, cancer or any other 
medical conditions.  Finally, none of the participants were on any lipid lowering 
medications. Therefore, the study results may not be generalizable to a wider 
population. 
6. Due to the different eligibility criteria, statistical analyses were stratified by 
gender.  It is possible that statistical power was reduced from a lower sample 
size. 
7. Participants in the control group were specifically asked not to change their 
exercise or dietary habits for a year.  While baseline and follow-up measures 
were taken to assess their compliance, it is important to note that these 
individuals could have already possessed active and healthy eating lifestyles. 
8. In order to assess change in body composition, body fat and body fat change was 
assessed using skinfold measures.  It is widely recognized that DEXA is the 
current gold standard for body composition measurement.  Percent body fat 
was included as a covariate for all analyses. 
9. Women were all postmenopausal and 45% were on HRT.  HRT is no longer a 
recommended course of treatment, however, to control for any differences for 
CRP or metabolic syndrome, HRT was included as a covariate in all analyses.
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Appendix III:  Body Fat Changes Between Intervention Groups (mean ± SE) 
 
 
Men    Control  Diet   Exercise  Diet plus Exercise 
Baseline Body Fat (%) 21.1 ± 0.63  21.3 ± 0.72  22.3 ± 0.84  21.6 ± 0.64 
Follow-up Body Fat (%) 21.6 ± 0.69  19.8 ± 0.71  21.8 ± 0.91  19.7 ± 0.72 
Body Fat Change (%)     0.5 ± 3.38  -1.5 ± 3.45*   -0.5 ± 3.96            -1.96 ± 3.33*+ 
 
Women   Control  Diet   Exercise  Diet plus Exercise 
Baseline Body Fat (%) 31.7 ± 0.96  31.8 ± 0.83  31.6 ± 0.94  32.8 ± 0.87 
Follow-up Body Fat (%) 33.2 ± 0.99  30.5 ± 0.92  32.0 ± 1.04   30.6 ± 0.99 
Body Fat Change (%)    1.5 ± 3.60  -1.3 ± 4.31*    0.4 ± 3.92   -2.2 ± 4.59+ # 
______________________________________________________________________________________________ 
* significantly different from control 
+ significantly different from exercise 

















Appendix IV:  Unadjusted CRP levels (mg/L)* at Baseline and Follow-up in Men and Women 
___________________________________________________________________________________________ 
Men (n=149) 
    Control  Diet   Exercise  Diet plus Exercise 
n    33   39   35   42 
CRP baseline   1.4 ± 1.47  1.0 ± 1.16  1.3 ± 1.26  1.4 ± 1.34 
CRP follow-up   1.3 ± 1.09  1.0 ± 1.01  1.2 ± 1.60  1.1 ± 1.02 
CRP change             -0.1 ± 1.71           -0.04 ± 0.66           -0.1 ± 1.21            -0.3 ± 1.32 
____________________________________________________________________________________________ 
Women (n=129) 
    Control  Diet   Exercise  Diet plus Exercise 
n    34   32   30   33 
CRP baseline   2.2 ± 2.24  1.8 ± 1.56  1.9 ± 1.56  2.0 ± 1.80 
CRP follow-up   2.1 ± 1.53  1.6 ± 1.32  2.2 ± 2.17  1.3 ± 1.00 
CRP change            -0.1 ± 1.88             -0.2 ± 1.04  0.3 ± 1.47            -0.7 ± 1.33 
_____________________________________________________________________________________________________________________ 
















Appendix V:  Frequencies of CRP Risk Categories* Between Intervention Groups in Men and Women  
 
________________________________________________________________________________________________ 
Men (n=149)   Control  Diet   Exercise  Diet plus Exericse 
    Baseline       Follow-up     Baseline       Follow-up     Baseline       Follow-up     Baseline       Follow-up                  
High Risk n(%)    3(9)           3(9)   2(5)           1(3)   5(14)           2(6)   5(12)           3(7) 
Low Risk n(%)  30(91)       30(91) 37(95)       38(97) 30(85)         33(94) 37(88)         39(93) 
 
Women (n=129)  Control  Diet   Exercise  Diet plus Exericse 
     Baseline       Follow-up    Baseline       Follow-up     Baseline       Follow-up     Baseline       Follow-up                  
High Risk n(%)    9(26)         9(26)   6(19)           3(9)    5(17)        7(23)   5(14)           3(8) 
Low Risk n(%)  25(74)       25(74) 26(81)         29(91)   25(83)     23(77) 28(85)          30(91) 
_________________________________________________________________________________________________ 
*High Risk CRP > 3 mg/L;  Low Risk CRP ≤ 3 mg/L (Myers et al., 2004) 
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Appendix VI:  Metabolic Syndrome Prevalence Changes in Men and Women 
 



















































































Appendix VII:  Unadjusted Mean CRP levels (mg/L)* in Men and Women With and Without Metabolic Syndrome  
 
Men:  Metabolic Syndrome 
    Total   Control  Diet   Exercise           Diet + Exercise 
n   47   9   13   11   14 
CRP baseline  1.5 ± 1.43        1.8 ± 1.57  0.8 ± 0.29  1.6 ± 1.46  1.9 ± 1.74 
CRP follow-up  1.4 ± 1.62  1.4 ± 1.24  1.0 ± 0.57  1.7 ± 2.53  1.5 ± 1.43 
CRP change            -0.1 ± 1.46            -0.3 ± 1.67   0.2 ± 0.58  0.1 ± 1.80            -0.3 ± 1.66 
______________________________________________________________________________________________________ 
Without Metabolic Syndrome 
Total   Control  Diet   Exercise           Diet + Exercise 
n   102   24   26   24   28 
CRP baseline  1.2 ± 1.24      1.3 ± 1.44  1.1 ± 1.40  1.1 ± 1.11  1.2 ± 1.05 
CRP follow-up  1.0 ± 0.92  1.2 ± 1.05  1.0 ± 1.24  1.0 ± 0.58  1.0 ± 0.71 
CRP change           -0.1 ± 1.15         -0.03 ± 1.75             -0.2 ± 0.67            -0.2 ± 0.85            -0.2 ± 1.14 
 
Women: Metabolic Syndrome 
Total   Control  Diet   Exercise           Diet + Exercise 
n   39   9   9   9   12 
CRP baseline  2.4 ± 1.67    2.6 ± 1.75  2.3 ± 1.82  2.2 ± 2.02  2.4 ± 1.40 
CRP follow-up  2.0 ± 1.39        3.0 ± 1.78  1.5 ± 0.72  2.2 ± 1.61  1.6 ± 0.90 
CRP change            -0.4 ± 1.10  0.4 ± 0.86            -0.8 ± 1.32          -0.04 ± 0.92            -0.8 ± 0.88 
______________________________________________________________________________________________________ 
Without Metabolic Syndrome 
Total   Control  Diet   Exercise           Diet + Exercise 
n   86   25   23   19   19 
CRP baseline  1.7 ± 1.87     2.0 ± 2.41  1.6 ± 1.45  1.6 ± 1.35  1.7 ± 2.08 
CRP follow-up  1.6 ± 1.54  1.7 ± 1.29  1.6 ± 1.50  2.0 ± 2.15  1.1 ± 1.09 
CRP change            -0.1 ± 1.60            -0.3 ± 2.12           0.01 ± 0.82  0.3 ± 1.46            -0.6 ± 1.62 
______________________________________________________________________________________________________________________________________ 
* means ± standard deviation 
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